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Summary 
The ontogeny of immunity in the honey bee, Apis mellifera L. 
Alice M. Laughton 
This thesis examines the ontogenetic development of the honey bee immune 
system in an ecological immunity context. I have optimised established 
immunological techniques to examine how aspects of the constitutive and 
induced innate immune response in the honey bee, Apis mel/if era L., are 
affected by life-history and parasite infection. I have used three optimised 
immune assays to gain a measure of the timing and magnitude of specific 
immune effector systems in the honey bee, and explored the consequences of 
variation in immune efficacy throughout development and aging. The major 
findings of this thesis are: 
1. Neither workers or drones employ phenoloxidase for immune defence 
in the pre-pupal stages 
2. Sexual selection does not eliminate the need for an immune response 
in adult drones 
3. In both sexes, there is an ontogenetic up-regulation in immune 
function with adult age 
4. In the case of workers, this increase in immune response is not linked 
to age polyethism, but rather a continuous increase in investment 
beginning immediately after adult eclosion 
5. Immune challenge results in a decrease in phenoloxidase activity, 
and an increase in antimicrobial peptide production in adults 
6. The antimicrobial peptide immune response shows signs of 
senescence in immune challenged adult workers and drones 
7. Colony investment in immune responses acts on a temporal scale 
and responds positively to an increased threat of parasitism 
8. Parasitism produces variation in colony defence strategies 
9. Rainfall is an important factor in the successful establishment of an 
infestation by the varroa mite, ValTOa destructor, in honey bees. 
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Chapter 1 
Introduction 
The risk of infection by, and interaction with, pathogens has resulted in the 
evolution of an immune system in insects. Despite not possessing the acquired 
immune system of vertebrates, insects have a well-developed innate immune 
system, which can be used as a model to investigate the generic function of 
innate immunity without the conceptual and practical difficulties of a tightly 
linked and complex acquired system. 
Understanding the insect immune system is important in its own right due 
to their role in economic (the ecological services provided by insects are valued 
at $60 billion p.a. in the USA, Losey & Vaughan, 2006) and world health issues 
(as vectors of disease; each year 500 million people are affected by malaria, 
WHO). In addition, insects are easy to rear and have much shorter generation 
times than vertebrates, and so allow the investigation of evolutionary and 
ecological issues within relatively short timescales. Studying the immune 
profiles of different sexes throughout their lifetime addresses theory on 
developmental trade-offs (Nylin & Gotthard, 1998), sexual selection (Andersson 
& Iwasa, 1996) and senescence (Kirkwood & Rose, 1991). 
The honey bee, Apis mellifera, has great economic value. There are 
approximately 300 commercial crops grown worldwide, 84% of which are reliant 
on insect pollination, with honey bees commonly the main pollinator (Allsopp et 
al., 2008). In the USA alone, the economic value of the honey bee has been 
estimated at $14.6 billion p.a., yet honey bees are currently under threat from 
Colony Collapse Disorder (Stokstad, 2007). This thesis establishes a basis from 
which to approach the issues concerning bee health and presents the honey 
bee as an excellent study system with which to investigate immunity theory in a 
social insect. Moreover, it is one of the first longitudinal studies of the ontogeny 
of immunity in an economically important insect that also explores the 
consequences of variation in immune efficacy throughout development and 
aging. 
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1.1 A background to immunity 
1.1.1 Parasite-mediated sexual selection 
Parasite-mediated sexual selection theory was proposed by Hamilton and Zuk 
(1982) based on their findings in North American passerines that females chose 
mates with the brightest plumage, and that these males also had a higher 
resistance to parasite infection. Following this, the hypothesis assumes that 
1. Females choose mates based on secondary sexual characteristics 
2. Expression of these traits is limited by parasitic infection 
3. By preferentially choosing a male with the most elaborate trait, 
females select for parasite resistance in their offspring 
4. Heritable variation in immunity is maintained by host-parasite 
coevolution (Hamilton & Zuk, 1982). 
Two predictions arise from this hypothesis. The intra-specific prediction 
assumes that females should select mates with the most elaborate traits, and 
that these males have lower levels of parasite infection than their less showy 
competitors. Females benefit from their choice by gaining good genes for 
parasite resistance for their offspring. The inter-specific prediction states that 
there should be a correlation between the level of trait elaboration and parasite 
load across species. Both of these predictions have been tested and provide 
mixed empirical support for the hypothesis (e.g. Zuk at a/., 1990; Saino & 
Moller, 1996; Hamilton & Poulin, 1997; Mf2IlIer at al., 1999). However, Mf2IlIer et 
al. (1999) found a strong correlation between secondary sexual traits and host 
immune function (as opposed to parasite load). They proposed that as hosts 
are subject to a range of parasites throughout their life, it is unlikely that the 
selection for investment in secondary sexual characteristics relies on the 
prevalence of a single parasite species, and that measuring host immunity 
would in fact provide a clearer understanding of parasite-mediated sexual 
selection (Mf2IlIer at a/., 1999). 
Subsequent to Hamilton and Zuk's theory, Folstad & Karter (1992) 
proposed the immunocompetence handicap hypothesis (ICHH) to explain the 
mechanistic link between epigamic sexual selection and immunity. 
Immunocompetence is an all-encompassing term referring to the ability of an 
individual's immune system to respond to parasites, and is known to be costly 
(Folstad & Karter, 1992; Siva-Jothy at al., 1998; Barnes et al., 2000; Moret & 
Schmid-Hempel, 2000; Armitage at al., 2003). The theory is based on the 
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proposal that testosterone has a dual role in sexual selection, stimulating the 
development of secondary sexual traits, whilst simultaneously suppressing 
immune function (Folstad & Karter, 1992). However there is mixed empirical 
evidence to support this hypothesis (Roberts et al., 2004). Although 
testosterone is a hormone restricted to vertebrates, research on insects has 
shown some support for the predictions of the ICHH (Ryder & Siva-Jothy, 2000; 
Siva-Jothy, 2000), although alternative hypothesis offer equally valid 
explanations of this relationship (Siva-Jothy, 2000; Rolff, 2002). 
1.1.2 The cost of an immune response 
Central to the relationship of immunity and parasite-mediated sexual selection is 
the assumption that parasites have a fitness cost (Sheldon & Verhulst, 1996). 
Evolutionary ecology assumes that all organisms have a finite level of resources 
that must be allocated across various life history traits in order to maximise 
fitness. Maintaining an immune response is one such cost (Schmid-Hempel, 
2003). Nutrient resources, reproduction, and levels of metabolic activity have all 
been found to affect the level of investment in an insect's immune response 
(Jacot et al., 2005; Boots & Began, 1993; Adamo et al., 2001; Hosken, 2001; 
McVean et al., 2002; K(:)nig & Schmid-Hempel, 1995; Doums & Schmid-
Hempel, 2000). Whilst maintaining and displaying immune resistance to 
infection can be detrimental to other characteristics, Similarly strong selection 
for other fitness-determining traits can be at the cost of an immune response 
(McKean et al., 2008). 
1.1.3 Gaining a measure of immunocompetence 
Typically a measure of the immunocompetence of an individual is gained 
through assaying one or two constituent parts of the immune response, but 
problems arise due to the lack of a clear definition of 'immunocompetence' and 
consequently there is no standardised method for measuring it. Assays should 
rely on general cellular or humoral immune responses to a standardised and 
novel immune challenge (Siva-Jothy, 1995). These measures are considered to 
be an indication of the overall immune ability, and a reflection of host fitness, 
but must be carefully considered in their interpretation (Ryder, 2003; Adamo, 
2004). Debate over whether phenoloxidase is a good measure of the immune 
response can be found in Chapter 6, Section 6.3.6. 
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1.1.4 Ecological Immunity 
The development of theoretical and empirical work into the costs of immunity, 
and how to measure it, has lead to the emergence of ecological immunity. The 
field seeks to examine immunity in a broader context, and understand the 
associated costs in relation to the constraints imposed by ecology and life 
history (Sheldon & Verhulst, 1996; Zuk & Stoehr, 2002; Rolff & Siva-Jothy, 
2003). These costs can be split into two types: 1) the evolutionary cost of 
developing immune defences, and 2) the physiological cost of maintaining them 
(Rolff & Siva-Jothy, 2003). The life history strategies involved in ecological 
immunity have been studied both theoretically and empirically, and provide a 
window into immunity in the context of 'real-world' (cf. laboratory) situations 
(e.g. Norris & Evans, 2000; Lochmi"er & Deerenberg, 2000; Zuk & Stoehr, 
2002; Rolff & Siva-Jothy, 2003). 
1.1.5 Ontogeny of immunity 
This thesis aims to investigate the ontogeny of immunity in insects, by which I 
mean the changes that occur in immune investment throughout an insect's life, 
incorporating development, adult selection pressures and aging. Mounting an 
immune response to infection during development results in lower growth rates 
and reduced viability (Boots & Begon, 1993; Freitak et a/., 2007; Eleftherianos 
et al., 2008). As insects develop into adults, the selection pressures acting on 
immunity change (Zuk & Stoehr, 2002, see Sections 3.1, 4.1 & 5.1), and the 
different life history strategies adopted by the sexes impact on immune 
investment. Bateman's principle states that males are selected to have high 
mating success whereas females gain fitness through longevity, which carries 
an associated risk of increased pathogen exposure (Bateman, 1948; Trivers, 
1972). Fo"owing this, males should be selected for lower immunity, which 
seems to be the case in insects (Rolff, 2002; Adamo et al., 2001; Hosken et a/., 
2001). However, whilst securing a successful mating by investing in sperm 
production or mating flights is vitally important for male fitness, surviving long 
enough to mate is also essential, and should be factored into hypothesis about 
immune investment. 
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1.2 Insect Immunity 
Insects are subject to a wide range of micro- and macro-parasites with a variety 
of infection modes (Ratcliffe & Rowley, 1987). Insects have responded by 
evolving an arsenal of defensive mechanisms, from behaviour to the 
development of innate immune responses. 
1.2.1 The innate immune system 
The mechanisms for detecting pathogens are largely unknown, but it is thought 
that haemocytes recognise invading pathogens either by direct interaction with 
surface receptors, or indirectly by recognition of receptors that bind to, and 
opsonize, the pathogen (Lavine & Strand, 2002). These receptors stimulate 
cascade responses and signalling pathways that produce an immune response. 
Figure 1.1 shows a schematic of the typical responses involved in the innate 
immune system. The innate immune system can be split into two response 
categories based on their temporal profiles: constitutive and induced (Schmid-
Hempel, 2005). Constitutive responses are mostly associated with the 
prophenoloxidase activating system and haemocyte (cellular) responses (see 
Sections 1.2.3 & 1.2.4.1), and whilst not maintained at a constant maximum, are 
present in the background without any prior challenge (Gillespie & Kanost, 
1997; Schimid-Hempel, 2005). They are unspecific but immediate in effect. On 
the other hand, induced responses only occur once the invading pathogen has 
been recognised. They are specific, more costly and take longer to produce 
(hours or days), but are longer lasting (Boman & Hultmark, 1987). 
The immune system in insects has 3 levels of response: the 
physicochemical barriers provided by the cuticle and gut, constitutive cellular 
responses that occur as soon as pathogens breach the physicochemical 
barriers, and the induced responses such as the production of antimicrobial 
peptides and Iysozymes, primarily in the fat body, which provide a more 
specifiC, long-lasting response (Gillespie & Kanost, 1997; Schmid-Hempel, 
2005). 
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Figure 1.1. Schematic of typical responses of the insect innate immune system 
following activation from different antigens (lipopolysaccharides, peptidoglycans 
and f3-1,3-glucans). Figure adapted from Tzou at al., 2002. 
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1.2.2 Physicochemical barriers 
The external cuticle is an effective protective barrier against direct attack. The 
rigid exoskeleton is covered in a secretion of wax and sclerotised with melanin 
(produced from the phenoloxidase activating system, see Section 1.2.4.1). To 
avoid having to penetrate the cuticle, many pathogens are transmitted by oral 
infection. In response to this, the fore- and hindgut and trachea are lined with 
tough chitinous membranes. The midgut, which lacks this defence, is instead 
lined with a peritrophic membrane, and mid-gut cells can be sloughed off if 
infected with a pathogen (Brooks et al., 2002). In addition, the gut represents a 
hostile environment as the proteolytic enzymes secreted to aid digestion can 
also cause pathogen breakdown (Schmid-Hempel, 2005). 
1.2.3 Cellular responses 
Haemocytes are utilised in a number of the innate immune responses including 
coagulation, phagocytosis, nodule formation and encapsulation, which are 
briefly described below. Haemocytes first develop during embryogenesis in the 
mesoderm, and are subsequently produced by division of stem cells or 
haemocytes already in circulation (Lavine & Strand, 2002). Several different 
types of haemocytes have been identified in insects, and up to eight different 
classes are distinguishable based on morphological, histochemical and 
functional characteristics (Lackie, 1988; Lavine & Strand, 2002). However, 
complications arise as not all types are found in all insects, and the function of 
the haemocyte types can change from species to species (Pech & Strand, 
1996). The immune function of some types remains unknown, but two classes, 
the plasmatocytes, and granular cells (granulocytes) are commonly involved in 
wound healing, phagocytosis, encapsulation and nodule formation (Lackie, 
1988; Lavine & Strand, 2002). Products from the prophenoloxidase activating 
system (ProPO-AS), which is a humoral response (see Section 1.2.4.1), have 
important roles in several of the cellular responses. This interaction and 
coordination between immune responses renders the division of the innate 
immune system into cellular and humoral responses somewhat arbitrary, but it 
will be organised as such here for clarity. 
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1.2.3.1 Coagulation 
Clotting is initiated as soon as the cuticle is broken and, in addition to 
preventing mass fluid loss from the insect, limits the spread of pathogens (Siva-
Jothy at al., 2005; Haine at al., 2007). Recognition of the wound initiates a 
proteolytic cascade to activate the clotting response. Two types of haemocyte 
are involved (granular cells and plasmatocytes), which disintegrate and form 
extracellular aggregates at the wound site. Activation of phenoloxidase 
produces melanin (see Section 1.2.4.1), which is laid down over the initial clot, 
causing it to harden (Theopold at al., 2004). 
1.2.3.2 Phagocytosis 
Phagocytosis is a multiple step process by which small particles can be 
removed from circulation by a specialised form of endocytosis (Gillespie & 
Kanost, 1997). Insect lectins (simple recognition molecules) mark the pathogen 
to be targeted for removal by the haemocytes (Bayne, 1990; Schmid-Hempel, 
2005). 
1.2.3.3 Nodule formation 
Multicellular aggregations of haemocytes that trap small pathogens such as 
bacteria, thereby neutralising them, are known as nodules (Lackie, 1988). The 
nodule is usually removed from circulation by adhering to tissue walls, or may 
be encapsulated. 
1.2.3.4 Encapsulation 
Encapsulation is initiated when invading pathogens are too large for 
phagocytosis or nodule formation, and can be used against a wide range of 
parasites such as nematodes, cestodes and insects, or against implanted 
tissues such as parasitoid eggs (Dunn, 1986; Lackie, 1988). There are two 
types of encapsulation reaction: cellular and melanotic (Gillespie & Kanost, 
1997). Melanotic encapsulation is associated with the prophenoloxidase 
activating system (Section 1.2.4.1) and occurs when melanin cross-links 
proteins to assemble a capsule around the pathogen (Kumar at al., 2003). 
Cellular encapsulation is the formation of a capsule by the overlapping of 
several layers of haemocytes, and is formed by a three-step process: granular 
cells adhere to the pathogen, which in turn causes layers of plasmatocyes to be 
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laid down. A final layer of granular cells indicates the capsule formation has 
finished (Pech & Strand, 1996). This response is the more complicated than the 
previous cellular responses due to the coordination needed in recruiting the 
different types of haemocytes (Gillespie & Kanost, 1997). 
1.2.4 Humoral responses 
Humoral responses refer to those that occur extracellularly. The activation of 
phenoloxidase, which occurs in the plasma, subsequently results in the 
production of melanin, a component used in many of the cellular immune 
responses. Other humoral responses involve complex pathways to produce 
antimicrobial peptides and agglutination factors, which are described below. 
1.2.4.1 Phenoloxidase 
The enzyme phenoloxidase (PO; monophenol, L-dopa:oxygen oxidoreductase, 
EC 1.14.18.1) is a major component of the fast acting constitutive part of the 
innate immune system, used in the defence against. and resistance to. parasite 
infections (see Ashida & Brey, 1998; Cerenius et al., 2008 for review). PO is 
widely distributed, being found in plants and fungi as well as animals (Mason, 
1955). In insects. PO has several important physiological roles. It is responsible 
for initiating the biosynthesis of the black pigment melanin. which is involved in 
cuticle sclerotisation. wound healing and defence responses such as nodule 
formation and encapsulation, and is associated with the stimulation of 
phagocytosis (Mason. 1955; Ratcliffe et al., 1984; Cerenius at al .. 2008). 
The prophenoloxidase-activating system (ProPO-AS) is a series of 
complex interactions between enzymes and their zymogens. the activation of 
which occurs in the plasma (Ashida & Brey, 1998). PO is highly active. 
catalysing the production of toxic byproducts, and is therefore generally stored 
as its inactive precursor, prophenoloxidase (ProPO), contained in haemocytes 
andlor plasma (Saul at al., 1987; Brehelin at al., 1989; Brookman et al., 1989). 
The activation of ProPO into PO through proteolysis occurs as part of a 
cascade triggered by miniscule amounts of microbial or fungal cell wall 
components (lipopolysaccharides (LPS). peptidoglycans or f3-1 .3-D-glucans) 
(Ratcliffe at al., 1984; S6derhall & Cerenius, 1998). Recognition molecules in 
the haemolymph respond to foreign particles as non-self and induce the 
activation of the ProPO-AS (see Figure 1.2). 
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The ProPO-AS can be split into 2 parts: 1) recognition reaction occurs 
between pathogen and pattern recognition proteins, 2) a signal triggered by 
pathogen invasion relays downstream to ProPO activating factors (Iwanaga & 
Lee, 2005). Once recognition of the immune challenge has occurred, a serine 
proteinase cascade mediates the activation of the prophenoloxidase activating 
enzyme (PPAE), which is itself stored in zymogen form. PPAE then lyses 
ProPO into PO. PO catalyses the oxidation of phenols into quinines, which 
subsequently polymerise to produce melanin (Cerenius & S()derh~lI, 2004). 
During the production of melanin many by-products and intermediates 
are formed, such as quinones, semiquinones, quinone methides and 
trihydroxyindoles (Riley, 1988; Hoffmann, 1995; Gillespie & Kanost, 1997). 
These can generate highly reactive oxygen species such as superoxide anions 
and hydroxyl radicals, whose cytotoxic effects may contribute to killing 
pathogens (Riley, 1988; Nappi at a/., 1995). These cytotoxic substances do not 
discriminate between self and non-self, and due to the nature of the open 
haemocoel in insects, could potentially attack the host (autoimmunity) (Nappi at 
a/., 1995; Nappi et a/., 2004). Recent research has focused on the regulation of 
the ProPO system through various mechanisms, including inhibitory serpins and 
quinine isomerases (Park at a/., 2000; De Gregorio et a/., 2002; Park at a/., 
2006; Sugumaran, 2002), and the pattern recognition proteins that initiate 
ProPO activation: these have been partially elucidated in several insects 
(Yoshida at a/., 1996; Ochiai & Ashida, 1999; Ma & Kanost, 2000; Cerenius at 
a/., 2008 (review». It is also thought that the melanin may act as a 'sink', 
preventing the cytotoxins from damaging the host tissues (Nappi & Vass, 1993; 
Carton & Nappi, 1997; Riley, 1997). 
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Figure 1.2. Schematic of the prophenolodixase-activating system (ProPO-AS) 
in arthropods, leading to the production of melanin (adapted from Cerenius & 
SOderhall, 2004). Miniscule amounts of microbial or fungal cell wall components 
can trigger the cascade. The activation of ProPO to PO is catalysed by the 
ProPO activating enzyme (PPAE), which is stored in zymogen form (Pro-
PPAE). Reactive phenols and oxide free radicals are produced during the 
process of melanin formation. 
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1.2.4.2 Antimicrobial peptides 
Antimicrobial peptides/polypeptides (AMPs) are synthesised in the fat body, a 
functional homologue of the mammalian liver, although some peptides such as 
lysozyme and defensin can also be produced in the haemocytes, gut cells, 
salivary gland cells and reproductive tract (Trenczek & Faye, 1988; Hoffmann et 
al., 1996; Gillespie & Kanost, 1997). AMPs work by disrupting the permeability 
of the pathogen membranes, causing lysis and death (Cociancich et al., 1993). 
Nearly 60 different AMPs have been identified, and are grouped into families 
based on structure and their specificity to different types of bacteria and fungi 
(Vilmos & Kurucz, 1998). 
Regulation of AMP gene expression in the fat body is through two signal 
transduction pathways: 1) the Toll pathway, which is activated by fungi and 
Gram-positive bacteria, and 2) the immune deficiency (Imd) pathway, mainly 
activated by Gram-negative bacteria (Hoffman et a/., 1996; Gillespie & Kanost, 
1997). Expression of the genes usually occurs within half an hour of an immune 
challenge. Transcription intensity peaks at 12 to 48 hours, after which time it 
decreases, although the effect of antibacterial peptides has been shown to last 
up to 14 days post challenge in bumble bees (Hoffman, 1995; Korner & 
Schmid-Hempel,2004). 
1.2.4.3 Other humoral responses 
The lectin-agglutination system: Lectins (also known as agglutinins) are 
defence molecules found in both haemocytes and plasma (Iwanaga & Lee, 
2005). In invertebrates, lectins are thought to have a role in non-self recognition, 
phagocytosis, and in the opsonization of invading pathogens by binding to their 
surfaces (Gillespie & Kanost, 1997; Wilson et a/., 1999). Many lectins have 
multiple binding sites, which allows for the agglutination activity of target cells 
(Gillespie & Kanost, 1997). 
Haemolin: Haemolin is an inducible haemolymph protein produced following an 
immune challenge with bacteria (Faye & Kanost, 1998). It is thought to have a 
role in immune recognition and modulation of defensive responses (Sun et a/., 
1990; Gillespie & Kanost, 1997). Haemolin can inhibit the aggregation of 
haemocytes, implying a function in the regulation of the adhesive properties of 
haemocytes during immune responses (Faye & Kanost, 1998). 
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1.3 Social insects and immunity 
Eusocial behaviour, as shown by the social insects (the social Hymenoptera 
plus termites) and some aphid, beetle and thrip species (Hughes et al., 2008) 
presents an opportunity to investigate the role of paraSitic selection on immunity 
in the context of group living. Sociality has many benefits compared to a solitary 
existence. Cooperative division of labour increases the efficiency of foraging, 
brood-care and anti-predator defence, allowing these species to become highly 
productive (Cremer at a/., 2007). However, group living comes at a cost. High 
host densities combined with the warm, resource-rich environment of the colony 
nest provides the perfect conditions for rapid pathogen proliferation (Schmid-
Hempel, 1998; Christe at a/., 2003). Social insects are particularly susceptible 
due to their high-density group living and constant social contact. Consequently, 
social insects have evolved mechanisms to limit the cost of parasitism. Through 
cooperation, colonies have developed a 'social immune system': altruistic 
behaviours of individuals or groups that benefit the colony as a whole (see 
Cremer at a/., 2007 for review). Some examples of this in bees include allo-
grooming to remove mites, inducing social fever to heat-kill infecting bacteria, 
and the hygieniC behaviour of workers to remove diseased brood (Starks et al., 
2000; Spivak & Boecking, 2001). 
Variation in physiological immune defences associated with increasing 
sociality is also possible. Density-dependent prophylactic immune responses, 
such as elevated levels of cuticular melanisation, are seen in several insect 
taxa, but to date has not been shown in a social insect (Barnes & Siva-Jothy, 
2000; Wilson at a/., 2001; Wilson at al., 2003; Pie et al., 2005). However, 
antimicrobial cuticular excretions have a prophylactic role in colonies, and have 
been shown to increase in strength with increasing sociality levels (Stow at a/., 
2007). 
Immune responses may be constrained by the different life histories of 
the colony members (Boomsma at a/. 2005; Bocher at ai, 2007). Within a social 
colony, individuals are divided into reproductive castes, each with different 
roles. Queens (only one or a few per colony) and males are responsible for the 
reproductive output of the colony, whilst large numbers of workers perform all 
other tasks needed for group survival (Robinson, 1992; Schmid-Hempel, 1998). 
The reproductive potential, and consequently fitness, of the colony is dependent 
on the survival of one or a few reproductives. We therefore expect that these 
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highly valuable colony members should invest in elevated levels of immune 
protection. Similarly, the tasks performed by workers, which can change 
throughout life (age polyethism) carry varying levels of associated pathogen 
risk, and subsequently selection may act on immune investment based on age 
and role. 
The reproductive division of labour in social insects involves all 
individuals within a colony being the offspring of a single queen, and thus 
potentially being susceptible to the same pathogens (Baer & Schmid-Hempel, 
2003; Palmer & Oldroyd, 2003; Hughes & Boomsma, 2004a). Increased genetic 
diversity within a colony, either through the presence of multiple queens, or the 
multiple mating of the single queen, reduces the rate of within-group pathogen 
transmission (Schmid-Hempel, 1994). Queen polyandry has been shown to 
reduce colony variation in resistance (Tarpy, 2003), and increase average 
resistance (Baer & Schmid-Hempel, 1999, 2001; Hughes & Boomsma, 2004a, 
2006; Tarpy & Seeley, 2006; Seeley & Tarpy, 2007; Reber et a/., 2008). 
1.4 The Honey Bee, Apis mellifera 
1.4.1 The British honey bee 
The native British honey bee, Apis mellifera mellifera L. (1758, Hymenoptera: 
Apidae), is also known as the European dark bee, or German black bee due to 
its dark body colour. A. m. mellifera is no longer used as a significant 
subspecies in the UK due to its aggressive behaviour, and since 1859 
beekeepers have imported other subspecies, leading to hybridisation of areas 
originally occupied by A. m. mellifera. The most popular of these are A. m. 
/igustica (Italian bee) and A. m. carnica (Carniolan bee), originally imported from 
Slovenia (Ruttner, 1988). Whilst these subspecies have desirable 
characteristics such as fast brood build-up, good disease resistance and easy 
handling nature, they are less resistant to British winters than A. m. mellifera, 
and overwinter in small colonies, which have a low survival rate (Ruttner, 1988). 
Bees used throughout this thesis were a hybrid known as British Hybrid bees. 
The honey bee has a three-tiered caste system based on the 
reproductive division of labour: a single reproductive queen, up to 50,000 
conditionally sterile female workers, and, in the summer, male drones (Hooper, 
1997). Figure 1.3 shows the morphological variation between the castes. 
Queens and drones are approximately twice the size of workers. Drones lack a 
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20mm 
Worker Queen Drone 
Figure 1.3. Diagram showing morphological differences between the castes of 
the honey bee, Apis mellifera. 
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sting and have evolved large bulbous eyes used for searching for a mate 
(Hooper, 1997). Within this thesis I study workers and drones, but do not 
consider queens. Explanation for this can be found in Chapter 6, Section 6.4.1. 
1.4.2 The valuable bee 
Honey bees are valued not only for the honey and wax that they produce, but 
as pollinators of many of our crops and wild flowers. In the UK 39 crops depend 
on insect pollination (Carreck & Williams, 1998). Honey and bumble bees make 
up the majority of these pollinators, with honey bees contributing £165 million 
annually to the agricultural output of the UK (BBKA). Approximately 274,000 
colonies are maintained in the UK by commercial and amateur beekeepers 
(OEFRA). In the last year, 30% of British bees have perished (see Section 
1.4.3), and this, combined with recent bad weather, has dented the industry. 
1.4.3 Bees and parasites 
The honey bee is subject to a wide range of micro- and macro-parasites, 
including 18 viruses and several deadly bacteria and fungi (Table 1.1, Bailey & 
Ball, 1991; Allen & Ball, 1997). Bee paraSites utilise all modes of infection, from 
ingestion offungal spores (Bailey & Ball, 1991), to the vectoring of viruses by 
ectoparasitic mites (e.g. Bowen-Walker at al., 1999; Brodsgaard at al., 2000; 
Chen at a/., 2004c; Yang & Cox-Foster, 2005), and the immune responses 
raised against these pathogens have been shown to impact on other life-history 
traits (Bailey & Ball, 1991; Evans & Pettis, 2005; see Section 5.1). The cost of 
immunity and how it may be partitioned in worker bees in particular has come 
under recent scrutiny due to a phenomenon termed Colony Collapse Disorder 
(CCO). First described in the USA in 2007, CCO refers to unusually low 
numbers of adults found within a hive with no obvious grounds for collapse. The 
cause is currently thought to be a combination of factors including multiple 
parasite infection, nutritional stress and insecticides (Oldroyd, 2007, Cox-Foster 
at a/., 2007). Colony loses in the UK have risen by 200% in the last two years 
(BBKA survey, 2008). Bad weather conditions during this time lead to bees 
being confined within their hives, where the stress provided opportunities for 
bacteria and viruses to proliferate. Consequently, the use of the honey bee as a 
model system with which to examine the immune profiles of social insect 
castes, and the responses to parasite infection, now has an additional 
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Parasite type Name Affected life stage Symptoms 
Defonned wing Larval Defonned wings and abdomen in adults 
Sacbrood Larval Failure to pupate, and death shortly after cell capping 
Black queen cell Larval Dark-walled cells, containing tough, yellow pupae 
Virus 
Acute bee paralysis All stages Death in brood and adults 
Chronic bee paralysis All stages Paralysis in adults 
Kashmir All stages Death in larvae and adults 
American foulbrood (Bacillus larvae) Larval Discolouration and putrification of propupae 
Bacteria 
European foulbrood (Melissococcus pluton) Larval Larvae displaced in cells; dead larvae discoloured 
Chalk-brood (Ascophaera apis) Larval Capped larvae die with white fluffy appearance 
Fungi Stone-brood (Aspergillus ftavus) Larval Capped larvae die with white fluffy appearance 
Microsporidia Nosema apis Adult Reduced lifespan, underdeveloped hypopharyngeal gland 
Malpighamoeba mellificae Adult Cysts on Malpighian tubules 
Protozoa Crithidia spp. Adult Cysts in midgut 
Gregarines, e.g. Leidyana Adult Crusts in midgut 
Tracheal mite, Acarapis woodi Adult Reduced survival in severely infested colonies Mites 
ValTOa destructor All stages Mites visible, reduced colony survival with high infestation 
Greater wax moth, Galleria mel/onel/a All stages Moth larvae tunnel through wax; may overwhelm weak colonies 
Insects 
Small hive beeUe, Aethina tumida All stages Beetle larvae tunnel through wax; may overwhelm weak colonies 
Table 1.1. Some examples of the range of parasites infecting the honey bee. Parasites comprehensively cover all life stages and 
modes of infection of the bee, and whilst some have few symptoms, others cause death and can lead to the collapse of a colony 
(Bailey & Ball, 1991). 
importance in its own right in an effort to understand what is causing the current 
collapse in global bee populations. 
1.5 Outline of the thesis 
The work presented in this thesis investigates development (ontogeny) of the 
immune system in honey bees. The questions of how immune responses 
change during development and aging are addressed for different castes, and 
finally, the impact of parasites on these immune responses is investigated. 
Chapter 2 details the development of assays to quantify phenoloxidase, 
prophenoloxidase and antimicrobial peptides in the honey bee. 
Chapter 3 investigates the changes in immune response for the worker 
bees throughout their lifecycle, including the development to adulthood, and the 
effect of age polyethism on immune responses. 
Chapter 4 investigates the effect of development and age on the drone 
immune responses. 
Chapter 6 investigates the impact of the ectoparasite, Varroa destructor, 
on the temporal immune responses of worker bees, and the effect that vectored 
viruses have on immune defences. 
Chapter 6 draws together the main findings from the thesis and 
highlights areas of future research. 
Appendix 1 provides further detail on the enzyme kinetic theory dealt 
with briefly in Chapter 2. Additional results from issues arising from immune 
assay development are also presented. 
Appendix 2 provides figures of the complete data sets from the thesis 
(for simplicity, two of the control treatment groups are not presented in the 
figures in the main chapters). 
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Chapter 2 
General Methods 
2.1 Introduction 
2.1.1 Chapter Aims 
This chapter introduces the honey bee, Apis mellifera, as a model organism and 
provides details of the three assays used for measuring the immune response 
throughout the thesis. The aims of this chapter are: 
1. To describe the bee-husbandry methods and protocols used to maintain 
and challenge bees in the lab (Section 2.2) 
2. To develop and optimise a specific assay for measuring phenoloxidase 
(Section 2.3). This will include: 
a. Ensuring that honey bee phenoloxidase enzyme kinetics conform 
with the Michaelis-Menton equation 
b. Obtaining a value for the Michaelis constant, Km 
c. Optimising the concentration of L-DOPA used in the assays 
3. To develop and optimise a specific assay for measuring 
prophenoloxidase (Section 2.4) 
4. To develop and optimise an assay for antimicrobial activity (Section 2.5) 
5. Estimating repeatabilities for all assays with respect to within-individual 
variation. 
2.2 The honey bee as a model organism 
2.2.1 Study organism 
The honey bees used throughout this thesis were from colonies of hybrid bees 
kept in Langstroth hives. In 2006 three new nucleus colonies of British Hybrid 
bees were purchased from Thorne's Bee Supplies. These colonies were 
allowed to build up from a standard 6-frame nucleus to fill a 10-frame 
Langstroth hive. A total of 10 different colonies were used in this thesis. With 
the exception of hives used in Chapter 5, all colonies used in this thesis were 
free from infestation with the ectoparasitic mite, ValTOa destructor. 
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2.2.2 Hive sites 
Hives were situated at three different sites within a 1 mile radius of each other, 
to the west of Sheffield City Centre (Tapton, Fulwood Road and Ranmoor, 
Figure 2.1). Sites were situated in residential areas with extensive gardens and 
open parkland, and all were within flying distance (bees can fly over 5 miles 
from the hive, Beekman & Ratnieks, 2000) of the Peak District National Park, 
providing heather moorland for foraging. 
At the beginning and end of each season (April and October) hives were 
supplemented with a 50% sugar syrup (50% sugar dissolved in water). At the 
beginning of the season this helps with the build up of the hive and encourages 
the start of foraging, while in the autumn the additional food is used for winter 
stores. At the start of each season hives were checked for surviving colonies. In 
Sheffield, field sites experience a 70% loss of hive stocks over each winter due 
to cold temperatures (M. Couvillon, pers. comm.). Surviving hives were checked 
each week to monitor the build up of brood frames. Colonies were used in 
experiments when the hive contained at least two frames of capped brood that 
could be removed for lab use. During the season additional supers (boxes of 
additional frames placed on top of the original hive) were added to each hive to 
provide space for food storage and egg laying as the colonies grew. 
2.2.3 Lab conditions 
Bees used in lab-based experiments were brought into the lab 24 hours before 
use as a frame of final stage brood. Brood frames were kept in a wooden frame 
box (Le. 24 hour dark photoperiod) inside an incubator set at 36°C ± 1°C. 
Humidity was maintained at 40% ± 2% using trays of water placed on the 
incubator floor. 
Adult bees were kept in purpose-built bee cages: a box of wooden sides 
(20cmx15cmx10cm) with a clear Perspex floor to allow easy bee viewing and a 
sliding metal mesh lid. Adults were also kept in an incubator at 36°C ± 1°C with 
a 12:12h L:D photoperiod. Adults were fed 50% sugar syrup from liquid drop 
feeders adapted from rabbit water bottles, to which the ball-bearing stopper had 
been replaced with a glass tube melted to provide a drip dispenser. A piece of 
filter paper was placed in the floor of the cage to soak up excess drips from the 
feeder. Each box could comfortably contain several hundred bees. 
20 
Figure 2.1. Aerial photograph of Sheffield showing field sites. The three field 
sites Tapton. Fulwood Road and Ranmoor are pinpointed. The University 
Animal and Plant Science (APS) Department and Sheffield City Centre are also 
highlighted. Field sites lie within a 1 mile radius of each other. The Peak District 
National Park is approximately 3 miles west of the Ranmoor site (aerial 
photograph taken from Google Earth) . 
21 
2.2.4 Administering an immune challenge 
The procedure for administering an immune challenge was the same for all 
adult bees used in this thesis. Bees were challenged via haemocoelic injection 
with a glass microcapillary (1 x 900mm) pulled and ground into a fine needle (tip 
diameter approximately 130~m) using a Narishige microelectrode puller (model 
PC-10, and microelectric grinder, model EG-44). Needles were sterilised with 
ethanol between injecting bees within a treatment group, and fresh needles 
were used for each treatment group. 
The immune challenge was elicited by an injection of lipopolysaccharide 
(LPS: 0.5mgmr1) in insect Ringer (128mM NaCI, 18mM CaCI2, 1.3mM KCI, 
2.3mM NaHC03, 11 dH20, pH 7.2). LPS (derived from E.coll) is a component of 
the outer membrane of Gram-negative bacteria. It is an endotoxin and is widely 
used as an elicitor of the immune response in insects (Moret & Schmid-Hempel, 
2000). Before injection, bees were cold anaesthetised on ice. Injections were 
made through the pleural membrane between the second and third sternites of 
the abdomen. Along with a full control (no challenge), additional treatment 
groups in each experiment provided controls for needle wounding via a sham 
injection (needle) and the effect of the buffer vehicle (injection with insect Ringer 
only). Unless otherwise stated, haemolymph was collected for assay 24 hours 
post challenge (Moret & Schmid-Hempel, 2000). 
2.2.5 Statistical analysis 
The majority of the statistical analysis in this thesis was performed using the 
statistical package R (version 2.6.2) on the Mac OS X platform. All data were 
analysed using parametric tests. Data were tested for normality using a normal 
Q-Q plot and a plot of residuals against fitted values. Distributions that were 
significantly non-normal were transformed (as indicated in results). Analysis of 
assay repeatabilities was performed using the statistical package StatView. In 
all cases, results presented are for the minimum adequate model, fitted with 
thorax width as a co-factor to control for body size. Survival data were analysed 
using a GLM with binary or Poisson distribution families. 
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2.3 Phenoloxidase 
2.3.1 Introduction 
Phenoloxidase (PO) is an important constituent of the cellular innate immune 
system. It is produced as part of a complex cascade, involving the activation of 
prophenoloxidase (ProPO) which then turns into PO, which subsequently 
catalyses the reaction for the formation of melanin (Cerenius & Soderh~lI, 
2004). More detail on the complexities of the cascade and its components can 
be found in Chapter 1, Section 1.2.4.1. Of concern in this chapter is the 
development of quantitative assays to measure PO in its different forms. This 
first section deals with the measurement of PO (the measurement of ProPO is 
discussed in Section 2.4). 
2.3.2 Assaying PO 
Two different measurements of PO are commonly taken when assaying 
immunity. Some researchers measure PO as the amount of activated enzyme 
present in the haemolymph. Others measure it as the total PO concentration 
present after the chemical activation of the precursor ProPO. For this thesis, 
two measurements of PO will be taken: free-standing activated PO (PO), and 
total potential PO activity, recorded after the artificial chemical activation of 
ProPO in vitro (ProPO - see Section 2.4). 
Several assays of PO have been developed over the years, but since 
1952 (Horowitz & Shen, 1952) assays typically use the addition of L-dopa (3,4-
dihydroxy-L-phenylalanine) to quantify PO levels in a haemolymph sample (e.g. 
Barnes & Siva-Jothy, 2000; Thompson, 2002). PO catalyses the conversion of 
L-dopa to dopachrome. The maximum linear rate of colour change (the Vmax) 
as the L-dopa (colourless) is converted to dopachrome (red-brown colour) is 
recorded using a spectrophotometer. To assay total PO, samples were 
incubated with a suitable chemical activator prior to the addition of L-dopa (see 
section 2.4). Although PO has been shown to follow the Michaelis-Menton 
equation (see Section 2.3.4) for enzyme kinetics in the mealworm beetle, 
Tenebrio molito" and all aspects of the assay thoroughly explored (Thompson, 
2002), there is some evidence that both the type and concentration of 
chemicals used in assaying PO and its precursor ProPO can have varying 
affects when used for different study organisms (Nayar & Bradley, 1994; 
Thompson, 2002). As no standardised method exists for studying PO and 
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ProPO in the honey bee. established protocols were further developed to 
ensure the assays were optimal for measuring honey bee immunity. 
2.3.3 Assaying PO: Materials and Methods 
The assay used was adapted from Barnes and Siva-Jothy (2000). Haemolymph 
for assaying was collected using a perfusion bleed method. Adult bees were 
cold-anaesthetised on ice for approximately 10 minutes. A small cut was made 
at the bottom of the abdomen using fine surgical scissors. A blade of the 
scissors was inserted inside the groove in which the sting sits (in the case of 
drones a sharp blade was inserted to make an initial incision). and a small cut 
made upwards in the abdominal wall. This cut has two uses: a) perfused 
haemolymph can drain and be collected from this opening and b) it allows the 
intestine to prolapse out of the body during the bleed. as the pressure of fluid 
used in the perfusion can cause the intestine to rupture if it is kept within the 
body cavity. Contamination of the sample with gut contents can give a false PO 
reading. even if the contaminating particles are filtered out (pers. obs.). A 
hypodermic needle (25G) was inserted into the dorsal prothorax. slightly off 
centre to avoid rupturing the digestive tract. 0.5ml of ice-cold sodium cacodylate 
buffer (0.001 M sodium cacodylate. 0.005M calcium chloride. pH 6.5) was 
steadily perfused through the body cavity. 0.5ml buffer was used for the 
perfusion bleed as it provided enough haemolymph extract to be split into three 
aliquots for use in different assays. 
The haemolymph was collected into a 1.5ml centrifuge tube. The sample 
was vortexed (HA TI Rotamixer) for a few seconds to ensure thorough mixing 
before being divided into three aliquots by splitting the sample into two further 
0.5ml centrifuge tube. The samples were immediately frozen at -90°C in a 
Revco Ultima II chest freezer for a minimum of 24 hours. Freezing the sample 
at -90°C is necessary to disrupt the haemocytes and allow stable storage of the 
enzyme. and does not affect the enzyme activity (Pye, 1978). 
After freezing. samples were defrosted on ice. vortexed for a few 
seconds and then centrifuged (4°C. 80.000G. 15 minutes) to remove cell debris. 
The supernatants were then used in the reaction mixture. For a standard PO 
assay. 140 .... 1 dH20, 20 .... 1 phosphate buffered saline (PBS. 8.74g NaCI. 1.78g 
Na2HP04.2H20. 11 dH20. pH 6.5) and 20 .... 1 sample are added to a well of a pre-
chilled 96-well plate. 20 .... 1 L-dopa (concentration to be confirmed, see Section 
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2.3.6) were added and the plate loaded into a plate reader (VersaMax tunable 
microplate reader, Molecular Devices) preheated to 30°C. The reaction was 
allowed to proceed for 1 hour, with automatic mixing of the sample before the 
first reading, and between subsequent readings (automixing). The standard PO 
assay quantifies the rate of conversion of substrate (L-dopa) into product 
(dopachome) when measured spectrophotometrically as the change in 
absorbance at a wavelength of 490nm. The rate of conversion is proportional to 
the concentration of PO present in the sample. The absorbency at 490nm is 
recorded every 15 seconds (241 readings in an hour) and the results plotted in 
an enzyme curve using the software Softmax Pro v5.0.1. 
2.3.4 Assaying PO: Finding Vmax and Km 
To determine the concentration of L-dopa needed for maximum conversion in 
bee haemolymph, the Km and Vmax of the reaction must first be determined. 
The assay must show conformity to the Michaelis-Menton equation for Km and 
Vmax to be calculated. For further information on enzyme kinetics see Appendix 
1, Section A1.1. 
Thompson (2002) analyses the reaction curve of the PO assay for the 
mealworm beetle, Tenebrio molitor in detail to determine which area of the 
standard PO curve is the rate of reaction, and what, if any, factors cause 
departure from this linearity. It was found that the initial lag phase of the curve is 
due to differences between the temperature of the initial reaction solution and 
the required reaction temperature. The end lag phase is due to inhibition by 
reaction products such as melanin. Neither of these factors effects the linear 
rate phase of the slope, and lag phases are not included in the final Vmax 
calculation. As with T. molitor, the haemolymph of the honey bee was shown to 
increase linearly with increasing L-dopa concentrations, thereby conforming to 
the Michaelis-Menton equation (pers. obs.). 
2.3.5 Assaying PO: Finding Vmax and Km - Methods 
Km and Vmax need to be calculated for the PO assay of honey bee 
haemolymph as the concentration of substrate (L-dopa) needed for the assay 
can differ between study systems (Thompson, 2002; Haine et al., 2007; K. 
Hammerschmidt, pers.comm.). By finding Km we can be sure that the Vmax (2 
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x Km) of the reaction is achieved, and that the substrate does not limit the rate 
of reaction. 
To find Km, the PO assay was run using 5 different concentrations of L-
dopa. Haemolymph was collected from perfusion bleeds of 23 newly emerged 
worker bees taken from the same colony. Bees were perfuse bled with O.Sml 
ice-cold sodium cacodylate buffer, and the samples pooled and frozen at-
90°C. 24 hours later the sample was defrosted on ice, vortexed and centrifuged 
(4°C, 2800G, 15 minutes). Based on the findings for T. molitor (Vmax required 
an L-dopa concentration of 3mM, Thompson (2002», L-dopa was assayed in 
the following concentrations: O.OmM, 0.5mM, 1.0mM, 2.0mM, 3.0mM and 
4.0mM. These concentrations were calculated for the total sample volume 
(150J.lI). Each sample was replicated 3 times. Following Thompson (2002), 
samples were added to the wells of a pre-chilled 96-well plate in a ratio of 1 :2. 
50J.lI of sample were mixed with 100J.lI L-dopa. The plate was loaded into the 
plate reader and the reaction was allowed to proceed as standard (30°C, 
490nm, 1 hour, automixing). The results were plotted in a direct linear plot 
(Figure 2.2), considered to be both easier and more accurate to calculate Km 
from than the more traditional Lineweaver-Burk double reciprocal plot (Cornish-
Bowden, 1995). The mean Vmax for each L-dopa concentration was plotted on 
the y-axis, and the negative of the L-dopa concentration plotted on the x-axis. 
Corresponding points were joined with a straight line and extended beyond the 
y-axis. The lines for different substrate concentrations should all cross each 
other. Points where lines cross give the values for Vmax (on the y-axis) and Km 
(on the positive x-axis). If the lines do not all cross in the same place, the 
crossing points are ranked left to right and the medium point is used to give the 
Km and Vmax (Cornish-Bowden, 1995). 
2.3.6 Assaying PO: Finding Vmax and Km - Results 
The average Vmax for each L-dopa concentration was plotted using a direct 
linear plot (Figure 2.2). The crossing points of the lines were not in the same 
place, so the medium point was used to determine Km and Vmax. This gave a 
Vmax value of 14.75 and a Km value of 5.75mM. The substrate (L-dopa) 
concentration needed to achieve Vmax for this assay was therefore 2 x Km = 
11.5mM. 
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Figure 2.2. Direct linear plot to determine Km and Vmax for honey bee 
phenoloxidase. The negative L-dopa concentration was plotted against the 
corresponding mean Vmax. The two points were joined and extended well into 
the positive x-axis. This was repeated for all L-dopa concentrations. The lines 
did not intersect at a single point, so crossing pOints were ranked from left to 
right. The Km and Vmax values were taken from the medium intersect (Cornish-
Bowden, 1995). This gives a Km value of 5.75mM for the honey bee. 
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2.3.7 Assaying PO: Evaluating Km 
Results from the determination of Km and Vmax (previous section) showed that the 
concentration of L-dopa needed for the PO assay to proceed at Vmax for honey 
bee haemolymph was 11.5mM, or 22.68 mgmr1 (to achieve this final concentration 
in the total sample volume). This concentration is several times greater than that 
found in T. molitor, but is similar to values subsequently found for the American 
cockroach Periplaneta americana, and the field cricket, Gryllus bimaculatus 
(Thompson, 2002; Haine et a/., 2007; K. Hammerschmidt, pers. com.). L-dopa has 
a low solubility in water: the Merck Index reports a solubility of L-dopa in water in 
the range of 66mg in 40ml, or 1.65mgmr1 (Merck Index, 2006). A concentration of 
10 mM of L-dopa in water has been reported (Sinsabaugh et a/., 1991), but L-dopa 
is described as "sparingly soluble" (Bredberg et a/., 1993). This makes it impossible 
to produce a solution of L-dopa in the concentration derived from the Km 
calculations. An experiment was carried out to investigate what concentration of 
soluble L-dopa could be used in experiments with bee haemolymph that would not 
be rate-limiting, and what affect this would have on PO and ProPO concentrations. 
Initially, L-dopa solutions were produced using the following concentrations: half Km 
(2.88mM), Km (5.75mM) and 2Km (11.50mM). The concentrations were made up in 
dH20 and vortexed for 15 minutes to ensure thorough mixing. As expected, the 
2Km solution failed to fully dissolve, and despite previous reports, the Km solution 
also reached saturation. Therefore, the experiment was carried out using just two L-
dopa concentrations: half Km (2.88mM) and the saturated solution (made up using 
5.75mM L-dopa, but with a final concentration = half Km < saturated < Km). The 
saturated solution was filtered (0.2JJm polypropylene filter, 25mm diameter, 
Whatman) to remove any un-dissolved particles that might have distorted the light 
absorbency in the spectrophotometer before use. 
Haemolymph was collected from perfusion bleeds of 10 newly emerged 
worker bees with 0.5ml sodium cacodylate buffer. All bleeds were pooled and 
the sample vortexed and frozen at -90°C. 24 hours later the sample was 
defrosted on ice, vortexed and centrifuged (4°C, 2800G, 15 minutes). To 
ensure that the concentration of PO in the haemolymph sample was not a 
limiting factor in the assay, the sample was tested with both L-dopa 
concentrations at the following dilution factors: 1, 1/2, 1/4, 1/8, 1/16. It was 
predicted that as dilution levels increased, we would see the PO concentration 
starting to become a limiting factor. Any difference between the L-dopa 
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concentrations would therefore be cancelled out at the higher dilution levels. 
20J.L1 of the sample was loaded into a pre-chilled 96-well plate, with 140f,!1 dH20 
and 20J.L1 PBS buffer. A control containing 20J.L1 sodium cacodylate buffer (no 
haemolymph) was also added to the plate. 20J.L1 of the L-dopa solutions were 
added to the samples. Each dilution level:L-dopa combination was repeated 7 
times. 
2.3.8 Assaying PO: Evaluating Km - Results 
Vmax decreased significantly with increasing dilution (Figure 2.3, regression, 
F1,48 = 186, p<0.0001, ~ = 0.795, data are log10 transformed). There was no 
significant effect of L-dopa concentration on PO Vmax. At the highest sample 
concentration, the enzyme curves become asymptotic for both L-dopa 
concentrations (Figure 2.3), implying that the concentration of PO in the 
samples was the limiting factor, and not the L-dopa concentration. This result, 
combined with those for ProPO (Section 2.4.3) confirmed that the concentration 
of L-dopa was conservative: consequently a saturated L-dopa concentration 
(made up using 5.75mM (11.34mgmr1) with a final concentration = half Km < 
saturated < Km) was used for all subsequent experiments. 
2.3.9 Assaying PO: Repeatability 
The perfusion method for sampling haemolymph in bees is destructive, so 
multiple samples cannot be taken from the same individual. To test the 
repeatability of the PO assay, repeatability, r, was calculated using the formula 
described in Lessels & Boag (1987). 
To test the repeatability of the PO assay, haemolymph samples were 
collected from 8 newly emerged workers (24 hours old). Samples were 
collected from a perfusion bleed with 0.5ml sodium cacodylate buffer. Each 
sample was split into 3 aliquots, briefly vortexed and frozen immediately for 24 
hours (-90°G). Samples were defrosted on ice, vortexed and centrifuged (4°C, 
2800G, 15 minutes). 20J.L1 of each aliquot for each sample was added to a pre-
chilled 96-well plate, along with 240J.L1 dH20 and 20J.L1 PBS. 20J.L1 L-dopa 
(saturated) was added and the plate run as standard. 
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Figure 2.3. PO assay changes in Vmax with different L-dopa concentrations. 
There was a significant decrease in Vmax with dilution factor, with the enzyme 
curve starting to level off at the highest concentrations. There was no significant 
effect of the L-dopa concentration on PO production . The L-dopa curve became 
asymptotic at saturation . 
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2.3.10 Assaying PO: Repeatability - Results 
The PO assay was highly repeatable with 90.3% of the total variation made up 
of variation among individuals (ANOVA, F7•16= 28.7, p< 0.0001, r = 0.903). 
2.3.11 Assaying PO: Standard PO Protocol 
Following these investigations, the protocol used for assaying PO activity will be 
as follows (unless stated otherwise): 
• Bees will be collected from brood frames incubated overnight at 36°C ± 
1°C, 40% ± 2% humidity 
• Emerging bees will be collected and if necessary, subjected to the 
experimental immune challenge protocol: no challenge, wounding control 
(sham needle injection), vehicle control (injection with 1 j,J1 insect Ringer 
(128mM NaCl, 18mM CaCI2, 1.3mM KCI, 2.3mM NaHC03, 11 dH20, pH 
7.2) and the full bacterial challenge (injection with 11J1lipopolysaccharide 
(LPS: 0.5mgmr1 in insect Ringer) 
• Bees will be kept in bee boxes for 24 hours (36°C ± 1°C with a 12:12h 
L:D photoperiod, dH20 and 50% sugar syrup ad libitum) 
• 24 hours post challenge, bees will be cold anaesthetised and perfuse 
bled with 0.5ml ice-cold sodium cacodylate buffer (0.001 M sodium 
cacodylate, 0.005M calcium chloride, pH 6.5) 
• Samples will be briefly vortexed to ensure thorough mixing, and split into 
three aliquots and frozen immediately (-90°C) for a minimum of 24 hours 
• Samples will be defrosted on ice, vortexed for a few seconds and then 
centrifuged (4°C, 80,OOOG, 15 minutes) and the supernatent used in the 
reaction mixture 
• 20~1 sample, 140~1 dH20 and 20~1 phosphate buffered saline (PBS, 
8.74g NaCl, 1.78g Na2HP04.2H20, 11 dH20, pH 6.5) will be added to a 
well of a pre-chilled 96-well plate 
• 20J.11 L-dopa (saturated solution, made using 5.75mM, 11.34mgmr1 in 
dH20, solution will be vortexed for 15 minutes and filtered, with a final 
concentration = half Km < saturated < Km) will be added to the well 
• The plate will be run in a spectrophotometer at 490nm for 1 hour at 30°C, 
with readings taken every 15 seconds, and automatic mixing of the 
sample occurring before the first reading, and between subsequent 
readings 
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• The rate of change of absorbency will be plotted in an enzyme curve and 
the maximum linear slope of the line calculated to obtain a Vmax value 
for the sample. 
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2.4 Prophenoloxidase 
2.4.1 Introduction 
Prophenoloxidase (ProPO) is the inactive precursor to PO. Its activation into PO 
allows us to measure the total PO within an individual, and consequently gain a 
measure of their potential immune response. Further information on the 
complexities of the ProPO activating system can be found in Chapter 1, Section 
1.2.4.1. 
2.4.2 Assaying ProPO 
This assay involves the activation of stored zymogen ProPO into PO, which is 
then able to react with L-dopa as in the standard PO assay. The assay used 
was adapted from Thompson, 2002. 20~1 of the sample are added to 135~1 
dH20 and 20~1 PBS in the well of a 96-well plate. To activate the ProPO, 5~1 of 
ProPO activator is added (see Section 2.4.5), and the plate taken off ice and 
incubated at room temperature (19°C ± 2°C) for 5 minutes. 20~1 of L-dopa 
solution is then added, and the plate is loaded into the plate reader. The 
reaction is allowed to proceed as normal for 1 hour (see Section 2.4.14). 
2.4.3 Assaying ProPO: Evaluating Km 
As discussed in Section 2.3.7, the value of Km calculated from the direct linear 
plot corresponded to a much higher concentration of L-dopa than was 
achievable. The experiment in Section 2.3.7 was repeated with a second set of 
samples, but this time ProPO was activated to gain a measure of the effect of L-
dopa concentration on total PO. 5~1 of dH20 was replaced with 5~1 a-
chymotrypsin (a ProPO activator - see Section 2.4.5) in dH20 (5mgmr1). 
Samples were incubated at room temperature (19°C ± 2°C) with the dH20, 
PBS and a-chymotrypsin for 5 minutes before the L-dopa was added and the 
samples run on the plate reader as standard (Section 2.4.14). 
2.4.4 Assaying ProPO: Evaluating Km - Results 
There was a significant interaction with the L-dopa concentration and the 
dilution factor (Figure 2.4, ANCOVA, F1,4s= 10.2, p=0.002549, data log10 
transformed): as the dilution factor increased, the difference between the L-
dopa concentrations was reduced. This was due to ProPO becoming the 
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limiting factor as the haemolymph samples become more dilute. As the dilution 
factor got closer to 1, a higher level of ProPO activity was recorded with the 
saturated L-dopa solution than the half Km. Although the L-dopa curve did not 
become asymptotic at saturation as with the PO result (Figure 2.3), conducting 
subsequent assays using the saturated solution (5.75mM (11.34mgmr1) with a 
final concentration = half Km < saturated < Km) was thought to be conservative 
compared to concentration of L-dopa used in previous studies (Thompson, 
2002). 
2.4.5 Assaying ProPO: Activator Suitability 
ProPO is naturally activated by bacterial and fungal cell wall components 
lipopolysaccharides (LPS), peptidoglycans and f3-1,3-D-glucans (Ratcliffe et a/., 
1984; SOderh~1I & Cerenius, 1998). Several other substances have been found 
to activate ProPO, including detergents (e.g. Sugumaran & Nellaiappan, 1990), 
alcohols (Asada, 1998) and nitrocellulose membrane (Brey et a/., 1991). 
Commonly laminarin, LPS and a-chymotrypsin are used as ProPO activators, 
but have been found to have different success levels in different insects 
(Brookman et a/., 1989; Thompson, 2002; Korner & Schmid-Hempel, 2004). 
Laminarin (a storage polysaccharide of brown algae, made up of 1,3-glucans) 
induces ProPO activation in T.mo/itor, and activation and nodule formation in 
the locust, Locusta migratoria migratorioides (Thompson, 2002; Mullen & 
Goldsworthy, 2006). LPS has been shown to induce nodule formation when 
injected into the desert locust, Schistocerca gregaria, and increased 
phagocytosis in wax moth, Galleria me/onel/a, (Gunnarsson & Lackie, 1985; 
Ratcliffe et a/., 1984). Chymotrypsin is a protein-lysing enzyme that fills the role 
of serine proteinases in the ProPO-AS, hydrolysing the peptide bonds in ProPO 
to break it down into active PO, and has been shown to activate ProPO in many 
insects (e.g. Saul & Sugumaran, 1988; Kopacek et a/., 1995). Laboratory grade 
chymotrypsin (a-chymotrypsin, Type II, SIGMA C-4129) is synthesised from 
bovine pancreas. 
2.4.6 Assaying ProPO: Activator Suitability - Materials and 
Methods 
To test the suitability of the activators in the honey bee, each was made up in 
the concentrations that activated the maximum PO for T. molitor (Thompson, 
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2002). The concentration of laminarin used was 1 mgmr1 and the concentration 
of LPS was 0.5mgmr1. In the case of a.-chymotrypsin where no concentration 
was specified, the concentration of 5 mgmr1 was used (R. Naylor, pers. 
comm.). All solutions were made up in dH20. 
Twelve newly emerged workers (24 hours old) were perfuse bled with 
0.5ml sodium cacodylate buffer. All samples were vortexed and frozen 
individually at -90°C. 24 hours later the samples were defrosted on ice, 
vortexed and centrifuged (4°C, 2800G, 15 minutes). Four 201-11 aliquots of each 
sample were added to a pre-chilled 96-well plate. Each aliquot received 5f.l1 of 
either laminarin, LPS, a.-chymotrypsin or a control of dH20. 20f.l1 of PBS and 
135J.l1 dH20 were also added. Additional controls replacing perfused 
haemolymph with sodium cacodylate buffer were run for each activator. The 
plate was taken off ice and incubated at room temperature for 5 minutes. The 
plate was gently shaken at the start of the incubation period to ensure thorough 
mixing. After 5 minutes, 20J.l1 L-dopa (saturated) was added and the plate 
loaded in to the plate reader and run as standard (Section 2.4.14). 
2.4.7 Assaying ProPO: Activator Suitability - Results 
There was a significant difference between ProPO activators (Figure 2.5, 
AN OVA, F3,40 = 46.5, p<0.001, data log10 transformed), with much more ProPO 
activated by a.-chymotrypsin than any of the other activators. 
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Figure 2.4. ProPO assay: changes in Vmax with different L-dopa 
concentrations. There was a significant interaction between L-dopa 
concentrations and the dilution factor; at higher concentrations, the ProPO 
activity was higher in the saturated L-dopa solution than the half Km 
concentration. 
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2.4.8 Assaying ProPO: Activator timecourse 
In his work on ProPO activators, Thompson incubated his samples at 30°C for 
30 minutes before adding L-dopa (Thompson 2002). Preliminary lab studies 
showed that samples left on ice for several hours gave very different ProPO 
measurements, depending on the length of time spent out of the freezer (pers. 
obs.). The potential degrading effects of a long incubation period on the 
activation of ProPO, and subsequent measurement of PO, have not previously 
been investigated. 
To test the effect of incubation time with different ProPO activators on 
final PO activity, 48 newly emerged worker bees (24 hours old) were perfuse 
bled with 0.5ml sodium cacodylate buffer. All samples were split into 4 aliquots. 
vortexed and frozen at -90°C. 60 randomly selected aliquots were defrosted on 
ice and 20J.11 of each were pooled together. The pooled sample was centrifuged 
(4°C, 50,OOOG, 15 minutes), and then kept on ice for the duration of the 
experiment. Laminarin (1mgmr\ LPS (0.5mgmr1) and ex-chymotrypsin (5mgmr 
1) were used as ProPO activators, along with a control of dH20. Additional 
controls replacing haemolymph samples with sodium cacodylate buffer were 
used for each activator. The plates were set up as before, with 5J.11 of activator, 
20111 sample, 20J.11 of PBS and 135J.11 dH20 added to each well. To test the effect 
of incubation time on ProPO activation, samples were incubated with each 
activator for 5, 10, 20 or 30 minutes at room temperature (19°C ± 2°C) before 
L-dopa (saturated) was added and the plates run in the plate reader as 
standard. Each time period:activator combination was repeated 5 times. 
2.4.9 Assaying ProPO: Activator timecourse • Results 
There was a significant effect of activator and incubation time on the activation 
of ProPO (Figure 2.6). Across all activator groups the concentration of ProPO 
assayed significantly decreased with increasing incubation time. There was a 
significant effect of activator on ProPO activation (ANOVA, F3•64 = 4730, 
p<0.0001), with ex-chymotrypsin activating vastly more ProPO than the other 3 
activators. Therefore, to gain a measure of the maximum level of ProPO 
activity, an incubation time of 5 minutes with the ex-chymotrypsin activator will 
be used in future assays. 
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Figure 2.6. ProPO activator timecourse. Three activators (Iaminarin, LPS and 
a-chymotrypsin) and a control were incubated for 5, 10, 20 and 30 minutes with 
the haemolymph sample prior to the addition of L-dopa and subsequent plate 
reading . There was a significant interaction between activator and time; longer 
incubation periods resulted in lower levels of ProPO activity for all activators, 
although incubation time had a greater effect on the ProPO activated by a-
chymotrypsin. 
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2.4.10 Assaying ProPO: Evaluating a-chymotrypsin 
When used as an in vitro activator of ProPO, a-chymotrypsin has no regulatory 
mechanism attached to it. This means the hydrolysis of ProPO will potentially 
continue unchecked. To minimise any "damage" caused by the a-chymotrypsin, 
it is important to use as Iowa concentration as possible. 
To test this, 10 newly emerged workers (24 hours old) from a single hive 
were perfuse bled with O.Sml ice-cold sodium cacodylate buffer, and the 
samples pooled. The sample was briefly vortexed before freezing for 24 hours 
(-90°C). The sample was then defrosted on ice, vortexed, centrifuged (4 eC, 
SO,OOOG, 1S minutes) and 20",1 aliquots added to 13SjJi dH20 and 20~.!I PBS in a 
96 well plate on ice. SIJI of a-chymotrypsin in the following concentrations was 
added to each well: 0.2Smgmr1, 0.Smgmr1, 1.0mgmr1, 2.0mgmr1, S.Omgmr1 
and 10.0mgmr1. A control replacing SjJl a-chymotrypsin with SjJl dH20 was 
used and each concentration was repeated S times. Once the a-chymotrypsin 
had been added, the plate was taken off ice and allowed to incubate at room 
temperature (19 eC ± 2 eC) for S minutes before 20",1 L-dopa (saturated) was 
added and the plate loaded into the plate reader and read as standard (Section 
2.4.14). 
2.4.11 Assaying ProPO: Evaluating a-chymotrypsin - Results 
A regression showed a significant effect of a-chymotrypsin concentration on 
ProPO activation (F1,28 = 19.2, p<0.0001, ~ = 0.406, Figure 2.7). Higher 
concentrations of a-chymotrypsin produced lower levels of ProPO activation. As 
a-chymotrypsin is potentially destructive, it is preferable to use the lowest 
concentration possible whilst still yielding maximum results. Consequently the 
lowest concentration was taken from the three concentrations that showed a 
higher level of ProPO activation (points above the regression line). All future 
experiments will therefore use an a-chymotrypsin concentration of O.SO mgmr1. 
2.4.12 Assaying ProPO: Repeatability 
As with the PO assay, the method of sampling haemolymph is destructive, so 
the same bee cannot be measured twice. To test the repeatability of the ProPO 
assay, 8 newly eclosed workers (24 hours old) were perfuse bled with O.Sml 
sodium cacodylate buffer. Each sample was vortexed and split into three 
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aliquots and frozen for 24 hours (-90°C). All samples were defrosted on ice and 
run as a standard ProPO assay (Section 2.4.14). Repeatability was calculated 
using the formula described in Lessels & Boag (1987). 
2.4.13 Assaying ProPO: Repeatability - Results 
The ProPO assay was highly repeatable with 99.6% of the total variation made 
up of variation among individuals (AN OVA, F7,1s= 730, p< 0.0001, r = 0.996). 
2.4.14 Assaying ProPO: Standard ProPO Protocol 
Following the results of these investigations, the standard procedure for 
assaying ProPO will be as follows (unless otherwise stated): 
• Method will be as the standard PO assay (Section 2.3.11) 
• Within each sample, 51J1 of dH20 will be replaced with 51J1 a-
chymotrypsin (0.5mgmr1 in dH20) 
• The reaction mixture will be incubated for 5 minutes at room temperature 
20~1 L-dopa (saturated solution made using 5.75mM (11.34mgmr1) in dH20 
with a final concentration = half Km < saturated < Km, solution vortexed for 15 
minutes and filtered) will be added to the well, and the plate will be run as in the 
PO assay (Section 2.3.11). 
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• Figure 2.7. Effect of a-chymptrypsin concentration (mgmr1) on ProPO 
activity. There was a significant effect of a-chymptrypsin concentration 
on ProPO activation, with higher concentrations of a-chymptrypsin 
producing lower levels of ProPO activity. 
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2.5 Determining sampling time in new bees 
2.5.1 Determining sampling time: Introduction 
Cuticle sclerotisation occurs in the first few hours post-eclosion, but in some 
cases may take several days (Andersen, 1974). During this period, PO and 
ProPO have a dual role, being utilised both in the immune response, and in 
sclerotisation, which involves the oxidative incorporation of phenolic compounds 
into the cuticle (Andersen et al., 1996). Consequently, assays carried out during 
this period may provide a false record of the use of PO and ProPO as an 
immune response. In honey bees, the process of cuticular sclerotisation takes 
approximately 1-2 days, but this must be balanced with the length of time it is 
practical to keep bees in the lab prior to testing (Hooper, 1997). To determine 
at what time post-eclosion PO and ProPO can successfully be measured as 
having a role in immune function, the following experiment was carried out. 
2.5.2 Determining sampling time: Materials and methods 
To investigate the affect that the post-eclosion period has on PO and ProPO 
levels and their role in the immune response, a timecourse was run over the 
first 72 hours post-eclosion, with bee samples from 2 different hives (Hive F and 
Hive G). To see the response of PO and ProPO in bees to an immune 
challenge, bees within the two hives were spilt into 4 treatment groups (No 
Challenge, Needle, Ringer injection (O.5iJl) and LPS injection (O.5iJl». 
Haemolymph samples were collected from perfusion bleeds (O.5ml sodium 
cacodylate) at 0, 5hr, 12hr, 24hr, 36hr, 48hr, 60hr and 72hr post challenge. 
Samples were collected and assayed for PO and ProPO as standard (Sections 
2.3.11 & 2.4.14). Thorax widths were measured using QCapture Pro 51 to 
control for body size. 
2.5.3 
2.5.3.1 
Determining sampling time: Results 
Hives Combined 
po: Results were analysed first by combining the two hives as one large data 
set and fitting Hive as a cofactor. The results for PO (Figure 2.8) show that PO 
activity significantly increased with age across all of the treatment groups. There 
was a Significant interaction of time with treatment, with the No Challenge group 
having a higher rate of PO production over time and the LPS challenged group 
exhibiting lower levels of PO activity (ANCOVA, F3.47s= 8.65, p<0.0001). There 
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was no effect of thorax width on PO concentration (ANCOVA, F1,476 = 1.08, 
p=0.2993), but there was a significant effect of Hive (ANCOVA, F1,476 = 190, 
p<0.0001). The continued increase in PO activity throughout the first 72 hours 
post-eclosion was subsequently seen to continue for at least the first 14 days of 
adult life (Section 3.3.4), and may be due to bees responding to cues in the 
hive, such as the presence of pathogens, or pheromone contact with incoming 
foragers, or the PO/ProPO immune response may simply increase because of 
the physiological processes of aging. 
ProPO: The results for ProPO (Figure 2.9) showed a significant interaction of 
time with treatment, with the No Challenge group having a higher rate of ProPO 
production over time (ANCOVA, F3,476 = 8.65, p<0.0001). Challenge with LPS 
produced lower ProPO concentrations. There was a significant effect of Hive 
(ANCOVA, F1,476 = 294, p<0.0001) and thorax width (ANCOVA, F1,476 = 6.68, 
p=0.01007) on ProPO activity. 
Thorax width was further investigated for each of the hives. Bees in Hive 
F were significantly larger (mean thorax width = 3.31mm) than in Hive G (mean 
thorax width = 3.23mm; t = 6.59, p< 0.0001 (two tailed), d.f. = 452), but there 
was no Significant difference in the variation in thorax widths between the two 
hives (HiveF = 0.0204, Hive G = 0.0172, F~test, p=0.1817). We expect some 
variation in the average body size between hives, as although similar hives 
were chosen for experiments based on estimated colony size, environmental 
factors that may influence body size could not be controlled. By adding thorax 
width as a co-factor in all future analysis models, we can control for the effect of 
differences in body size between hives. 
As the results for PO and ProPO show a Significant effect of Hive on 
enzyme activity, the data were re-analysed by Hive to compare the differences 
between the two. 
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Figure 2.8. Change in PO concentration over the first 72 hours post-eclosion . 
Samples were split into 4 treatment groups: No Challenge, Needle, Ringer and 
LPS challenged groups. Results shown are combined for 2 hives. All treatment 
groups showed an increase in PO concentration over time. There was a 
significant interaction of time with treatment, with the No Challenge group 
having a higher rate of PO production over time. 
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Figure 2.9. Change in ProPO concentration over the first 72 hours post-
eclosion. Samples were split into 4 treatment groups: No Challenge, Needle, 
Ringer and LPS challenged groups. Results shown are combined for 2 hives. 
There was a significant interaction between time and treatment, with the No 
Challenge group increasing in ProPO production over time whilst the challenged 
groups all fell. 
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2.5.3.2 Hives Separated 
Data were split into the two Hive groups: Hive F and Hive G. 
HiveF 
PO: The PO results for Hive F (Figure 2.10) showed a significant interaction 
between time and treatment groups (ANCOVA, F3,212 = 3.66, p=0.01333). The 
concentration of PO increased over time for all treatment groups, with the No 
Challenge treatment group producing higher PO concentrations overall. 
ProPO: The ProPO results (Figure 2.11) showed no Significant increase in 
ProPO concentration over time for all treatment groups (ANCOVA, F1,212 = 
0.456, p=0.5005). There was a significant effect of treatment on ProPO, with the 
No Challenge treatment group producing higher PO concentrations overall 
(ANCOVA, F3,212 = 13.1, p<0.0001). Both PO and ProPO results showed no 
effect of thorax width on enzyme activity. 
HiveG 
PO: The PO results for Hive G (Figure 2.12) showed a significant interaction 
between time and treatment groups (ANCOVA, F3,256 = 4.07, p=0.007529). PO 
concentration increased over time for all treatment groups, with the No 
Challenge treatment group producing higher PO concentrations overall. There 
was a significant effect of thorax width on PO (ANCOVA, F1,256 = 12.9, 
p<0.001). Overall, less PO was produced in Hive G compared to Hive F. 
ProPO: The ProPO results (Figure 2.13) showed a significant interaction 
between time and treatment, with the differences between the treatment groups 
becoming more pronounced over time (ANCOVA, F3,256 = 7.49, p<0.0001). 
ProPO activity increased over time for all treatment groups, with the No 
Challenge treatment group producing higher PO concentrations overall. There 
was a significant effect of thorax width on ProPO (ANCOVA, F 1,256 = 6.47, 
p=0.01158). 
Comparing the two hives 
Splitting the two hives showed that PO values followed the same pattern for 
both hives. Quantitatively, Hive G had a lower PO levels than Hive F (ANCOVA, 
F 1,476 = 190, p<0.0001), but the main effects and interactions were qualitatively 
the same, with the No Challenge treatment group having a higher concentration 
of PO than any of the other treatment groups. 
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The ProPO assay for the two hives also produced the same qualitative result for 
both hives, with the No Challenge treatment group having the highest 
concentration of ProPO. Hive F showed no effect of time on ProPO, whilst Hive 
G had a significant interaction of time with treatment groups. Again, Hive G 
overall had lower ProPO concentrations than Hive F (ANCOVA, F1•476 = 293, 
p<O.0001). The lower levels of ProPO stored in Hive G bees may predispose 
them to an increased sensitivity to immune challenges. 
The pattern of responses seen in the PO and ProPO assays, with PO 
activity increasing with age, whilst ProPO activity increases at a lower rate or 
stays constant, is seen in subsequent assays with workers and drones 
(Sections 3.3.4 & 4.3.2). In the PO assay, the level of response of PO activity 
following an immune challenge is similar in all challenged treatment groups, 
including the control challenges. This suggests that PO is used up immediately 
following any immune challenge. PO activity increases with age, which may be 
a response to pathogen exposure, or the physiological process of aging. The 
maximum capacity of haemolymph for active PO unknown, but the fact that it 
continues to rise with worker age suggests that the levels stored in "resting" 
bees never reaches its maximum limit. The pattern of activity in ProPO shows a 
significant staggered response in the reaction to different treatment groups, 
which is maintained across time. It may be that ProPO activity is maintained at 
a maximum for a given set of ecological constraints (e.g. immune challenge), or 
that ProPO is being used up at a constant rate relative to the level of immune 
challenge. 
Most importantly, at 24 hours post challenge, Hive F and Hive G show 
the same pattern of results for both the PO and ProPO assay, and there is a 
clear difference in response between the four treatment groups. This indicates 
that PO and ProPO both have a role in the immune response at 24 hours post-
eclosion, and consequently this sampling time will be used when collecting 
haemolymph from new bees in all future assays. 
Analysis of Hive G showed a Significant effect of thorax width, with larger 
bees having higher levels of PO and ProPO. We expect larger bees to contain a 
greater volume of haemolymph, and given the method of collection (i.e. a 
perfusion bleed), this will be seen as an increase in haemolymph concentration 
per unit bleed. By controlling for body size we take this into account. 
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Figure 2.10. Change in PO over first 72 hours post eclosion for Hive F. All 
treatment groups showed an increase in PO concentration over time. There was 
a significant interaction between time and treatment. 
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Figure 2.11 . Change in ProPO over first 72 hours post eclosion for Hive F. 
There was no significant increase in ProPO concentration over time for any of 
the treatment groups, but there was a significant effect of treatment on ProPO, 
with the No Challenge treatment group producing higher PO concentrations 
overal l. 
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treatment groups showed an increase in PO concentration over time. There was 
a significant interaction between time and treatment groups. 
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Figure 2.13. Change in ProPO over first 72 hours post eclosion for Hive G. 
There was a significant interaction of time and treatment on ProPO 
concentration. 
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2.6 Assaying antimicrobial activity 
2.6.1 Assaying Antimicrobial Activity - Introduction 
In honey bees, the up-regulation of antimicrobial peptides (AMPs) is seen in 
response to wound infections and injection of bacterial cells into the haemocoel, 
with increasingly severe immune challenges inducing higher levels of up-
regulation of antimicrobial production (Casteels et al., 1989). An immune 
challenge with E. coli has been shown to elicit a much greater antimicrobial 
response than India ink or latex beads (Casteels et al., 1989). 
The honey bee AMP response consists of four complimentary 
polypeptides: apidaecin, hymenoptaecin, abaecin and defensin. Apidaecins are 
highly active against Gram-negative bacteria, and are likely to be the candidate 
peptide being assayed in response in an immune challenge with LPS (Casteels 
et al., 1989; Casteels-Josson et al., 1994). Antimicrobial activity is seen in the 
lymph fluid of honey bees from 8 hours post-challenge, and can be assayed at 
24 hours post-challenge (Casteels et al., 1989). 
AMPs can be assayed using a zone of inhibition assay, using 
Arthrobacter globifonnis (a Gram-positive bacteria). The method used to assay 
AMPs in honey bees was adapted from Moret & Schmid-Hempel (2000). 
2.6.2 Assaying Antimicrobial Activity - Materials and methods 
Newly emerged ("new") and "old" (collected from the hive entrance and showing 
evidence of foraging behaviour - i.e. carrying pollen) workers were collected 
from the same hive. Worker foragers are typically 18-28 days old (Winston, 
1987). Bees of each age were split into 2 treatment groups: no challenge, or 
immune challenged with 0.5J.JI LPS in Ringer (0.5 mgmr1). Bees were incubated 
overnight as standard. Haemolymph was collected 24 hours post challenge 
from the bees, which were anaesthetised on ice. The original assay, using the 
bumble bee, Bombus terrestris, collected haemolymph by homogenising the 
thorax with Ringer solution. Honey bees have a much lower haemolymph 
volume than bumble bees, and it was not known if a perfusion bleed (i.e. a 
diluted sample) would produce measurable levels of AMPs. Therefore, for each 
age and treatment grouping, half of the bees had haemolymph collected via a 
perfusion bleed with 0.5ml sodium cacodylate, and half was collected as a neat 
haemolymph sample. Neat haemolymph was collected from the stump of a pair 
of legs, removed using fine scissors. A pre-chilled glass capillary tube that was 
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pulled and ground into a point fine enough to enter the wound was used to 
collect the haemolymph. A maximum volume of 3j..11 can be obtained this way. In 
all cases, haemolymph samples were immediately frozen for 24 hours (-90°C). 
A total of 12 new and 12 old bees were used to test this assay; each 
age:treatmentbleed combination contained three bees. 
The method for assaying antimicrobial activity in bees was adapted from 
the original assay by Moret & Schmid-Hempel (2000, Figure 2.14). A single A 
globiformis colony was selected from a plate of colonies and grown in 10ml LB 
(Luria-Bertani) broth overnight (30°C, automatic shaker). 50ml of 1 % agar 
solution was autoclaved and placed in a water bath at 44°C. When the solution 
had cooled to 44 °C, 1001-'1 of Aglobiform;s broth was added, and the solution 
swirled to mix. 5ml of the resulting solution was pipetted into Petri dishes within 
a laminar flow cabinet. The solution was left to solidify for 30 minutes. Petri 
dishes can be stored in a fridge (4°C) until needed. Just before use, wells were 
punched into the set agar using a sterile glass Pasteur pipette (area = 2mm2). A 
paper template placed underneath the Petri dish allowed well position and 
contents to be recorded. 
11-'1 samples of the haemolymph collected from the bees was carefully 
pipetted into the wells, ensuring no overspill. Petri dishes were incubated for 48 
hours at 30°C. After incubation, a uniform lawn of bacterial growth could be 
seen, with clear zones plainly visible where inhibition of the bacteria by the 
haemolymph had occurred. The area was photographed and measured. 
2.6.3 Assaying Antimicrobial Activity - Results 
There was a significant 3-way interaction between age, bleed type and immune 
challenge on antimicrobial peptide production (ANOVA, F1,16 = 41.4, p=<0.001, 
Figure 2.15, Table 2.1). When using a neat bleed method, antimicrobial activity 
was recorded in old bees both with and without an immune challenge, but 
antimicrobial peptides were only measurable in new bees following an immune 
challenge. The perfuse bleed method only produced recordable results for the 
immune challenged old bees. 
2.6.4 Assaying Antimicrobial Activity: Repeatability 
As collecting haemolymph samples was destructive, whether collected as neat 
haemolymph or by a perfusion bleed, individuals could not be multiply sampled 
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to test repeatability. Repeatability of the method used to measure the area of 
bacterial inhibition was tested using the samples from the previous experiment. 
The diameter of each clear zone was measured 3 times to get a mean 
diameter, from which the area of the inhibition zone can be calculated. This was 
repeated three times for each zone. Repeatability of the measurement method 
was calculated using the formula described by Lessels & Boag (1987). 
2.6.5 Assaying Antimicrobial Activity: Repeatability - Results 
The method of measuring the antimicrobial assay was highly repeatable with 
99.9% of the total variation between repeated measures was made up of the 
variation among individuals (AN OVA, F10,22 = 1167, p<0.001, r=0.999). 
2.6.6 Assaying Antimicrobial Activity: Standard AMP Protocol 
Following these results, the standard protocol for assaying AMP used 
throughout this thesis will be as follows: 
• When relevant, bees will be subjected to the experimental immune 
challenge protocol: no challenge, wounding control (sham needle 
injection), vehicle control (injection with 1~1 insect Ringer (128mM NaCl, 
18mM CaCI2, 1.3mM KCI, 2.3mM NaHC03, 11 dH20, pH 7.2) and the full 
bacterial challenge (injection with 1 ~I lipopolysaccharide (LPS: 0.5mgmr1 
in insect Ringer) 
• 24 hours post challenge, bees will be cold anaesthetised and neat 
haemolymph collected from a leg stump 
• Haemolymph samples will be immediately frozen for 24 hours (-90°C) 
• A single Arthrobacter gJobiforrnis colony will be selected and grown in 
10ml LB (Luria-Bertani) broth overnight (30°C, automatic shaker) 
• 50ml of 1 % agar solution will be autoclaved and placed in a water bath at 
44 °e. When the solution has cooled to 44°C, 1 OO~I of AgJobiforrnis 
broth will be added, and the solution swirled to mix 
• 5ml of the resulting solution will be pipetted into Petri dishes within a 
laminar flow cabinet and left to solidify for 30 minutes 
• Just before use, wells will be punched into the set agar using a sterile 
glass Pasteur pipette (area = 2mm2) 
• Haemolymph samples will be defrosted on ice and 1 ~I samples pipetted 
into the wells 
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• Petri dishes will be incubated for 48 hours at 30°C 
• Clear zones of inhibition will be photographed and measured for area 
(QCapture Pro 51) 
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Figure 2.14. Method for antimicrobial assay. A petri dish containing agar 
colonised with a lawn of Arthrobacter g/obiformis has 12 x 2mm2 wells punched 
in it. 11J1 of haemolymph sample is added to each well (1) . Plates are incubated 
for 48 hours, after which clear zones can be seen caused by the inhibitory effect 
of antimicrobial activity on the A. g/obiformis (2). Clear zones are photographed 
and the area calculated (3). 
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Figure 2.15. Antimicrobial Assay Test. Figure shows the results for control (no 
challenge) and challenged (LPS injected) bees, split by bleed type (neat or 
perfuse) and age (new and old). There was a significant 3-way interaction 
between age, bleed type and challenge on antimicrobial peptide production. 
When using a neat bleed method, antimicrobial activity was recorded in 
foragers both with and without an immune challenge. Antimicrobial peptides 
were only measurable in new bees following an immune challenge. The perfuse 
bleed method only produced recordable results for the immune challenged old 
bees. 
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Source d.f. Sum of F-value P 
squares 
Age 1 834 9.80 0.006445 
Treatment 1 11900 139 <0.0001 
Bleeding method 1 29600 346 <0.0001 
Age x treatment 1 2190 25.5 <0.0001 
Age x bleed 1 264 3.08 0.09862 
Treatment x bleed 1 9290 108 <0.0001 
Age x treatment x bleed 1 3540 41.4 <0.0001 
Residuals 16 1370 
Table 2.1. ANOVA results for the effect of age, immune challenge and 
haemolymph collection method on antimicrobial peptide assay. 
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2.7 Discussion 
This chapter has focussed on three main areas: firstly the beekeeping 
techniques and methods used in the lab, second the optimising of the PO and 
ProPO assays for use with the honey bee and thirdly, optimising the use of an 
antimicrobial assay. 
2.7.1 Bee Specificity 
The optimisation of the PO and ProPO assay to be bee-specific highlighted 
some species-specific responses. The use of a-chymotrypsin as the most 
successful activator of ProPO in bees contrasts with the results of Thompson 
(2002) in T. molitorwhere LPS was a stronger activator. a-chymotrypsin is a 
general protease, and as such is capable of causing damage if not controlled. 
Higher levels of a-chymotrypsin were shown to have a negative effect on 
ProPO activation, and highlighted the sensitivity of the assay to changes in 0.-
chymotrypsin concentration. High concentrations of LPS and a-chymotrypsin, 
when used as activators, have also been shown to have a negative effect on 
ProPO activation in T. mo/itor (Thompson, 2002). 
Further research into the effect of the activators has shown that long 
incubation times with the activator, as used by many previous researchers (e.g. 
Schmid et a/., 2008), can dramatically reduce the concentration of ProPO 
available for assay. Consequently an incubation time of 5 minutes was chosen 
for all subsequent ProPO assays in this thesis. Longer incubation times allow 
more of the PO (activated from the ProPO) to be degraded by the PPAE, or 
removed by combining into larger protein aggregates, both regulatory 
mechanisms to avoid the deleterious autoimmune effects of high concentrations 
of active PO (Nappi et a/., 1995; Nappi et al., 2004; K. S()derh~lI, pers. comm.). 
Although samples assayed with long incubation times within an experiment will 
be comparable with each other, it is difficult to say exactly what the assay is 
measuring, as it is neither the maximum immune investment (Le. all ProPO and 
all PO), nor just the PO or ProPO responses. 
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2.7.2 Determining sampling time in new bees 
Results for the timecourse showed an increase in PO concentration with age, 
with a significant difference in the PO responses of the different treatment 
groups. This difference became more pronounced with time: up to 12 hours 
there was little difference between the responses of the treatment groups. This 
suggests that during the first 12 hours post-eclosion, PO is being utilised in the 
sclerotisation of the cuticle and is therefore not available for immune response. 
Overall, ProPO concentrations within each treatment group remained 
constant throughout the timecourse, although there was a significant difference 
in the responses between the treatment groups. The contrast between the PO 
and ProPO results, with PO activity increasing over time whilst ProPO activity 
remained relatively constant, were seen in subsequent experiments (Sections 
3.3.4 and 4.3.2, see Section 2.5.3.2 for discussion). Results from the 
timecourse showed a decrease in PO and ProPO activity levels following an 
immune challenge with LPS. Previous studies have shown the opposite 
response, with active PO levels increasing as ProPO is activated during the 
immune response (Ashida and Yamazaki, 1990). However, the response seen 
with the honey bees has recently been replicated in the African armyworm, 
Spodoptera exempta, and damselfly larvae, Ischnura elegans (S. Povey, S. 
Slos, pers. comm.). The lower levels of PO and ProPO activity seen following 
an immune challenge may be due to the rapid utilisation of PO in the immune 
response, which in turn leads to the activation of ProPO to replace the active 
PO. The reduction in levels may therefore be due to the inability of the 
haemocytes to replenish ProPO at the same rate as it is being used. 
The experiment highlighted a difference in the immune responses of 
different hives. Whilst Hive F recorded higher concentrations of PO, and Hive G 
showed a change in ProPO with time, the overall immune responses of the four 
treatment groups were qualitatively similar. Previous research on honey bee 
immunity differs in the number of colonies included within an experiment, 
although there are obvious differences in levels of parasite infection and 
immunity between colonies (e.g. Yang & Cox-Foster, 2007; Wilson-Rich et al., 
2008; Chen et al., 2004a; Evans & Pettis, 2005; Decanini et a/., 2007). Future 
experiments in this thesis will compare the immune responses in two hives as a 
check that immune responses measured are consistent and repeated in more 
than one hive. 
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2.7.3 AMP Assay in Bees 
Antimicrobial peptide (zone of inhibition) assay can be successfully used to 
measure antimicrobial peptide production in honey bees. Haemolymph samples 
collected using a perfusion bleed showed little antimicrobial response, and this 
is undoubtedly due to the dilution of the active compounds and hence the 
subsequent lack of sensitivity of the assay. Future assays will therefore be 
conducted using neat haemolymph samples. Both an immune challenge with 
LPS and increasing age produced an increase in antimicrobial peptide 
production, and this will be fully explored in later chapters. These results, 
combined with the low error in measuring the zones of inhibition suggest that 
this assay can successfully be added to the arsenal of techniques for measuring 
immune responses in the honey bee. 
2.8 Summary 
In this chapter, I have: 
1. Described the honey bee husbandry methods and protocols used to 
maintain and challenge bees in this thesis 
2. Developed and optimised an assay for measuring phenoloxidase in the 
honey bee and have: 
a. Shown that honey bee phenoloxidase enzyme kinetics conform to 
the Michaelis-Menton equation 
b. Obtained a value for the Michaelis constant, Km 
c. Calculated the optimal workable concentration of L-DOPA used in 
the assays 
3. Developed and optimised an assay for measuring prophenoloxidase in 
the honey bee 
4. Developed and optimised an antimicrobial peptide assay in the honey 
bee 
5. Shown all assays to be highly repeatable 
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Chapter 3 
Ontogeny of worker immunity 
3.1 Introduction 
3.1.1 Developmental Immunity 
Relatively few studies have followed the changes that occur in invertebrate 
immune systems throughout development and metamorphosis (Schmid et al., 
2008; Wilson-Rich et al., 2008). The expression of immunity-related genes is 
known to differ both between and within developmental stages, but little is 
known about the impact of this variation on immune responses (Evans, 2004; 
Chan et al., 2006). Cellular and antimicrobial responses have been shown to 
vary with developmental stage in several different insects (Natori et al., 1999; 
Chung & Ourth, 2000; Evans & Lopez, 2004; Meylaers et al., 2007; Freitak et 
al., 2007; Dubovskiy et al., 2008; Elefthianos et al., 2008; Wilson-Rich et al., 
2008), with small changes in age resulting in significant changes in immune 
response, which are variable across different study species (e.g. Eleftherianos 
et al., 2008; Wilson-Rich et al., 2008). 
Honey bees are holometabolous with a developmental period of 21 days 
for workers (see Figure 3.1, Hooper, 1997). Larvae are fed by nurse bees, 
which produce brood food from their hypopharyngeal and mandibular glands 
and feed the larvae until the cell is sealed with a wax cap (Winston, 1987). 
Brood food contains honey, which has been shown to have antibiotic properties, 
and may offer some bacterial resistance to the larvae (Winston, 1987; Lusbyet 
a/., 2005; Maeda et a/., 2008). Brood is kept at the centre of the hive, and this 
structural organisation provides a prophylactic defence barrier, minimising 
forager's (potentially carrying pathogens) contact with brood (Schmid-Hempel, 
1998; Cremer etal., 2007). 
In addition, the hygienic behaviour of adult bees towards the larvae, and 
physiological processes that occur during development, make it hard for a 
pathogen to become established (Bailey & Ball, 1991; Schmid-Hempel, 1998; 
Spivak & Boecking, 2001; Cremer et a/., 2007). Once the cell is capped, larvae 
form a propupa and stop feeding. The capped cell represents a protective 
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Figure 3.1. Developmental stages of the worker honey bee (taken from Winston, 1987). Development from egg to 
imago takes approximately 21 days. Pupal stages can be distinguished by their eye colour: day 12-14 = white-eyed 
pupae, day 15-20 = red eyed pupae (red stage may be further split into pink-eyed (days 15-17) and purple-eyed 
(days 18-20». Older red-eyed stages are accompanied by an increase in cuticular melanisation (Hooper, 1997; 
Michelette & Soares, 1993). 
environment in which to undergo metamorphosis (see Chapter 5 for 
exceptions), during which time the high levels of proteases needed for the 
degradation of larval tissue present a hostile environment for invading 
pathogens (e.g. Natori et al., 1999). All of these factors contribute to the 
reduced risk of pathogen infection during development. Despite this, bees are 
subject to a wide range of parasites (see Section 1.4.3, Table 1.1), many of 
which infect bees during the larval and pupal stages of development. 
PO activity in bee pupae has been shown to increase successively as 
pupae age and increase their cuticular melanisation (Zufelato et al., 2004), but 
to date little work has linked developmental stages and response to immune 
challenge in bees (Schmid et al., 2008; Wilson-Rich et al., 2008). 
3.1.2 Age polyethism 
In the summer months, honey bee workers exhibit age polyethism, with younger 
bees performing tasks within the hive, such as nurSing, and older bees working 
as foragers (Robinson, 1992). This task partitioning represents a temporary, 
dynamic division of labour. Figure 3.2 shows the different tasks performed, and 
the age range associated with each task. The transition from hive bee to forager 
is brought about by physiological and behavioural changes (Robinson, 1992). 
As workers approach foraging age, the mandibular, hypopharyngeal and wax 
glands all reduce in size, and the mandibular glands switch production from 
brood food to alarm pheromone. The onset of foraging activity is also 
associated with a 40% decrease in body mass and an increase in oxygen 
consumption and tissue glycogen levels, all of which help to increase the 
effiCiency of the forager (Neukirch, 1982; Winston, 1987). Foraging activity 
involves a high level of energy expenditure, and 98% of all bees die whilst 
foraging (Lundie, 1925; Neukirch, 1982). 
The switch from hive bees to foragers is associated with an increase in 
levels of juvenile hormone (JH) and a decrease in the yolk precursor 
vitellogenin (Robinson, 1987; Om holt & Amdam, 2004). Despite being 
conditionally sterile, workers still produce vitellogenin, which has an additional 
role as a regulator for somatic maintenance in foragers (Om holt & Amdam, 
2004). Vitellogenin is the main carrier protein for zinc in the haemolymph, a 
lack of which causes pycnosis (cell death) of the haemocytes (Falchuk, 1998; 
Amdam et a/., 2004, Amdam et al., 2005). This decrease in functioning 
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Figure 3.2. Overlap of age-related tasks performed by workers. Table taken 
from Winston, 1987. There is considerable variation in the ages at which these 
tasks are performed, and a worker may carry out several different tasks at the 
same time. 
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haemocyte number should reduce the bee's capacity for cellular-based immune 
responses such as PO, encapsulation and phagocytosis (Bedick et al., 2001; 
Amdam et a/., 2004; Robinson, 1992; Omholt & Amdam, 2004; Amdam et al., 
2005). Support for this is seen by the loss of a nodulation response (a cellular 
immune response) in foragers compared to newly emerged bees (Bedick et al., 
2001), but other immune responses have yet to be investigated. 
Commonly, aging in both vertebrates and invertebrates is associated 
with increased activation of the innate immune system (DeVeale et al., 2004; 
Zerofsky et al., 2005), but the maintenance of an immune system throughout 
life is costly (e.g. Kaaya & Darji, 1988; Zerofsky et al., 2005; KOnig & Schmid-
Hempel, 1995; Moret & Schmid-Hempel, 2000). Foraging bees leaving the hive 
experience a higher risk of pathogen infection, and may therefore favour an 
increased level of immune investment (Bocher et a/., 2007). Conversely, the 
process of age polyethism selects nutrient depleted foragers to undertake the 
most hazardous tasks towards the end of their life, and therefore the need and 
ability to invest in an immune response may be removed. It is therefore unclear 
whether newly emerged bees or foragers should have the higher immune 
system. 
3.1.3 Chapter Predictions 
Based on this information, we can make predictions about the expected 
outcome of the investigation into ontogeny and the immune response. I predict 
that: 
1. Larvae, which are nursed in a protective environment will exhibit little 
or no investment in the immune response 
2. During the physiological changes that occur throughout the transition 
into the pupal stage, and subsequent melanisation of the cuticle, PO 
levels will increase, but not as a function of the immune response 
3. There will be an effect of age polyethism on immune investment but 
the direction of this change is unclear. 
3.1.4 Chapter Aims 
This chapter aims to investigate the impact of different aspects of aging on 
immunity in worker bees. Using assays developed in Chapter 2, I examine: 
1. The impact of immune challenge on bee survival (Section 3.2.1) 
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2. Developmental changes in a) PO and b) ProPO responses (Section 
3.2.2) 
3. The effects of age polyethism on measures of a) PO, b) ProPO and c) 
antimicrobial peptides (Sections 3.2.3, 3.2.4 & 3.2.5). 
3.2 Materials and Methods 
3.2.1 Bee longevity 
Bee longevity in the lab was examined to ensure that lab conditions did not 
significantly reduce mortality. When kept in hives, the life expectancy of a 
worker bee is approximately 36 days in the summer months (Hooper, 1997). 
This extends to 6 months for overwintering individuals, although this figure is 
subject to wide variation both within and between subspecies of bee (Hooper, 
1997). Although none of the lab experiments designed during this research 
required bees to be kept alive in the lab for more than 3 days, it was important 
to ensure that, as far as possible, the lab-based bee boxes provided a suitable 
habitat for the bees over this time-frame. In addition, bees were divided into 
treatment groups to monitor the effect of immune challenge on longevity. 
A brood frame was collected from a single hive and incubated overnight 
to allow adults to emerge. Bees were split into 4 treatment groups: no challenge 
(n=42), sham injected (n=56), injected with 1 J.l1 insect Ringer (n=88), injected 
with 1 J.l1 LPS (0.5mgmr1) in insect Ringer (n=99). Each treatment group was 
housed in a bee box (36°C ± 1°C with a 12:12h L:D photoperiod) and provided 
with a 50% sugar solution and dH20 ad libitum. Bees were checked daily for 
deaths, and dead bees were removed and recorded. 
3.2.2 Developmental Immunity 
Brood frames were collected from two hives (Hives A & B). Frames contained 
brood at different stages of development. Bees were assayed at five different 
developmental stages: 4th instar larvae (uncapped), 5th instar larvae (capped), 
white-eyed pupae (white-eyed), red-eye pupae (red-eyed) and newly emerged 
adults (adult). Preliminary experiments found that no PO or ProPO could be 
measured in early instar larvae (pers.obs.). Bees were assessed on their 
developmental stage based on size, positioning within the cell and, in the case 
of pupae, eye and thorax colouring (Hooper, 1997; Michelette & Soares, 1993). 
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Bees in each developmental stage were removed from the brood cells. Care 
was taken not to damage the fragile larval and pupal stages. Individuals that 
sustained damage (seen as a dark melanin response) were discarded. 
Individuals were housed in 25-well sectioned boxes. They were laid on moist 
cotton wool to maintain a high humidity and, in the case of larvae, provided with 
brood food obtained from brood cells. Adults were incubated in bee boxes as 
standard. Body mass (wet weight) was recorded as a measure of body size. 
Each of the 5 developmental stages was split into 4 treatment groups to 
measure the effect of an immune challenge on immune response (No 
Challenge, Needle, 11J1 Ringer, 11J1 LPS in Ringer, n = 11-79 per treatment age 
group). Larvae are essentially a fluid-filled sac, so extra fine needles (11 OIJI 
diameter) were used to puncture the cuticle without causing loss of 
haemolymph. Injections were made approximately one third of the way down 
the right-hand side of the larval body. Bees were incubated for 24 hours (45% 
humidity ± 5% in incubator, 24 hour dark photoperiod). 24 hours post challenge, 
bees were assessed for survival. In pupae, this was recorded as a continued 
development, confirmed by changes in eye and body colour. In uncapped 
larvae, survival was recorded as any voluntary movement. In capped larvae, 
individuals that lacked body shape and definition, showed no initiation of head 
development or had turned an opaque white colour throughout were judged to 
be dead, and discarded. 
Haemolymph samples from surviving bees were collected through 
perfusion bleeds with 0.25ml sodium cacodylate buffer. A volume of 0.25ml of 
buffer was used for all bees in order to obtain recordable PO and ProPO levels 
in the earlier developmental stages. Samples were assayed for PO and ProPO 
by the standard method (Chapter 2, Sections 2.3.11 & 2.4.14). Larval bees 
contain a lot of fat, which was unavoidably collected in the haemolymph 
samples, and the effect of the lipid on the PO and ProPO assays was 
investigated (Appendix 1, A 1.3). Lipids were shown to breakdown during the 
assay, which resulted in negative enzyme curves. Samples that recorded this 
breakdown contained no recordable PO or ProPO, and the presence of lipids 
did not affect this immune result. 
After defrosting, all samples were centrifuged twice (4°C, 80,OOOG, 15 
minutes), with as much lipid as possible removed by pipette between cycles. 
The clear supernatant was then used in the reaction mixture as standard. 
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3.2.3 Age Polyethism and Phenoloxidase 
To investigate the difference in immune responses of hive (new) and forager 
(old) bees, workers were collected from two hives (Hives A and B) at two 
distinctly different life-stages. New bees were collected as newly emerged 
workers from a brood frame incubated overnight (36°C ± 1°C, 40% ± 2% 
humidity). Old bees were collected as they returned to the hive following a 
foraging trip. Although not controlled for age, old bees had to exhibit a sign of 
foraging activity (pollen collected on legs) in order to distinguish them from 
younger workers making test flights. 
To examine how the different ages responded to an immune challenge, 
each age group was split into 4 treatment groups (No Challenge, Needle, 11-11 
Ringer and 11-11 LPS in Ringer, n=15-44 for each age:treatment group per hive). 
Treatment groups were housed in separate bee boxes and haemolymph 
samples collected 24 hours post-challenge. Samples were assayed for PO and 
ProPO as standard (Chapter 2, Sections 2.3.11 & 2.4.14). Thorax width was 
recorded for all bees to obtain a control for body size. 
3.2.4 Age Polyethlsm: Timecourse 
Bees venture out of the hive on test flights at approximately 5 days old (Hooper, 
1997). Therefore, they are likely to be exposed to pathogens outside of the hive 
before they become foragers. If foragers increase their immune investment in 
response to the increase in pathogens encountered outside the hive, this up-
regulation in immunity should be initiated as soon as they start to leave the 
hive, regardless of polyethism structure. If an up-regulation in immune 
investment occurs in response to cumulative pathogen encounters, we would 
expect to see immunity increased continually with age. If however, the up-
regulation of the immune system in foragers occurs as part of the suite of 
physiological changes associated with the shift in polyethism, then we would 
expect investment in immune response to remain low in younger hive bees. To 
establish whether changes in immune response with age are a reaction to 
increased interaction with pathogens as bees start to venture outside, worker 
brood frame was collected from two hives (Hives G and H), and incubated 
overnight (36°C ± 1°C, 40% ± 2% humidity). Newly emerged workers were 
marked with a dot of acrylic paint on the thorax and released back into their 
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original hive. Marked bees were recaptured at 1, 2, 3,4, 5, 6, 7,and 14 days 
old. None of the bees should have started foraging at this age. 
To examine how different ages responded to an immune challenge, each 
age group was split into 4 treatment groups (No Challenge, Needle, 1j.J1 Ringer 
and 1j.JllPS in Ringer, n = 4 - 20 per treatment group, per hive (low sample 
size in some groups is due to incubator overheating causing death». Treatment 
groups were housed in separate bee boxes with 50% sugar syrup and dH20 ad 
libitum. Haemolymph samples were collected 24 hours post challenge and 
assayed for PO and ProPO as standard (Chapter 2, Sections 2.3.11 & 2.4.14). 
Thorax width was recorded for all bees to obtain a control for body size. 
3.2.5 Age Polyethism and Antimicrobial Peptides (AMPs) 
Preliminary studies had found an immune challenge and increasing age lead to 
an increase in AMP production (Section 2.6.3). Bees were sampled from two 
different hives (Hives F and G). The presence of AMPs in the haemolymph was 
investigated using the zone of inhibition assay (Chapter 2, Section 2.6.2). 
Workers were sampled at two different ages, corresponding to the extremes of 
age polyethism that are observed with honey bees. New bees were sampled at 
24 hours old, and old bees were collected as they returned to the hive following 
a foraging trip. Although not controlled for age, foragers had to exhibit a sign of 
foraging activity (pollen collected on legs) in order to distinguish them from 
younger workers making test flights. 
To obtain the new bees, frames of worker brood were collected from two 
hives and incubated over night (36°C ± 1°C, 40% ± 2% humidity). Newly 
emerged workers were collected the following day, as were the old bees, which 
were collected directly from the hives. To investigate the effect of an immune 
challenge on the two age groups, the bees in each age group were further split 
into 4 treatment groups (No Challenge, Needle, 1j.J1 Ringer and 1j.JllPS in 
Ringer, treatment sample sizes ranged from 13-28, average n = 20). Treatment 
groups were housed in separate bee boxes and neat haemolymph was 
collected 24 hours post challenge. Samples were assayed for AMP activity as 
standard (Chapter 2, Section 2.6.6). The thorax width of each bee was 
measured to control for body size, and the mortality rate for each treatment 
group was recorded. 
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3.2.6 Presentation of Results 
In all experiments, the No Challenge and LPS treatment groups showed the 
extremes of the range of immune responses seen. For clarity, graphical data 
are only presented for these two treatment groups. The Needle and Ringer 
treatment groups provided wounding and vehicle controls, and showed a 
staggered response between the two extremes. Graphs with all four treatment 
groups can be found in Appendix 2, Section A2.1. 
3.3 Results 
3.3.1 Bee Longevity 
Bee longevity was recorded using a binomial score for time to death, and an 
analysis of deviance run using a GLM with a Gamma family error structure (as 
the variance is proportional to the square of the means). 
There was a significant effect of treatment on bee longevity (Figure 3.3). 
Survival analysis showed that there is a significant effect of treatment on 
survival (GLM, p<O.001, d.f. =3,281, gamma errors), with the challenge of LPS 
and Ringer leading to lower survival. This suggests that there is a cost to 
mounting the immune response. 
3.3.2 Developmental Immunity 
Both hives produced qualitatively similar results, but were analysed separately 
due to quantitative differences in the immune responses. 
Within both hives, the earlier developmental stages, particularly the 
larvae, commonly contained no recordable PO (samples recorded negative 
enzyme curves - see Appendix 1, Section A 1.3 for explanation). This resulted 
in a positive skew in the distribution, and subsequently the dataset could not be 
transformed to conform to the assumptions of normality. Data were scored 
categorically as having a positive or zero PO response, and the proportion of 
each was analysed using a binomial distribution. Figures 3.4 and 3.5 show the 
full results for the 5 different developmental stages samples for Hives A and B. 
The proportion of samples recording zero PO concentration was then compared 
for each age:treatment group combination for Hive A (Figure 3.6) and Hive B 
(Figure 3.7). Samples containing no recordable PO were then removed from the 
data sets, and remaining samples were analysed against each other for each 
hive. 
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Figure 3.3. Bee longevity showing the percentage survival of worker bees over 
time post challenge. Four treatment groups were used to measure the effect of 
an immune challenge on survival (No Challenge, Needle (sham injection), 11-11 
Ringer and 11-'1 LPS in Ringer). Survival analysis using a GLM with gamma 
errors showed that there was a significant effect of treatment on survival, with 
the challenge of LPS and Ringer leading to lower survival. 
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Hive A 
PO: Figure 3.6 shows the proportion of samples that contained no recordable 
PO concentrations. There was a significant effect of developmental age on the 
proportion of samples containing no recordable PO (Figure 3.6, F 4,522 = 60.5, 
p<0.0001, binomial errors), with early developmental stages commonly 
containing no recordable PO, whilst adults always had a measurable level of 
PO activity. 
Figure 3.8 shows the PO results with those samples that recorded a PO 
concentration of zero removed. There was a significant effect of body size, age 
and immune challenge on PO activity (Table 3.1). Challenge with LPS produced 
lower levels of PO activity, and, where present, larval and pupal stages had 
higher levels of PO activity than adults. 
ProPO: There was a significant effect of body size, age and immune challenge 
on ProPO activity (Figure 3.10, Table 3.2), with adults containing higher 
concentrations of ProPO than the larval and pupal stages. 
HiveB 
PO: Figure 3.7 shows the proportion of samples that contained no recordable 
PO activity. There was a significant interaction between age and treatment 
groups (Figure 3.6, F12.625= 2.08, p=0.01519, binomial errors), with all 
developmental stages except adults commonly containing at least 60% samples 
with no recordable PO levels. 
Figure 3.9 shows the PO results with all samples recording a PO 
concentration of zero removed. There was a significant effect of age and body 
size on PO activity, with adults having lower PO levels compared to the other 
developmental stages that produced an immune response (Table 3.3, ANOVA, 
F4.224 = 10.9, p<0.0001, data log10 transformed). There was no effect of 
treatment group on PO activity. 
ProPO: There was a significant effect of body size, age and treatment on 
ProPO concentration (Figure 3.11, Table 3.4). ProPO activity was maintained at 
a constant level throughout development, and increased in adults following 
eclosion. ProPO activity was lower overall in LPS challenged bees. 
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Figure 3.4. Hive A: PO concentrations for all samples for all 5 developmental 
stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed pupae, 4 = red-
eyed pupae, 5 = adults), for the No Challenge and LPS immune challenge 
treatment groups. The larval and pupal stages contained a high proportion of 
individuals with no recordable PO concentration. 
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Figure 3.5. Hive B PO concentrations for all samples for all 5 developmental 
stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed pupae, 4 = red-
eyed pupae, 5 = adults) , for the No Challenge and LPS immune challenge 
treatment groups. The larval and pupal stages contained a high proportion of 
individuals with no recordable PO concentration . 
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Figure 3.6. Hive A: Percentage of bees in each developmental stage by 
treatment group recording zero PO for each developmental stage: 0 = No 
Challenge, [J = Needle, • = Ringer and • = LPS. There was a significant 
effect of age on the proportion of samples containing no recordable PO. 
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Figure 3.7. Hive B: Percentage of bees in each developmental stage by 
treatment group recording zero PO for each developmental stage: 0 = No 
Challenge, Cl = Needle, • = Ringer and • = LPS. There was a significant 
interaction between age and treatment group. 
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Figure 3.S. Hive A: Concentrations of PO in samples that returned a recordable 
value for all 5 developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 
= white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge and 
LPS treatment groups. There was significant effect of body size, age and 
immune challenge on PO concentration (Table 3.1, data are log10 
transformed). 
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Figure 3.9. Hive B: Concentrations of PO in samples that returned a recordable 
value for all 5 developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 
= white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge and 
LPS treatment groups. There was a significant effect of body size and age on 
PO concentration (Table 3.3, data are log10 transformed). 
79 
Source d.f. Sum of . F-value P 
Body size 1 10.1 33.9 <0.0001 
Develop. stage 4 9.51 7.96 <0.0001 
Treatment 3 7.85 8.75 <0.0001 
Residuals 261 78.0 
Table 3.1. Hive A PO results for developmental immunity, with those samples 
that recorded a PO concentration of zero removed (data are log10 
transformed). There was a significant effect of treatment, developmental stage 
and body size on PO activity. 
Source d.f. Sum of F-value P 
Body size 1 14.6 146 <0.0001 
Develop. stage 4 31.5 78.6 <0.0001 
Treatment 3 3.29 10.9 <0.0001 
Residuals 519 52.0 
Table 3.2. Hive A ProPO results for developmental immunity (data are log1 0 
transformed). There was a significant effect of treatment, developmental stage 
and body size on ProPO levels. 
Source d.f. Sum of F-value P 
Body size 1 8.55 27.1 <0.0001 
Develop. stage 4 13.7 10.9 <0.0001 
Residuals 224 70.8 
Table 3.3. Hive B PO results for developmental immunity (data are log 1 0 
transformed). There was a significant effect of age and body size on PO levels. 
Source d.f. Sum of F-value P 
Body size 1 29.0 363 <0.0001 
Develop. stage 4 16.3 51.1 <0.0001 
Treatment 3 3.84 16.0 <0.0001 
Residuals 603 48.2 
Table 3.4. Hive B ProPO results for developmetal immunity (data are log10 
transformed). There was a significant effect of treatment, developmental stage 
and body size on ProPO activity. 
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Figure 3.10. Hive A: Concentrations of ProPO in samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults) , for the No Challenge and LPS 
treatment groups. There was a significant effect of body size, age and immune 
challenge on ProPO concentration (Table 3.2, data are log1 0 transformed) 
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Figure 3.11 . Hive B: Concentrations of ProPO in samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge and LPS 
treatment groups. There was a significant effect of body size, age and treatment 
on ProPO concentration (Table 3.4, data are log10 transformed). 
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3.3.3 Age Polyethism and Phenoloxidase 
In all cases, old bees had higher PO and ProPO concentrations than new bees 
(Figures 3.12, 3.13, 3.14 & 3.15). There was a significant difference between 
the responses of new and old bees in the two hives for both PO (AN OVA, F1,524 
= 39.5, p<0.0001) and ProPO (ANOVA, F1,524 = 149, p<0.0001), although both 
hives show a similar pattern of response. In both the PO and ProPO assays, 
the challenge with LPS resulted in lower PO and ProPO responses in the new 
bees. This suggests that in new bees, PO and ProPO are being utilised in the 
immune response faster that they can be manufactured and replaced. In old 
bees, immune levels are higher, which may reflect their increased exposure to 
parasites. As there was a significant difference between the responses of the 
two hives, each hive was analysed separately. 
Hive A: All treatment groups had higher levels of PO and ProPO concentrations 
in the old bees compared to the new bees. There was a significant interaction 
with age and immune challenge on PO (ANOVA, F3,209= 10.8, p<0.0001, Figure 
3.12, Table 3.5) and ProPO (ANOVA, F3,209 = 7.56, p<0.0001, Figure 3.13, 
Table 3.6) concentration. 
Hive B: In all treatment groups there was an up-regulation in PO and ProPO 
concentrations in the old bees compared to the new bees. There was a 
significant interaction with age and immune challenge on PO activity (ANOVA, 
F3,305 = 4.97, p=0.002, Figure 3.14, Table 3.7). 
There was a significant effect of age and immune challenge on ProPO 
activity (Figure 3.15, Table 3.8), with old bees having higher levels of ProPO 
activity. Treatment with LPS produced lower ProPO levels in both age groups. 
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Figure 3.12. PO response of the two age groups. new and old. in Hive A to the 
No Challenge and LPS treatment group. There was a significant interaction with 
age and immune challenge, with LPS challenged bees producing lower PO 
concentrations than the controls (results are log10 transformed). 
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Figure 3.13. ProPO response of the two age groups, new and old, in Hive A to 
the No Challenge and LPS treatment groups. There was a significant interaction 
of age with immune challenge (results are log1 0 transformed). 
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Source d.f. Sum of squares F-value P 
Thorax width 1 0.077 0.772 0.3808 
Age 1 31.3 312 <0.0001 
Treatment 3 19.0 63.3 <0.0001 
Age x treatment 3 3.25 10.8 <0.0001 
Residuals 209 20.9 
Table 3.5. PO results for age polyethism in Hive A (results are log10 
transformed). There was a significant interaction of age with treatment, with all 
treatment groups showing an increase in PO activity with age. Treatment with 
LPS resulted in lower PO levels overall. 
Source dJ. Sum of squares F-value P 
Thorax width 1 0.104 4.64 0.03233 
Age 1 1.73 76.8 <0.0001 
Treatment 3 1.60 23.7 <0.0001 
Age x treatment 3 0.510 7.56 <0.0001 
Residuals 209 4.70 
Table 3.6. ProPO results for age polyethism in Hive A (results are log10 
transformed). There was a significant interaction with age and treatment, with 
old bees having increased levels of ProPO activity. Treatment with LPS resulted 
in lower concentrations of ProPO, which was more pronounced in new bees. 
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Figure 3.14. PO response of the two age groups, new and old, in Hive B to the 
No Challenge and LPS treatment groups. There was a significant interaction 
with age and immune challenge on PO activity (Table 3.7, results are log10 
transformed) . 
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Figure 3.15. ProPO response of the two age groups, new and old, in Hive B to 
the No Challenge and LPS treatment groups. There was a significant effect of 
treatment and immune challenge on ProPO activity (Table 3.8, results are 10910 
transformed). 
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Source d.f. Sum of squares F-value P 
Thorax width 1 0.002 0.0145 0.9042 
Age 1 20.7 175 <0.0001 
Treatment 3 2.94 8.33 <0.0001 
Age x treatment 3 1.75 4.97 0.002221 
Residuals 305 35.9 
Table 3.7. PO results for age polyethism in Hive 8 (results are log10 
transformed). There was a significant interaction of age with treatment, with old 
bees exhibiting higher levels of PO activity. Challenge with LPS resulted in 
lower concentrations of PO in new bees. 
Source d.f. Sum of squares F-value P 
Thorax width 1 0.0675 2.70 0.1013 
Age 1 3.54 142 <0.0001 
Treatment 3 0.280 3.73 0.01162 
Residuals 308 7.69 
Table 3.8. ProPO results for age polyethism Hive 8 (results are log10 
transformed). There was a significant effect of age and treatment on levels of 
ProPO activity, with old bees having higher levels of ProPO activity. Challenge 
with LPS resulted in reduced levels of ProPO activity. 
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3.3.4 Age Polyethism: Timecourse 
None of the recaptured bees showed signs of foraging activity (pollen on legs). 
As foraging occurs at around 18+ days old (Seeley, 1982) it was assumed that 
none of the bees used in this experiment were working as foragers. There was 
a significant effect of Hive on both PO (ANCOVA, F1,617 = 121, p<0.0001) and 
ProPO (ANCOVA, F1,612= 229, p<0.0001) results, so hives were analysed 
separately. 
HiveG 
PO: There was a significant increase in PO activity with age (ANCOVA, F1,373 = 
15.8, p<0.0001, Figure 3.16, Table 3.9). There was also a significant effect of 
treatment group on PO, with the LPS challenged group having lower PO levels 
than the control (ANCOVA, F3,373 = 3.68, p=0.01229). 
ProPO: ProPO activity increased significantly over time (ANCOVA, F1,373 = 
15.6, p<0.0001, Figure 3.17, Table 3.10), with LPS challenged bees having 
lower levels of ProPO than the controls throughout the timecourse (ANCOVA, 
F3,373 = 4.36, p=0.00495). 
HiveH 
PO: There was a significant increase in PO activity with worker age 
(Regression, F1,238 = 9.26, p=0.002599, Figure 3.18, Table 3.11), but no effect 
of treatment group on immune response. 
ProPO: LPS challenged bees had significantly lower levels of ProPO activity 
than control bees (ANOVA, F1,236 = 6.29, p=0.0004, Figure 3.19, Table 3.12), 
but there was no significant increase in activity with age (p=0.05155). However, 
as age is nearly statistically significant, it does support the trend for increasing 
PO and ProPO levels with increasing age. 
If we look at these results compared to those with old workers that have started 
foraging activities (Section 3.3.3), it can bee seen that foraging old bees had 
slightly higher levels of PO and ProPO activity than the 14-day old bees seen 
here. However, they are comparable with a continued increase in immunity at 
the rate seen during the first 14 days of adult life. In both hives, the start of test 
flights does not correspond to a sudden increase in immune investment; rather 
the levels of PO and ProPO activity seem to be continuously increasing from 
the moment of eclosion. 
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Figure 3.16. Hive G: Change in PO with age, for the first 14 days of adult 
worker life, for the No Challenge and LPS treatment groups. Dashed line 
represents the age at which test flights start. There was a significant effect of 
age and treatment on PO activity (Table 3.9, data are log10 transformed). 
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Figure 3.17. Hive G: Change in ProPO with age, for the first 14 days of adult 
worker life, for the No Challenge and LPS treatment groups. Dashed line 
represents the age at which test flights start. There was a significant effect of 
age and treatment on ProPO activity (Table 3.10, data are log 1 0 transformed). 
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Figure 3.18. Hive H: Change in PO with age, for the first 14 days of adult 
worker life, for the No Challenge and LPS treatment groups. Dashed line 
represents the age at which test flights start. There was a significant effect of 
age on PO activity (Table 3.11, data are log10 transformed). 
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Figure 3.19. Hive H: Change in ProPO with age, for the first 14 days of adult 
worker life, for the No Challenge and LPS treatment groups. Dashed line 
represents the age at which test flights start. There was a significant effect of 
treatment on ProPO activity (Table 3.12, data are log10 transformed). 
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Source d.f. Sum of squares F-value P 
Thorax width 1 0.0078 0.161 0.6883 
Age 1 0.767 15.8 <0.0001 
Treatment 3 0.535 3.68 0.01229 
Residuals 373 18.1 
Table 3.9. PO results for polyethism timecourse in Hive G (results are log10 
transformed). There was a significant increase in PO activity with age. LPS 
challenged individuals had lower levels of PO activity overall. 
Source d.f. Sum of squares F-value P 
Thorax width 1 0.000 0.0152 0.9019 
Age 1 0.448 15.6 <0.0001 
Treatment 3 0.375 4.36 0.00495 
Residuals 373 10.7 
Table 3.10. ProPO results for polyethism timecourse in Hive G (results are 
log10 transformed). There was a significant increase in ProPO activity with age. 
LPS challenged individuals had lower levels of ProPO activity overall. 
Source 
Thorax width 
Age 
Residuals 
d.f. Sum of 
1 0.544 
1 0.490 
238 12.6 
F-value 
10.3 
9.26 
p 
0.001533 
0.002599 
Table 3.11. PO results for polyethism timecourse in Hive H (results are log 1 0 
transformed). There was a significant increase in PO activity with age. 
Source 
Thorax width 
Treatment 
Residuals 
d.f. 
1 
3 
236 
Sum of squares 
0.113 
0.284 
3.55 
F-value 
7.48 
6.29 
p 
0.006726 
<0.001 
Table 3.12. ProPO results for polyethism timecourse in Hive H (results are 
log10 transformed). LPS challenged individuals had significantly lower levels of 
ProPO activity. 
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3.3.5 Age Polyethism and Antimicrobial Peptides 
Mortality rate: There was no effect of immune challenge on mortality, but there 
was a significantly higher mortality rate in the old bees compared to the new 
bees (F1.577 = 24.5, p<0.0001, binomial errors, data from both hives combined). 
The overall percentage mortality for new bees = 29.6%, and old bees = 50%. 
Antimicrobial peptides: Overall, there was an up-regulation of AMP 
production following an immune challenge with LPS. Figure 3.20 shows the 
zones of inhibition plates for new and old bee samples. In both plates, the effect 
of an immune challenge can be seen as larger zones of inhibition around the 
wells. Old bees showed much higher levels of melanin (seen as brown pigment) 
in their haemolymph samples, which is expected given the elevated levels of 
PO and ProPO found in the previous experiment. The presence of the melanin 
has been shown to have no effect on the inhibition assay (E. Haine, pers. 
comm.), so will not have biased the results. 
Hive F: There was a significant interaction between age and immune challenge 
(Figure 3.21, Table 3.13, ANOVA, F3.130 = 9.94, p<0.0001, results are square 
root transformed). Across both age groups, AMP production increased following 
an immune challenge. In the No Challenge group, AMP production was seen to 
increase in old bees. The LPS challenged group showed the opposite pattern, 
with a decrease in AMP production with increasing age. 
Hive G: There was a significant interaction between age and immune challenge 
(Figure 3.22, Table 3.14, ANOVA, F3.163= 8.75, p<0.0001, results are square 
root transformed). Hive G showed a similar pattern of responses as Hive F, with 
both age groups exhibiting an increase in AMP production following an immune 
challenge. Again, AMP production increased with increasing age in all but the 
LPS treatment group. 
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Figure 3.20. Zones of inhibition within a lawn of A. g/obiformis, caused by antimicrobial peptides from haemolymph samples 
of A) new bees, and 8) old bees. The plate was split between the 4 different treatment groups: 1 = No challenge, 2 = 
Needle, 3 = Ringer, 4 = LPS. In old bees there was an obvious increase in melanin , seen as the dark areas around the 
wells. The presence of the melanin has been shown to have no effect on the inhibition assay (E. Haine, pers. comm.), and 
is likely to be a result of the elevated PO and ProPO concentrations found in old bees. 
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Figure 3.21. Antimicrobial peptide response of the two age groups, new and old 
bees, in Hive F in the No Challenge and LPS treatment groups. AMP activity was 
measured as the area of bacterial growth inhibition (mm2). There was a significant 
interaction between age and immune challenge (Table 3.13, results are square 
root transformed). 
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Figure 3.22. Antimicrobial peptide response of the two age groups, new and old 
bees, in Hive G in the No Challenge and LPS treatment groups. AMP activity was 
measured as the area of bacterial growth inhibition (mm2). There was a significant 
interaction between age and immune challenge (Table 3.14, results are square 
root transformed). 
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Source d.f. Sum of squares F value P 
Thorax width 1 4.74 0.984 0.3230 
Age 1 6.71 1.40 0.2398 
Treatment 3 786 54.4 <0.0001 
Age x treatment 3 143 9.94 <0.0001 
Residuals 130 626 
Table 3.13. Antimicrobial results for Hive F (results are square root transformed). 
There was a significant interaction of age and treatment group, with AMP 
production increased following an immune challenge with LPS. There was some 
indication of senescence, with the old bees unable to produce the same high levels 
of AMPs seen in new bees following an immune challenge. 
Source d.f. Sum of squares F value P 
Thorax width 1 19.9 3.70 0.05606 
Age 1 98.5 18.4 <0.0001 
Treatment 3 1590 98.8 <0.0001 
Age x treatment 3 141 8.75 <0.0001 
Residuals 163 874 
Table 3.14. Antimicrobial results for Hive G (results are square root transformed). 
There was a significant interaction of age and treatment group, with LPS 
challenged bees having higher concentrations of AMPs. The different response of 
the age groups suggests a senescence of the immune response. 
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3.4 Discussion 
This chapter has demonstrated that there are clear differences in the immune 
activity at different stages in honey bee development. Larvae and pupae have little 
immune activity, which may be because they are unlikely to be challenged with 
parasites: the brood is effectively sterile. However, adults are challenged with 
parasites and therefore invest in immune activity. Immune responses increased 
with age, which may be a reflection of the increased risk of pathogen encounters. 
There is no evidence that the increase in activity is associated with the switch to 
foraging activities, and may instead be due to an increase in cumulative pathogen 
exposure with age. 
3.4.1 Developmental Immunity 
As predicted, a large proportion of the larval and pupal samples did not contain a 
recordable level of PO activity (an average of 56% in Hive A and 72% in Hive B). 
This result is unlikely to be due to experimental error as all factors of this assay 
have been thoroughly investigated (Chapter 2, Section 2.3 and Appendix 1, 
Section A 1.3). These developmental stages may not need to maintain a costly 
active constitutive immune response as threat of pathogen infection is reduced due 
to the hygienic behaviour of nurse bees, or the protective housing of the capped 
brood cell. Active PO may be present but constantly utilised for functions outside of 
immunity such as cuticle sclerotisation and melanin production, and so be 
undetectable with this assay. Across all developmental stages, where present, 
active PO was maintained at very low concentrations (compared to the levels 
stored as ProPO), which is likely to be due to the cytotoxic effects of storing excess 
active PO in the haemolymph. 
Pre-adult developmental stages that did contain a recordable concentration 
of PO had levels of activity higher than those found in adults. Developing 
individuals with a high level of PO activity may be responding to previous immune 
challenge, such as feeding by Varroa mites, which were subsequently removed by 
the grooming practices of nurse bees (see Chapter 5). Alternatively, the high PO 
concentrations seen may be a consequence of the natural variation in immunity. As 
the analysis was carried out on developing stages from which a large percentage 
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of the population had been removed due to the lack of PO response, what remains 
may not be comparable to the adult population results as a whole. 
However, the capped larval and white-eyed pupal stages in both hives 
contained a higher proportion of individuals with recordable levels of PO activity 
than the other pre-adult stages (57% and 43% respectively), and this level of 
activity was, on average, higher than that in adults (Figures 3.8 & 3.9), which 
suggests that there may be a physiological reason for up-regulation in PO activity 
during this developmental period. 
Where recordable, PO levels were lower in individuals from the pupal and 
adult stages fol/owing an immune challenge with LPS. This response has been 
seen in several other insect species, and we believe is an indication of the use of 
PO in the immune response (5. Povey, S. Slos, pers. comm.) Larval stages with 
recordable PO levels showed little change in PO activity following a challenge with 
LPS, which suggests that either PO is not used for immunity at this life stage, or 
that PO levels recorded in these individuals are already a response to an 
undetermined immune challenge. 
Developmental results show that larval and pupal stages had a lower ProPO 
response compared to adult bees, and activity levels were qualitatively similar 
throughout development in both hives. In contrast to PO however there was a 
measurable level of ProPO in all larvae and pupae samples. In the control groups 
there was a stage-specific decrease in ProPO activity in the capped larval stage 
(see full graph in Appendix 2, Figure A2.1.5 & A2.1.6). This response was lost in 
the LPS challenged group, when ProPO activity increased to the same level as the 
other developmental stages. Processes occurring in the capped larval stage, such 
as the spinning of the cocoon may utilise ProPO, but resource allocation may be 
diverted towards the immune response following a challenge. ProPO activity was 
maintained at a steady level in all other larval and pupal stages, and may represent 
a maximum capacity for ProPO storage. 
Body mass was included in the analysis as a control for body size. As the 
uncapped larval stage stops feeding and undergoes metamorphoSis, body mass 
decreases as lipid stores are utilised. Therefore, the adult bees in this experiment 
had the lowest body mass, yet overall the highest levels of PO and ProPO activity. 
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This resulted in a significant effect of body size on both the PO and ProPO assays 
in both hives. 
3.4.2 Age Polyethism 
Results showed a universal up-regulation in PO, ProPO and AMP responses with 
increasing age in unchallenged bees. Previous research suggests that the oppOSite 
should be true, as the increase in haemocyte apoptosis with transition from hive 
bee to forager should reduce the level of cellular immune responses available 
(Robinson, 1992; Bedick et al., 2001; Amdam et al., 2004; Om holt & Amdam, 
2004; Amdam et al., 2005). Foragers have reduced numbers of functioning 
haemocytes (Amdam et al., 2005), which suggests that remaining cells may 
increase their levels of PO and ProPO production in order to produce the results 
obtained. Alternatively, as types of haemocytes have different functions in different 
insects, selection may be acting towards the survival of haemocytes with immune 
activity whilst causing pycnosis in those cell types with no link to immunity (Lavine 
& Strand, 2002). Recent work has shown both a decrease in haemocyte counts 
and a juxtaposed increase in PO activity with age in the honey bee (Wilson-Rich et 
al., 2008). 
Following an immune challenge with LPS, PO and ProPO levels decreased 
in new bees. This response was reduced or lost altogether in the old bees. Old 
bees may maintain a constant maximum level of PO and ProPO production. If they 
are under continuous attack from pathogens, the mechanisms for manufacturing 
and replacing PO and ProPO as it is used up in the immune response may already 
be operational. 
Results from the timecourse experiment showed that the difference in PO 
and ProPO levels between new and old bees was the product of a continuous 
increase in activity levels, beginning immediately after eclosion (see Section 2.5). It 
was predicted that an up-regulation of the immune response in old bees could be a 
prophylactic measure as the risk of pathogen encounter increases, or may be due 
to a greater cumulative exposure to pathogens. As the increase in PO and ProPO 
activity began even before new bees had left the hive for their first test flights, this 
cannot be the case. The increase may be due to bees responding to cues in the 
hive, such as the presence of pathogens, or pheromone contact with incoming 
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foragers, or the PO/ProPO immune response may simply increase as part of the 
physiological processes of aging. 
Workers up-regulated AMP production following an immune challenge with 
LPS. This response is seen in several other insects (Boulanger et al., 2001; 
Boulanger et al., 2002). As with PO and ProPO, there was also an increase in 
activity with age in unchallenged bees. The level at which AMP production was 
maintained in non-challenged bees was much higher than that seen in drones 
(Section 4.3.3), suggesting that workers have the resources to invest in a costly 
immune response even when not under threat. 
The AMP response in LPS-challenged bees decreased with age in Hive F 
(although not in Hive G), which may be a sign of immune senescence (Doums et 
al., 2002; Hillyer et al., 2005). Recent research has found a decrease in the fat 
body mass in old bees compared to new bees (Wilson-Rich et a/., 2008). Although 
the reduced fat body still produced AMPs in old bees, age-imposed limits on 
functioning ability would support the decrease in AMP production seen in the 
immune challenged old bees. 
The transition to foragers in bumble bees has been shown to correlate to a 
decrease in 'immunocompetence' (KOnig & Schmid-Hempel, 1995; Doums & 
Schmid-Hempel, 2000), but evidence for this in the honey bee is mixed and so far 
such concluSions cannot be drawn (Amdam et al., 2005; Schmid et al., 2008; 
Wilson-Rich et al., 2008). 
Summary 
This chapter investigated the impact of different aspects of aging on immunity in 
worker bees. Using assays developed in Chapter 2, I have shown that: 
1. Immune challenge significantly increased mortality (Section 3.3.1) 
2a. PO responses varied with developmental age (Section 3.3.2) 
2b. The ProPO immune response was maintained at a constant level 
throughout development, and increased following elcosion to an adult 
(Section 3.3.2) 
3a. PO and ProPO responses were higher in old bees compared to new 
bees, but this seemingly large up-regulation was the result of a 
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continuous increase that began immediately post-adult eclosion 
(3.3.4) 
3b. AMPs were up-regulated in old bees compared to new bees, and 
their production was greatly increased following an immune challenge 
(Section 3.3.5) 
4. Overall. immune challenge produced a decrease in PO and ProPO 
activity, and an increase in AMP production. 
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Chapter 4 
Ontogeny of drone immunity 
4.1 Introduction 
This chapter examines the development, and changes with age, of the immune 
responses of drones. Workers and drones have very different life histories, and 
drones provide an opportunity to investigate the immune investment of sexuals 
in the colony. Although in some circumstances the suppression of reproduction 
in workers of a colony may be reversed, this is rare and difficult to predict or 
reproduce for experimental purposes. The reproductive queens can be 
artificially reared to large numbers, but as only one can reside in a hive at a 
time, it is impractical to work on them under natural conditions. Therefore, by 
investigating immune investment in drones throughout development and adult 
life, this chapter aims to highlight the differences that exist between two of the 
honey bee castes, and attempt to link them to life-history. 
4.1.1 The Drone 
Unfertilised eggs laid by the queen develop into male drones. Drones have a 
slightly longer developmental time (24 days) compared to workers (21 days) 
(Winston, 1987), and their life history is very different. A colony produces only 
200-1,000 drones (compared to 50,000 workers) during the most productive 
summer months, and their sole function is to mate with a queen (Hooper, 1997). 
Drones are twice as big as workers, although they are reared on similar food 
(Hooper, 1997). They reach sexual maturity at 13 days post eclosion, and live 
approximately 22 days (Winston, 1987). They have no age polyethism and do 
not work for the colony, and all leave the hive for test-flights soon after 
emergence. 
During their lives, drones are potentially exposed to a similar range of 
parasites that infect workers. Workers and drones start their lives in the same 
brood environment, where they are subject to infection with a variety of 
parasites (see Table 1.1), and in the case of the Varroa mite, Varroa destructor, 
drone brood is favoured over workers for infestation (Hooper, 1997; Otten and 
Fuchs, 1988; Fuchs, 1992). Although as adults they have different behavioural 
patterns (for example, drones do not land on flowers), both castes return to the 
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hive at night, where the mixing of drones and foraging workers provides 
opportunities for the transfer of novel pathogens (Hooper, 1997; Boomsma et 
al., 2005; Cremer et al., 2007). 
Immune responses in the bumblebee, Bombus teffestris, have found that 
drones have a less intense encapsulation response than workers (Gerloff et al., 
2003; Baer & Schmid-Hempel, 2006), although results show no difference 
between male and female susceptibility to transmissible parasites (Ruiz-
Gonzalez & Brown, 2006). Male ants also have a lower immune response than 
both workers (Baer et al., 2005) and queens (Vainio et al., 2004). As honey bee 
drones are relatively short-lived compared to workers, we may also expect them 
to invest even less in an immune response, and instead channel their resources 
into sperm production and mating flights. 
4.1.2 Chapter Predictions 
From their life-history, we can formulate some predictions about the immune 
responses we might expect to see in drones throughout their development and 
adult life. I predict that: 
1. There will be little or no immune response in the larval stages, as they 
are tended by nurse bees and raised in a relatively sterile 
environment 
2. There will be an increase in PO and ProPO activity as it is needed for 
cuticle formation and melanisation in pupal drones 
3. Adult drones will have little or no immune responses, due to their 
short lifespan and selection to invest all resources into obtaining a 
successful mating. 
4.1.3 Chapter Aims 
This chapter will investigate the impact of different aspects of aging on immunity 
in the drone. Using assays developed in Chapter 2, I examine: 
1. Developmental changes in a) PO and b) ProPO responses (Section 
4.2.1) 
2. The effects of age on measures of a) PO, b) ProPO, c) mortality and 
d) antimicrobial peptides (Sections 4.2.2 and 4.2.3). 
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4.2 Materials and Methods 
4.2.1 Developmental Immunity 
The protocol of this experiment is identical to that used for investigating workers 
(Section 3.2.2). The same five developmental stages (uncapped larvae, capped 
larvae, white-eyed and red-eyed pupae and newly eclosed adults) were 
collected from two similar hives (D & E). Individuals were housed in 25-well 
sectioned boxes. They were laid on moist cotton wool to maintain a high 
humidity and, in the case of larvae, provided with brood food obtained from 
brood cells. Adult bees were incubated in bee boxes as standard. Body mass 
(wet weight) was recorded as a measure of body size. 
Each developmental stage was split into four treatment groups to measure the 
effect of an immune challenge on the immune response (No Challenge, Needle, 
1 IJI Ringer, 1 IJI LPS,-n=5-41, average n=19). Post challenge, bees were 
incubated for 24 hours (36DC, 45% humidity ± 5% in incubator, 24 hour dark 
photoperiod). Haemolymph samples from surviving bees were collected through 
perfusion bleeds with 0.25ml sodium cacodylate buffer. Samples were assayed 
for PO and ProPO as standard (Chapter 2, Sections 2.3.11 & 2.4.14). To 
reduce the lipid contamination of haemolymph samples (see Appendix 1, A 1.3), 
after defrosting, all samples were centrifuged twice (4DC, 80,OOOG, 15 minutes), 
with as much lipid as possible removed by pipette in ,between cycles. The clear 
supernatant was then used in the reaction mixture as standard. 
4.2.2 Age and Phenoloxldase 
My work on worker bees found an increase in PO and ProPO activity with age, 
and a decrease in activity following an immune response (Section 3.3.3). To 
investigate if PO and ProPO immune responses were the same in new and old 
drones, drones were collected at two different ages. 
A frame of drone brood was brought into the lab and allowed in hatch 
overnight (36DC ± 1DC, 40% ± 2% humidity). Approximately 180 newly emerged 
drones were marked with a spot of acrylic paint on the thorax, and released 
back into the hive. These drones were recaptured for assaying 2 weeks later, 
when they had reached sexual maturity ('old' drones). A second set of drones 
from the same brood frame was assayed at 24 hours old as 'new' drones. 
Drones (both new and old) were split into four treatment groups to test the 
response to an immune challenge (No Challenge, Needle, 1 IJI Ringer, 1 IJI LPS, 
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n=11-25). Insects were challenged and samples collected and assayed for PO 
and ProPO as in Section 3.2.3 and Chapter 2, Sections 2.3.11 & 2.4.14. Thorax 
width was measured to control for body size. Percentage mortality was also 
recorded for each age:treatment group combination. 
4.2.3 Age and Antimicrobial Peptides (AMPs) 
My work on worker bees found an increase in AMP production with age and 
immune challenge (Section 3.3.5). To test whether this increase also occurs in 
drones, drone frame was collected from a single hive. Brood was incubated 
overnight (36°C ± 1°C, 40% ± 2% humidity) and emerged drones were 
collected. Samples were split into two groups: approximately 50 drones were 
marked with a spot of acrylic paint and released back into the hive. These were 
recaptured two weeks later for assaying ('old' drones, 22 recaptured, of which 
17 survived). The second group ('new') drones were assayed at 24 hours old. 
Before assaying, bees from both groups were split into four treatment groups to 
test the response to an immune challenge (No Challenge, Needle, 11J1 Ringer, 
11J1 LPS, n=5-32). Post challenge, treatment groups were housed in separate 
bee boxes and neat haemolymph was collected 24 hours post challenge. 
Samples were assayed for AMP activity as standard (Chapter 2, Section 2.6.6). 
The thorax width of each bee was measured to control for body size. 
4.2.4 Presentation of Results 
In all experiments, the No Challenge and LPS treatment groups showed the 
extremes of the range of immune responses seen. For simplicity, graphical data 
are only presented for these two treatment groups. The Needle and Ringer 
treatment groups provided wounding and vehicular controls, and showed a 
staggered response between the two extremes. Figures for all four treatment 
groups can be found in Appendix 2, Section A2.2. 
4.3 Results 
4.3.1 Developmental Immunity 
Hives produced qualitatively similar results, but were analysed separately due 
to quantitative differences in the immune response (ANCOVA, F1•742 = 20.7, 
p<0.0001). As predicted, within both hives, earlier drone developmental stages 
commonly contained no recordable concentrations of PO (see Appendix 1, 
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Section A1.3 for explanation}. This resulted in a positively skewed distribution, 
and subsequently the dataset could not be transformed to conform to the 
assumptions of normality. The complete data sets for Hives D (Figure 4.1) and 
E (Figure 4.2) show the large number of samples in the larval and pupal stages 
that contained no measurable levels of PO. The proportion of samples 
recording a zero PO concentration was compared for each age:treatment group 
combination. Samples containing no recordable PO were then removed from 
the data sets, and remaining samples were analysed against each other for 
each hive. 
The complete data sets for ProPO in Hives D (Figure 4.7) and E (Figure 
4.8) also showed a number of samples in some developmental stages that 
contained no recordable levels of ProPO. As with the PO assay, the proportion 
of samples containing no recordable ProPO was analysed for each hive. 
Samples containing no recordable ProPO were then removed from the data 
sets, and remaining samples were analysed against each other for each hive. 
Hive 0 
PO: There was a significant effect of developmental stage on the proportion of 
samples containing no recordable PO (Figure 4.3, F 4,379 = 36.9, p<0.0001, 
binomial errors). There was a significant effect of both body size and 
developmental stage on PO concentration for those samples that contained a 
recordable concentration of PO (Figure 4.5, Table 4.1). Where PO was 
recordable, larval and pupal stages produced higher concentrations than the 
adult drones (see Section 4.4.1 for discussion). 
ProPO: There was a significant decrease in the proportion of samples with no 
recordable ProPO with increasing developmental age (Figure 4.9, F4,379 = 32.4, 
p<0.0001, binomial errors). There was a significant effect of body size and 
developmental stage on ProPO concentration for those samples that contained 
a recordable concentration of ProPO (Figure 4.11, Table 4.3). ProPO 
concentrations increased sequentially with developmental stage. 
Hive E 
PO: There was a significant effect of developmental stage on the proportion of 
samples containing no recordable PO (Figure 4.4, F4,359 = 26.2, p<0.0001, 
binomial errors). There was a significant effect of body size, developmental 
108 
stage and treatment on PO concentration for those samples that contained a 
recordable concentration of PO (Figure 4.6, Table 4.2). Where PO was 
recordable, larval and pupal stages produced higher concentrations than the 
adult drones. Treatment with LPS resulted in lower PO concentrations. 
ProPO: There was a significant effect of developmental stages on the 
proportion of samples containing no recordable ProPO, with later 
developmental stages containing more samples with recordable ProPO (Figure 
4.10, F4.359= 53.1, p<0.0001, binomial errors). There was a significant effect of 
body size, developmental stage and treatment on ProPO activity for those 
samples that contained a recordable concentration of ProPO (Figure 4.12, 
Table 4.4). ProPO activity increased with age, with the LPS treated drones 
recording lower levels of ProPO activity over all. 
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Figure 4.1. Hive D: PO concentrations for all samples for all 5 developmental 
stages (1 = uncapped larvae,_ 2 = capped larvae, 3 = white-eyed pupae, 4 = red-
eyed pupae, 5 = adults) , for the No Challenge and LPS treatment groups. The 
larval and pupal stages contained a high proportion of individuals with no 
recordable PO concentration . 
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Figure 4.2. Hive E: PO concentrations for all samples for all 5 developmental 
stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed pupae, 4 = red-
eyed pupae, 5 = adults) , for the No Challenge and LPS treatment groups. The 
larval and pupal stages contained a high proportion of individuals with no 
recordable PO concentration. 
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Figure 4.3. Hive 0: Percentage of drones in each developmental stage by 
treatment group recording zero PO: 0 = No Challenge, = Needle, • = 
Ringer and • = LPS. There was a significant effect of developmental stage on 
the proportion of samples containing no recordable PO. 
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Figure 4.4. Hive E: Percentage of drones in each developmental stage by 
treatment group recording zero PO: 0 = No Challenge, = Needle, • = 
Ringer and • = LPS. There was a significant effect of developmental stage on 
the proportion of samples containing no recordable PO. 
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Figure 4.5. Hive 0: Drone PO activity in samples that returned a recordable 
value, for all 5 developmental stages (1 = uncapped larvae, 2 = capped larvae, 
3 = white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge 
and LPS treatment groups. There was a significant effect of body size and 
developmental stage on PO concentration (Table 4.1, results are log1 0 
transformed). 
113 
_ It) 
~ d 
-o 
'I"" 
_8> 0 d 
C! 
.... , 
Control (No challenge) 
o 
I 
I 
I 
I 
-1... 
..,... 
I 
I 
I 
I 
I 
I 
I 
I g 
I 
-1... 
1 234 5 
~~I~er 
Developmental stage 
Treatment (LPS injection) 
C! _ 
.... 
- ~ -~ 0 
-o 
'I"" 
C> 
.Q C! _ 
o 
It) 9 -
C! _ 
.... , 
..,... 
I 
J ..,... 
..,... I I 
~~B 
I 
I 
I 
I 
I 
-1... 8 
..,... 
I 
I 
I 
8 
I 
I 
I 
I 
-1... 
o 
I , , , I 
1 234 5 
~~llr  
Developmental stage 
Figure 4.6. Hive E: Drone PO activity for samples that returned a recordable 
value, for all 5 developmental stages (1 = uncapped larvae, 2 = capped larvae, 
3 = white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge 
and LPS treatment groups. There was a significant effect of body size, 
developmental stage and treatment on PO concentration (Table 4.2, results are 
log10 transformed,). 
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Figure 4.7. Hive D: ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge and LPS 
treatment groups. The larval stages commonly contained no recordable level of 
ProPO. 
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Figure 4.8. Hive E: ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for the No Challenge and LPS 
treatment groups. The larval stages contained a high proportion of individuals 
with no recordable ProPO activity. 
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Figure 4.9. Hive D: Percentage of drones in each developmental stage by 
treatment group recording zero ProPO: 0 = No Challenge, = Needle, • ::: 
Ringer and • = LPS. There was a significant effect of developmental stage on 
the proportion of samples containing no recordable ProPO. 
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Figure 4.10. Hive E: Percentage of drones in each developmental stage by 
treatment group recording zero ProPO: 0 = No Challenge, = Needle, • = 
Ringer and • = LPS. There was a significant effect of developmental stage on 
the proportion of samples containing no recordable ProPO. 
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Figure 4.11 . Hive D: Drone ProPO activity in the samples that returned a 
recordable value. Results are shown for all 5 developmental stages (1 = 
uncapped larvae, 2 = capped larvae, 3 = white-eyed pupae, 4 = red-eyed 
pupae, 5 = adults), for the No Challenge and LPS treatment groups. There was 
a significant effect of body size and developmental stage on ProPO 
concentration (Table 4.3, results are square root transformed) . 
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Figure 4.12. Hive E: Drone ProPO activity in samples that returned a 
recordable value. Results are shown for all 5 developmental stages (1 = 
uncapped larvae, 2 = capped larvae, 3 = white-eyed pupae, 4 = red-eyed 
pupae, 5 = adults), for the No Challenge and LPS treatment groups. There was 
a significant effect of body size, developmental stage and treatment on ProPO 
activity (Table 4.4, results are square root transformed). 
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Source 
Body size 
Development stage 
Residuals 
d.f. Sum of squares 
1 30.6 
4 3.70 
155 29.8 
F-value P 
159 <0.0001 
4.81 0.001095 
Table 4.1. PO results for Hive 0 for the 5 developmental stages (results are 
log10 transformed). There was a significant effect of development stage on PO 
activity, with adults containing lower PO levels. 
Source d.f. Sum of squares F-value P 
Body size 1 73.3 537 <0.0001 
Development stage 4 11.7 21.4 <0.0001 
Treatment 3 1.38 3.38 0.01922 
Residuals 201 27.4 
Table 4.2. PO results for Hive E for the 5 developmental stages (results are 
log10 transformed). Adults contained significantly lower levels of PO than other 
developmental stages. Challenge with LPS resulted in reduced PO in adults. 
Source 
Body size 
Development stage 
Residuals 
d.f. Sum of squares 
1 872 
4 224 
340 822 
F-value 
360 
28.1 
P 
<0.0001 
<0.0001 
Table 4.3. ProPO results for Hive 0 for all 5 developmental stages (results are 
square root transformed). There was a significant increase in ProPO 
concentration with age. 
Source d.f. Sum of sguares F-value P 
Body size 1 73.6 32.8 <0.0001 
Development stage 4 112 12.5 <0.0001 
Treatment 3 33.3 4.94 0.002296 
Residuals 308 691 
Table 4.4. ProPO results for Hive E for the 5 developmental stages (results are 
square root transformed). There was a significant effect of age and treatment on 
ProPO activity. There was a general increase in ProPO concentration with age. 
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4.3.2 Age and Phenoloxidase 
Mortality: 91 old drones (-50%) were recaptured from the original released 
sample. Of those that survived to be used in the experiment, there was a 
significant difference in the percentage mortality between the new and old 
drones, with new drones having an average 4% mortality rate, compared to 
29% in the old drones (F1.214 = 26.8, p<0.0001). 
po: There was a significant effect of age and treatment on PO activity (Figure 
4.13, Table 4.5). Old drones had higher concentrations of PO in the 
haemolymph. An immune challenge with LPS produced lower levels of PO in 
new drones, but there was no effect of immune challenge on PO activity in the 
old drones, where PO activity remained constantly high. 
ProPO: There was a significant effect of treatment on ProPO concentration, 
with the LPS challenged groups having lower levels of ProPO activity than the 
controls (Figure 4.14, Table 4.6, F3.148 = 2.97, p=0.03397). This provides 
support for the hypothesis that ProPO is being activated into PO and utilised in 
an immune response faster than it can be manufactured and replaced. There 
was no effect of age on ProPO concentration. 
4.3.3 Age and Antimicrobial Peptides (AMPs) 
There was a significant effect of treatment on AMP response, with challenged 
individuals containing higher concentrations of AMPs. Figure 4.15 shows all of 
the results for the No Challenge and LPS treatment groups. A significant 
number of the No Challenge treatment samples did not produce a recordable 
AMP response (58% of young and 71 % of old drones), which produced a 
positively skewed distribution (F3.114 = 18.8, p<0.0001, binomial errors). 
Samples that did not contain a recordable level of AMPs were removed from the 
data set before analysis, so that data conformed to normality. 
Figure 4.16 shows the AMP results for No Challenge and LPS treatment 
groups, after the samples containing no recordable AMP were removed. There 
was a significant interaction of age and treatment on AMP concentration (Table 
4.7). AMP activity increased with immune challenge, but production was lower 
in old, immune challenged drones. This decrease may be a sign of immune 
senescence. 
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Figure 4.13. PO response of the two age groups, new and old drones, to the 
No Challenge and LPS treatment groups. There was a significant interaction 
with age and immune challenge, with new drones challenged with LPS 
producing lower PO concentrations than the controls (data are log10 
transformed, see Table 4.5). 
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Figure 4.14. ProPO response ofthe two age groups, new and old drones, to 
the No Challenge and LPS treatment groups. There was a significant effect of 
immune challenge on ProPO concentration, with LPS challenged drones 
producing lower ProPO concentrations than the controls (data log10 
transformed, see Table 4.6). 
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Figure 4.15. Antimicrobial peptide (AMP) response for new and old drones to 
the No Challenge and LPS treatment groups. The figure shows the results for 
all samples. AMP activity was measured as the area of bacterial growth 
inhibition (mm2). A significant number of the No Challenge samples did not 
contain any recordable AMPs, which produced a positively skewed distribution. 
These results were removed before analysis (Figure 4.16, Table 4.7). 
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Figure 4.16. Antimicrobial peptide (AMP) response for new and old drones to 
the No Challenge and LPS treatment groups, for those samples that contained 
a recordable level of AMPs. AMP activity was measured as the area of bacterial 
growth inhibition (mm2). There was a significant interaction with age and 
treatment (Table 4.7, data are square root transformed). AMP production 
increased with immune challenge, but this increase became less with age. 
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Source dJ. Sum of squares F-value P 
Thorax width 1 0.0510 1.22 0.2710 
Age 1 16.8 402 <0.0001 
Treatment 3 0.670 5.35 0.001589 
Residuals 147 6.14 
Table 4.5. PO results for new and old drones. PO response increased with age, 
but levels were lower following an immune challenge (data are log10 
transformed). 
Source 
Thorax width 
Treatment 
Residuals 
dJ. Sum of squares F-value P 
1 
3 
0.00505 
0.147 
148 2.44 
0.306 
2.97 
0.5810 
0.03397 
Table 4.6. ProPO results for new and old drones. ProPO responses were lower 
in new drones following an immune challenge, but in general levels were similar 
across both age groups (data are log10 transformed). 
Source dJ. Sum of squares F-value P 
Thorax width 1 49.4 19.6 <0.0001 
Age 1 18.8 7.46 0.007688 
Treatment 3 1130 150 <0.0001 
Age * treatment 2 31.7 6.30 0.002849 
Residuals 83 209 
Table 4.7. Results for AMP production in new and old dones. There was a 
significant interaction of age and treatment (data are square root transformed). 
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4.4 Discussion 
This chapter has demonstrated that PO, ProPO and AMP are all present in 
drones, and that the allocation of resources towards these responses varies 
throughout development and adult life. Larvae and pupae have little immune 
activity, which may be a response to the low risk of parasite infection in brood. 
However, adult drones do invest in immune responses, although age has a 
significant impact on the level of response. 
4.4.1 Developmental Immunity 
The presence of large numbers of developmental samples containing no 
recordable levels of PO activity are unlikely to be caused by experimental error 
due to the extensive investigation of the PO assay carried out in Chapter 2 and 
Appendix 1 Section A 1.3. The proportion of samples containing no recordable 
levels of PO during development may be interpreted in two ways. Firstly, if the 
data for red-eyed pupae are removed from Figures 4.3 and 4.4, the proportion 
of samples with a recordable level of PO activity increases linearly with 
developmental age. The high proportion of red-eyed pupae containing no 
recordable PO levels may be due to a stage-specific physiological process. 
Spermatogenesis and spermiogenesis occur at this stage, and PO may be 
required for these processes (Page & Peng, 2001). 
The second interpretation of the proportion data is that developmental 
stages up to adult have low levels of active PO in the haemolymph, but that 
there is an increase in recordable PO levels during the white-eyed pupal stage, 
and to some extent the capped larval stage, similar to that seen in workers 
(Section 3.3.2). On average, 77% of the white-eyed pupae samples contained a 
recordable concentration of PO, compared to an average of 24% for all the 
other developmental stages (excluding adults), which suggests that its presence 
is unlikely to be due to experimental error. This increase in PO activity may be 
connected to physiological processes associated with the formation of the pupal 
stage (Chumurzynska & Wojtczak, 1963; Hopkins & Kramer, 1992; Russell & 
Dunn, 1996). Both of these scenarios suggest that it is unlikely that PO is being 
used for immunity during development, which questions whether drones utilise 
PO for an immune response at all. However, if we look at the proportion of 
newly emerged adult drones with recordable levels of PO we see a different 
pattern. An average of 11 % of drones from the control groups in both hives did 
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not contain a recordable concentration of PO. This proportion rose to 35% for 
the LPS challenged adults, supporting my theory that PO levels decrease as it 
is used in response to an immune challenge (S. Povey, S. Slos, pers. comm.), 
and that drones may, in adult life, employ it as an immune defence. 
The presence of ProPO increased with developmental age, and the older 
developmental stages showed a significant effect of immune challenge on 
ProPO activity. In contrast to the workers, ProPO was much lower in the early 
larval stages. In line with the first interpretation of the PO results, this suggests 
that drones may not use ProPO as an immune response, and only employ it in 
the latter developmental stages when it is required for cuticle formation and 
melanisation (Chumurzynska & Wojtczak, 1963; Hopkins & Kramer, 1992). 
ProPO results for workers showed little response to immune challenge 
during development, although ProPO activity was maintained at a high 
concentration throughout development (Section 3.3.2). PO levels in developing 
workers did not show the stage-wise increase as suggested in drones, although 
workers were seen to use PO in response to an immune challenge in the pupal 
and adult stages. These results suggest that neither workers nor drones employ 
PO and ProPO for an immune defence in the pre-pupal developmental stages, 
which may be due to lack of resources and/or a lack of need. The findings also 
highlight the differences in levels of investment in PO and ProPO between the 
two castes at different life stages, the causes of which may only be speculated. 
There was a significant negative relationship of body size with PO and 
ProPO for both hives. In the developmental stages measured, body size 
(measured as wet weight) decreases with age, as larvae stop feeding and 
undergo metamorphosis. Therefore, adults had the lowest body weight, but the 
highest immune response. Incorporating body size into the analysis controls for 
th is effect. 
4.4.2 Age and Immunity 
Results of the changes in immune response with age showed an increase in PO 
activity with age, at a similar level to that found in workers (Section 3.3.3). This 
suggests that adults in both sexes maintain a higher level when outside the 
hive, possibly in response to increased exposure to pathogens. There was no 
effect of immune challenge on PO in old drones (an effect also seen in 
workers): the continual maintenance of such elevated levels of PO activity may 
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mean that any drops caused by response to a challenge are not seen. 
Alternatively, the increase of PO with age in drones may be associated with the 
onset of sexual maturity, and not a role in immunity. There is some evidence 
that PO is involved in production of gametes in females (Li et al., 1996; Sai et 
al., 1997), and this may be the case in drones. However, as with the previous 
experiment, new drones responded to a challenge with LPS with a decrease in 
PO concentration, which suggests an immune function. 
ProPO levels were maintained at a constant level throughout adult life, a 
level that is lower than that found in corresponding workers (Section 3.3.3). LPS 
challenged drones had a lower ProPO response than the controls, which 
suggests that, as in workers, ProPO does have a role in immunity in adult life. It 
should be remembered when making comparisons with the immune response in 
workers that drones are twice the size, so although immune responses may be 
of a similar magnitude, this cost represents a lower absolute level of investment. 
Unlike workers, AMP production was only induced following an immune 
challenge. The amount of AMPs produced in drones when challenged was 
lower than that found in the corresponding worker age groups, suggesting that 
drones have fewer resources to invest in this immune response. If PO and 
ProPO have limited use as immune defences in the drone, the importance of 
induced responses, such as AMPs, to the immune arsenal is amplified. As seen 
in workers, levels of AMP production decreased with age, even when 
challenged, which may be an indicator of immune senescence (Doums et al., 
2002; Hillyer at al., 2005). Recent research has found a decrease in the fat 
body mass with age in workers (Wilson-Rich at al., 2008). If such a decrease 
also exists in drones, limits on functioning ability of the fat body would support 
the decrease in AMP production seen. Alternatively, as sperm viability reaches 
its peak in 2-week old drones, resources from the fat body may be needed for 
sperm production in the older, sexually mature males (Page & Peng, 2001). 
4.5 Summary 
This chapter has investigated the impact of different aspects of aging on 
immunity in drone bees. Using assays developed in Chapter 2, I have shown: 
1 a. Variation in the PO activity in developing drones, with all 
developmental stages containing samples with no recordable PO. 
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White-eyed pupae have the highest level of PO activity (Section 
4.3.1) 
1 b. An increase in ProPO activity with developmental stage, with the 
uncapped larval stage commonly having no recordable levels of 
ProPO (Section 4.3.1) 
2a. PO activity increased with adult drone age (Section 4.3.2) 
2b. ProPO activity remained constant throughout adult drone life 
(Section 4.3.2) 
2c. AMPs were produced in response to an immune challenge, but 
the level of response was significantly reduced with age (Section 
4.3.3). 
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Chapter 5 
Varroa destructor and the honey bee immune response 
5.1 Introduction 
A. mel/if era is subject to a range of internal and external parasites (Bailey & 
Ball, 1991). The ectoparasitic mite Varroa destructor is one of the most 
destructive parasites of managed honey bee colonies (De Jong et al., 1982; 
Sammataro et al., 2000) and is thought to be the cause of parasitic mite 
syndrome, or Varroasis, a disease which, if left untreated, may destroy colonies 
worldwide (Ball & Allen, 1988; Martin et al., 1998; Martin, 2001a). 
5.1.1 Va"oa destructor 
First discovered in 1904, the Varroa mite shifted from its natural host, the Asian 
honey bee, A. cerana, to A. mel/if era in 1957 when A. mel/if era was introduced 
into areas inhabited by A. cerana (Oldroyd, 1999; Gregory et al., 2005). From 
this initial infection it rapidly spread to A. mel/if era colonies worldwide, although 
it was not found in the UK until 1992 (Bailey & Ball, 1991; Oldroyd, 1999). Adult 
female mites (Figure 5.1, A and B) are reddish-brown in colour, 1 mm long, 
dorso-ventrally flattened, with a concave dorsal shield and weigh approx. 
0.14mg (De Jong et al., 1982; Rath; 1999). Their shape allows them to slide 
between sternal plates avoiding detection and removal during grooming (Rath, 
1999). The males are smaller and lighter in colour (Sammataro et al., 2000). 
The adult female mites live either attached to an adult honey bee (phoretic 
phase, Figure 5.1 C), or within a sealed drone or worker cells where they 
undergo the reproductive phase of their lifecycle (Martin, 2001b). Mites move 
between adult hosts, preferentially moving onto nurse bees over foragers, and 
preferring drone brood to worker brood for the reproductive phase (Otten & 
Fuchs, 1988; Boot et al., 1992; Fuchs, 1992; Kuenen & Calderone, 1997). 
Mites can only survive off the host for 18 - 70 hours, depending on the 
substrate (de Guzeman et al., 1993). They reproduce on a 10-day cycle within 
capped brood cells (Figure 5.2). Female mites attached to nurse bees drop off 
into larval brood cells. A female enters a brood cell approximately 24 hours prior 
to capping for worker cells, and 48 hours prior to capping for drone cells. The 
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Figure 5.1. Dorsal (A) and ventral (8) side of adult female Varroa. Female 
offspring emerge on bees as they eclose and can be seen clinging to the thorax 
(C, two mites on thorax of a newly eclosed drone), or more often slide in 
between the sternal plates (photos by R. Naylor). 
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Figure 5.2. Life cycle of the Varma mite. Female mites, depicted in red , drop 
from the host into uncapped larval cells . The reproductive cycle, which lasts 
about 10 days, occurs within capped brood cells . New adult bees emerge from 
their cells carrying the mated female offspring, which are then free to transfer to 
other bees during close contact, and seek another cell in which to repeat the 
cycle. 
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female mite submerges herself in the larval food (provided by the nurse bees). 
After the cell has been capped the larva eats all remaining food, so freeing the 
mite, which begins to feed on the larva. The mite feeds on the host's 
haemolymph, which is obtained by piercing the inter-segmental membrane of 
adults, or the cuticle of pupae with their chelicerae (Sammataro et al. 2000). 
When feeding on host larvae, the female shows no preference for a particular 
feeding site and may make several incisions on the host's abdominal pleural 
pads (Donze & Guerin, 1994). When the bee moults into a pupa, the female 
mite feeds at a single site, which is chosen before the pupal cuticle sclerotises 
and is kept open to feed herself and her offspring throughout the pupal stage 
(Kanbar & Engels, 2003). 
The female mite begins to lay eggs about 48-60 hours after the cell is 
capped. The first mite egg is not fertilised and develops into a male. 
Subsequent eggs are laid at 30-36 hour intervals, fertilised and develop into 
adult females in approximately 7.5 days. The male mates with his sisters within 
the sealed cell, and dies before emergence (Martin, 2001b). Surviving mother 
mites and mated daughter mites emerge from the cell riding on the adult bee, 
and begin the cycle again. 
5.1.2 Colony Collapse 
The mechanism by which Varroa can cause the collapse of a bee colony is not 
properly understood. "Parasitic mite syndrome" is a non-specific term that refers 
to colonies simultaneously infested with mites and infected with viruses, with a 
high mortality rate (Shimanuki et al., 1994). Symptoms of parasitic mite 
syndrome include morphological deformities in adult bees, reduced flying and 
learning ability, increased mortality of brood and general colony weakening, with 
colony collapse occurring within four years after infestation (Shimanuki et al., 
1994; De Jong & De Jong, 1983; Akratanakul & Burgett, 1975; Hung et al., 
1995; Martin et al., 1998; Sammataro et al., 2000; Kralj et al., 2007). The 
highest death rate in colonies occurs during the winter, as mite populations are 
allowed to build up in a relatively small, and resource limited population of bees 
(De Jong et al., 1982). In addition, the cessation of drone production towards 
the end of the summer causes mites to switch to reproducing solely in worker 
cells. This increased pressure on workers may contribute towards colony 
collapse during the winter months. 
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The feeding of VafTOa on bees has been shown to cause a reduction in the 
protein content of the haemolymph (Glinski & Jarosz, 1984), weight loss of up to 
25% in the newly emerged bee (De Jong et al., 1982), reduced longevity and 
wing and body deformity (De Jong & De Jong, 1983; Akratanakul & Burgett, 
1975). Wing deformity may be due to reduced hydrostatic pressure brought 
about through loss of haemolymph (Daly et al., 1988). Higher numbers of mites 
feeding on each bee leads to a greater proportion of emerging bees exhibiting 
deformities (De Jong et al., 1982). However, bees with a single or no mites can 
develop deformities, and bees with high numbers of mites can show no 
deformity at all (Bowen-Walker et al., 1999). There is no direct evidence of a 
link between mite populations and colony collapse, and similar sized mite 
populations have been found in both collapsing and surviving colonies (Martin 
et al., 1998; Martin, 2001a). Consequently doubts are raised over whether 
mites acting alone cause bee deformity and colony death. It is suggested that 
these symptoms are in fact due to the vectoring of viruses or other pathogenic 
agents during mite feeding (Ball, 1985; Hung et al., 1995; Hung et al., 1996; 
Martin et al., 1998). 
5.1.3 Deformed Wing Virus 
There are 18 viruses known to infect honey bees (Bailey & Ball, 1991, Allen & 
Ball, 1997). Of these, deformed wing virus (OWV) is a positive, single-stranded, 
picorna-like RNA virus, belonging to the genus lfIavirus (Christian et al., 2002), 
with isometric particles approximately 20-30nm in diameter (Allen & Ball, 1996; 
Chen et. al., 2004a). VafTOa did not arrive in the UK until 1992, but like many 
other honey bee viruses, DWV can persist in a population as a covert infection 
(Oall, 1985; Bailey, 1967; Tentcheva et al., 2004; Yang & Cox-Foster, 2005), 
and can be detected in adult workers of Varroa-free colonies in the UK (Martin, 
2001a). 
OWV replicates slowly, and infected pupae either die, or emerge with 
deformed or poorly developed wings, a shortened abdomen and discolouration; 
symptoms which were previously attributed to the feeding activity of VafTOa 
(Ball, 1989; Bailey & Ball, 1991; Bowen-Walker et a/., 1999). Infected bees also 
show a reduction in lifespan (Kovac & Crailsheim, 1988). OWV can cause 
mortality in naturally infected populations, but is thought to have increased in 
prevalence due to transmission by VafTOa (Ball, 1997). 
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Mites may affect a colony by vectoring DWV, or by the activation of covert 
infections (Ball & Allen, 1988; Bowen-Walker et a/., 1999; Brodsgaard et a/., 
2000). In the most straightforward scenario, the mites could directly transmit 
DWV during feeding (Bowen-Walker et a/., 1999; Hung et a/., 2000; Nordstrom, 
2003; Ongus et a/., 2004; Tentcheva et al., 2004; Shen et a/., 2005a; Shen et 
a/., 2005b). Alternatively, there is some evidence that the presence of more 
mites may increase the stress exerted on the pupae, either through loss of 
haemolymph or increased immune suppression, to an extent which triggers the 
replication of latent infections (Anderson & Gibbs, 1988; Ball & Allen, 1988; 
Bowen-Walker et a/., 1999; Brodsgaard et a/., 2000; Chen et a/., 2004c; Yang & 
Cox-Foster, 2005). Significantly higher levels of DWV are found associated with 
mite infestations (Shen et a/., 2005b), and there is a strong body of evidence 
that mites can effectively transmit DWV in the field (Ball & Allen, 1988; Bowen-
Walker et a/., 1999; Nordstrom, 2003; Chen et a/., 2004b). 
5.1.4 Varroa and the Immune Response 
Recent studies have started to investigate the impact of ectoparasites on the 
immunity of invertebrate hosts (Rivers et a/., 2002), and more specifically, of 
Varroa on the honey bee (Gregory et a/., 2005; Yang & Cox-Foster, 2005; Yang 
& Cox-Foster, 2007). 
The population dynamics of ValTOB closely follows that of the bees but 
lags a month behind, peaking during August and September, and within two 
years can exceed thresholds for colony survival to the following summer 
(Martin, 2001 a). As the threat of ValTOB cycles annually with the bee population, 
it may be adaptive for bees to up-regulate their immune response as the season 
progresses, in line with increasing ValTOB infestation levels. 
The act of puncturing the cuticle of the pupae or adult bee during feeding 
produces a wound, the healing of which is initiated by an accumUlation of 
haemocytes, a cellular immune response (Kanbar & Engels, 2003). The 
process of scarring and healing increases towards the end of the pupal phase, 
although large wounds may not heal until just before adult emergence, 
providing a longer window of opportunity for secondary pathogen infections 
(Kanbar & Engels, 2003). However, all wounds are healed before the adult bee 
emerges, preventing secondary infection from pathogens outside the brood cell. 
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There is some evidence that mite-parasitised bees have a reduced survival, and 
are less able to mount an immune response to secondary infections (Yang & 
Cox-Foster, 2005; Yang & Cox-Foster, 2007). Wounds are known to harbour a 
wide variety of bacteria, including foulbrood agents Melissococcus pluton and 
Paenobacil/us larvae (Glinski & Jarosz, 1992; Ball, 1997; Kanbar & Engels, 
2003). Bacterial infections of wounds do not carry a corresponding mortality 
rate, suggesting that such secondary infections are not directly fatal to the bees, 
and the level of infection does not differ between mite infested and non-infested 
bees (Kanbar & Engels 2003; Gregory et al., 2005). However, bacterial 
infections have been shown to stimulate the multiplication of OWV, so although 
secondarily infected bees may survive to eclosion, their survival may be 
severely compromised during their adult life (Yang & Cox-Foster, 2005). 
Little is known about other cellular and humoural immune responses to 
Varroa infestation. The response of antimicrobial peptide transcripts seems to 
vary between the peptides they encode, although all show some level of 
suppression with mite infestation (Gregory et al., 2005; Yang & Cox-Foster, 
2005). The expression of genes encoding PO was found to be lower in Varroa 
infested bees compared to those without mites, within a heavily infested colony 
(Yang & Cox-Foster, 2005). As it is not known how these levels relate to 
unparasitised colonies, it is difficult to gain a measure of the direct cost of the 
mites on the immune response. 
5.1.5 The Control of Varroa 
The chemical control of Varroa is difficult. As Varroa must live on the bee hosts, 
only pesticides that cause little or no harm to the bees can be used. Whilst 
various acaricides have been produced around the world, no single one is able 
to completely eliminate Varroa from a colony (De Jong et al., 1982). A large part 
of this problem is due to the fact that once sealed inside brood cells, mites 
cannot be targeted by the acaricides. On top of this, honey produced by 
colonies must be fit for human consumption, and so cannot have absorbed the 
pesticide. Currently the most popular treatment in the UK are the acaricide 
strips "Apistan", polymer beehive strips containing 824mg of the pyrethriod tau-
fluvalinate (10.3% wlw), which has acaricidal properties but is tolerated by bees. 
The strips are suspended between brood frames for a period of between 6-8 
weeks, which is a short enough time to prevent the evolution of resistance. 
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Apistan is applied in late summer and after the main honey is harvested to 
prevent contamination of honey, and to reduce mite numbers before bees 
overwinter. However, even with controlled and rotational use, resistance to 
pyrethriods has been detected in Varroa across Europe since 1991 (Trouiller, 
1998). 
5~ 1.6 Chapter Predictions 
Given what we know about immune response to pathogen infections in other 
insects, we could make some predictions about the response of bees to the 
Varroa mite. Throughout this chapter, I will refer to "immune investment" as the 
level of PO or ProPO measured in an individual i.e. the level of resources 
maintained in an individual available for an immune response, and "immune 
response" as the difference in PO and ProPO levels between the control and 
challenged groups of bees. Following this, I predict that: 
1. Colonies will up-regulate their levels of immune investment in 
response to the increasing threat of a parasite infection. By 
"stockpiling" resources in the form of PO and ProPO, bees will be 
better able to respond to a parasitic infection 
2. If bees face extra stress on their resources to maintain an elevated 
immune investment when the threat of Varroa infestation is high, any 
additional immune challenge (LPS) will result in a greater immune 
response (larger drop in PO and ProPO levels) than that seen in 
Varroa-free colonies 
3. Successful removal of Varroa with a pesticide will result in lowered 
levels of immune investment in the colony 
4. There will be an effect on the immune response in bees infested with 
Varro8, with and without deformed wings (symptomatic of DWV), but 
the direction of this change is unpredictable. 
5.1.7 Chapter Aims 
The impact of mite infestations on honey bee immunity is largely unknown. This 
chapter aims to examine the effect of mite population dynamics on the 
phenoloxidase (PO) and prophenoloxidase (ProPO) responses in worker bees. 
Using the assays developed in Chapter 2, I will investigate: 
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1. The immune response to Varroa in infested colonies, in terms of a) 
PO and b) ProPO (Section 5.2.1) 
2. The effect of eliminating a mite population using an acaricide on the 
bee's immune response in terms of a) PO and b) ProPO (Section 
5.2.2) 
3. The immune response in Varroa-infested bees exhibiting deformities 
akin to those caused by OWV, in terms of a) PO and b) ProPO 
(Section 5.2.3). 
5.2 Materials and Methods 
5.2.1 Effect of Varroa on seasonal immune response 
To gain an understanding of how the standing immune response of workers 
changes temporally in line with Varroa populations, the immune responses of 
two similar hives (each hive had one super (total of 20 frames), and at least 6 
frames of brood. Colonies were judged to be strong and of similar size by eye) 
were measured throughout the season (May-October 2007). Neither hives were 
treated for Varroa, so any infestation present was allowed to build up naturally 
over the season. Although the hives were similar in terms of size, treatment and 
environment, as the season progressed, one hive showed high levels of Varroa 
infestation, whilst the other had consistently low levels of infestation. This 
provided an opportunity to investigate the impact that different levels of Varroa 
infestation have on immune responses within the hive. Of interest in this 
experiment were the effects of a parasite infestation on the immune responses 
of uninfested bees, as we predict that bees will maintain an elevated level 
immune response when the threat of Varroa infestation is high, but as immunity 
is costly, immune responses may be reduced when this threat is low or absent. 
Brood frames from each hive were brought into the lab at the same time 
each month. To ensure that bees used in the experiment had no known 
exposure to Varroa, individuals were collected as they eclosed from the brood 
cells. Bees carrying mites, or those with evidence of mites left within their cell 
were discarded. Where sample sizes could not be collected within one day, 
frames were incubated overnight (36°C ± 1°C, 40% ± 2% humidity). The 
following day, any bees that had emerged overnight were discarded, as Varroa 
could have transferred between individuals during the night. The process of 
139 
sample collection was repeated. All samples were collected over a maximum 2-
day period. 
The response of the bees to an immune challenge was recorded to 
investigate how the pressure of a ValTOa infestation may affect the ability to 
respond to an additional immune challenge. In order to test the response to an 
immune challenge, the monthly samples of bees from each hive were split into 
4 treatment groups (No Challenge, Needle, 1 J,JI Ringer and 1 J,JI LPS in Ringer, 
sample size ranged from 14-48 per group, average sample size = 36). 
Treatment groups were housed in separate bee boxes with 50% sugar syrup 
and dH20 ad libitum. Haemolymph samples were collected via a perfusion 
bleed 24 hours post-challenge with 0.5ml ice-cold sodium cacodylate buffer. 
Haemolymph samples were split into 2 aliquots and frozen for 24 hours (-90°C). 
Samples were then defrosted on ice, vortexed and centrifuged (4°C, 2800G, 15 
minutes) before being run on a plate reader for standard PO and ProPO assays 
(Chapter 2, Sections 2.3.11 & 2.4.14). Thorax width was recorded for all bees 
to obtain a control for body size. 
In addition, mite numbers were regularly recorded for each hive from 
May to October. Mite numbers were recorded by fitting a ValTOa floor to each 
hive. This consists of a 3-sided wooden frame that sits between the brood box 
and the hive floor that holds a sheet of fine epoxy coated mesh, through which 
mites can fa" as they die or are dislodged. The mesh is too fine for bees to fall 
through, and prevents bees from removing dead mite bodies. A thin sheet of 
aluminium was cut to the same dimensions as the ValTOa floor and the leading 
edge bent upwards so that it could be slid in and out between the ValTOa floor 
and the hive floor like a drawer. In order for ValTOa to stick to the aluminium to 
allow counting, the drawer was sprayed with vegetable oil. To record mite 
numbers, the tray was slid out of the hive and all debris (frass and mites) 
scraped into a collecting bag. The drawer was re-sprayed with oil and returned 
to the hive. The content of the drawer was inspected under a dissecting 
microscope, and mite numbers recorded. 
USing the actual mite drop numbers collected, samples were added up 
over each month, and divided by the number of days to get the mite drop per 
day, per month. The total proportion of the emergent mite population dropped 
daily during brood emergence is 30% (Martin, 1998), so the estimated total 
monthly mite population for each hive can be calculated. This can then be 
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compared with the expected total mite population, as taken from Martin (2001a). 
As this calculation averages out data within each month, some of the detail of 
population growth will be lost, but it will give a good measure of the overall mite 
populations in our hives to compare with the model. 
The weather for the spring/summer season 2007 was poor - it was 
Britain's wettest May-July since records began in 1776. June was one of the 
wettest months on record in Britain (more than double the average for the 
month) and Sheffield experienced severe flooding throughout this period. 
Although bees can fly and forage in rain, if the weather is severe, few bees 
leave the hive to forage (Riessberger & Crailsheim, 1997). This was the case at 
Sheffield field sites, with few individuals observed to be foraging during the 
heavy rain (pers. obs.). During this time, hives were supplemented with 50% 
sugar syrup to prevent starvation, but generally hives were very slow to build up 
during the start of the summer. As the Varroa population dynamics are 
dependant both on the increasing bee population within the hive, and on 
transmission by foragers to other hives, it was predicted that the weather might 
have impacted on the population dynamics of the Varroa. Therefore, weather 
data (and in particular, rainfall) was collected from Western Park Weather 
Station, a station situated next to the Animal and Plant Sciences Department, 
(supplied by Western Park Museum) to investigate the effect of weather on mite 
population dynamics. 
5.2.2 Effect of acaricide on the immune response 
Varroa at the Tapton field site show no sign of resistance to the acaricide 
Apistan (pers. obs.) In susceptible mites, exposure to Apistan for a 12 hour 
period typically results in a 90% death rate (Martin et al., 2002). By treating 
hives with Apistan we can therefore effectively remove the Varroa infestation 
from a colony, and observe how the immune response reacts to the removal of 
this paraSitic threat. 
Two similar colonies (Hives A and B) were sampled at the start of 
September (Hive A = 07/09/06, Hive B = 01-03/09/06), October (Hive A = 01-
04/10/06, Hive B = 01-06/10/06) and throughout November 2006 (Hive A = 04-
08/11/06 and 20-22/11/06; Hive B = 07-14/11/06 and 20-22/11/06). The late 
summer that year meant that colonies continued to forage into the autumn 
months. Due to the late season, hives initially showed no mite infestation, but in 
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October increasing mite populations were present in both hives. Immediately 
after bees were collected for the October samples, Apistan acaricide strips were 
added to each hive to reduce Varroa populations within the colonies. 
To measure the immune response to Apistan treatment, brood frames 
from each hive were brought into the lab and emerging workers collected after 
an overnight incubation period (36°C ± 1°C, 40% ± 2% humidity). In addition to 
monitoring the effect of Apistan, bees from each sample were tested for their 
response to an immune challenge. Bees from each hive were split into 4 
treatment groups (No Challenge, Needle, 1 J,JI Ringer and 1 J,JI LPS in Ringer, 
treatment groups sample size ranged from 8-50, mean sample size = 32). If 
bees down-regulate their immune system following the removal of Varroa by 
Apistan, we would expect to see this reflected in their response to a novel 
immune challenge. 
Treatment groups were housed in separate bee boxes with 50% sugar 
syrup and dH20 ad libitum. Haemolymph samples were collected via a 
perfusion bleed 24 hours post-challenge with 0.5ml ice-cold sodium cacodylate 
buffer. Haemolymph samples were split into 2 aliquots and frozen for 24 hours 
(-90°C). Samples were then defrosted on ice, vortexed and centrifuged (4°C, 
2800G, 15 minutes) before being run on a plate reader for standard PO and 
ProPO assays (Chapter 2, Sections 2.3.11 & 2.4.14). Thorax width was recoded 
for all bees to obtain a control for body size. 
Mite numbers were recoded as the proportion of the sample of new 
workers emerging with one or more mites attached to them. Workers that were 
infested were not used in the experiment, and therefore all bees assayed had 
no known previous exposure to mites. November bees are sampled twice -
once just after the addition of Apistan, and once at the end of the month, to see 
how the response to Apistan changed post treatment. Sampling in Hive Bran 
over a longer period in November, as brood production slowed down so 
samples took longer to collect. 
5.2.3 Effect of deformed wings on the Immune response 
To test what the effect of a physical deformity might have on ProPO and PO 
activity, bees were collected from a single hive infested with Varroa mites. A 
single brood frame was brought into the lab, and workers were collected as they 
emerged from the brood cells. 
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Workers were split into 3 groups: those with had no mites and no deformities 
(Normal- mites, n=26), those with one or more mite on them, but with no 
visible deformity (Normal + mites, n=19), and those with one or more mites on 
them and showing visible signs of deformed wings (Deformed wings, n=10). 
The 3 treatment groups were housed in separate bee boxes for 24 hours {and 
provided with 50% sugar syrup and dH20 ad libitum. When bees were 24 hours 
old they were perfuse bled with 0.5ml ice-cold sodium cacodylate buffer. 
Haemolymph samples were split into 2 aliquots and frozen for 24 hours (-90oG). 
Samples were then defrosted on ice, vortexed and centrifuged (4°G, 2800G, 15 
minutes) before being run on a plate reader for standard PO and ProPO assays 
(Chapter 2, Sections 2.3.11 & 2.4.14). 
5.2.4 Presentation of Results 
In all experiments, the No Challenge and LPS treatment groups showed the 
extremes of the range of immune responses seen. For simplicity, graphical data 
are only presented for these two treatment groups. The Needle and Ringer 
treatment groups provided wounding and vehicle controls, and showed a 
staggered response between the two extremes. Graphs for all four treatment 
groups can be found in Appendix 2, Section A2.3. 
5.3 Results 
5.3.1 Effect of VS"OS on seasonal immune response 
There was no significant difference overall in the PO responses between the 
low and high level Vaf1Oa-infested hives (ANGOVA, F1,1724 = 1.94, P = 0.1636), 
but there was a significant difference in the level of ProPO activity (ANCOVA, 
F1,1719 = 229, p<0.0001). Consequently, hives were analysed separately. 
Low level infected hive 
Figures 5.3 and 5.4 show the results for PO and ProPO in the low level Varroa 
infected hive. There was a steady reduction in PO and ProPO over time, 
following a quadratic, rather than a linear curve. Therefore, time was fitted as 
both a linear and a quadratic effect. Both PO and ProPO results were log10 
transformed to produce normal distributions. 
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PO: The results for PO (Figure 5.3, Table 5.1) show that there was a significant 
effect of time, treatment and thorax width on PO. All treatment groups showed a 
reduction in PO concentration over time. 
ProPO: Results for ProPO (Figure 5.4, Table 5.2) showed a significant 
interaction between treatment and time (ANCOVA, F3.856 = 2.96, p=0.03139). All 
groups showed a reduction in ProPO over time, with the LPS immune 
challenged group showing the biggest decrease. 
High level infected hive 
As can be seen from Figures 5.5 and 5.6, the results for PO and ProPO in the 
high level infested hive follow a quadratic curve over time for all treatments, 
dropping mid-season (July) and rising again towards the end of the summer. 
Time was fitted as both a linear and a quadratic effect. Both PO and ProPO 
results were log10 transformed to follow a normal distribution. 
PO: Results for PO (Figure 5.5, Table 5.3) showed a significant interaction with 
time and treatment (ANCOVA, F3.858 = 13.4, p<0.0001). All treatment groups 
showed a drop in PO response down to July, rising sharply again in September 
and October. The PO activity in the LPS treatment group dipped later in the 
season, and had a lower response towards the end of the season than the 
other treatment groups. 
ProPO: Results for ProPO (Figure 5.6) follow a quadratic curve for all treatment 
groups, dropping in July and rising sharply in September and October. There 
was a significant effect of time, treatment and thorax width on ProPO 
concentrations (Table 5.4). The challenged groups produced lower levels of 
ProPO activity throughout the season. 
Mite populations and the immune response 
Mite numbers for the two hives can be seen in Figure 5.7. Analysis of the mite 
count data confirmed that there was a significant difference between the mite 
counts for low and high level infected hives (GLM, p<0.0001, d.f. = 1,29, 
Poisson errors) and that these counts varied Significantly over time (GLM, 
p<0.0001, d.f. = 1,29, Poisson errors). 
Summary: Although the curves fitted to the two hives appear different, there 
was in fact no significant difference between the levels of PO activity in the two 
144 
hives. The slightly different responses seen towards the end of the season, 
although not statistically significant, may represent the effect of Varroa 
infestation on the immune response. However, there were highly significant 
different in the levels of ProPO activity between the hives with low and high 
infestation. The lower concentrations of ProPO in the hive with low level 
infestation may be a response to the lack of Varroa in this hive, so eliminating 
the need to maintain a costly level of immune investment. The high level 
infested hive also showed an initial decrease in ProPO immune response, but 
this was up-regulated immediately following the increase in Varroa numbers in 
September. 
The extreme variation in the ProPO immune response seen between the 
hives may be attributed to the presence of the Varroa mites. However, whilst all 
other Vaffoa-free colonies used in this thesis have shown qualitatively similar 
immune responses (a trait which is lacking in this data), their significantly 
different quantitative results has lead to them being analysed individually. The 
differences seen between the low and high level Varroa-infested colonies may 
therefore be due to the natural variation in colony response. Surveying a larger 
sample size (n=8) of colonies at low, medium and high levels of Varroa 
infestation would enable the effect of hive to be fitted as a random factor and so 
allow focus on the difference in colony responses to Varroa infection levels. If 
the variation in colony response was found to be due to mites, then the 
presence of Varroa should be taken into consideration when choosing colonies 
to use as a representative sample of honey bees in future experiments. 
Thorax width had a significant positive relationship with enzyme activity 
in all but the PO activity in the high level infested hive. Larger bees are likely to 
have more haemolymph, and consequently with the sampling method used 
(perfusion bleed), this will be recorded as a higher haemolymph concentration 
per unit buffer. Incorporating a measure of body size into the analysis controls 
for this effect. 
Mite populations and the weather 
Figure 5.8 shows the mite population for the high level infected hive (calculated 
from weekly mite drops using Martin, 1998, see Section 5.2.1 for explanation), 
plotted with the expected mite population (see Martin, 2001a for predictive 
model). It can be seen that the observed mite population for the high level 
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infected hive was much lower than that expected. Total monthly rainfall was 
also plotted on the graph, with the solid black line representing the actual 
rainfall in Sheffield over summer 2007. The dashed black line shows the 
average rainfall (data collected over 29 years from 1971-2000), giving an 
indication of what is expected for these months. Sheffield experienced extreme 
rainfall in summer 2007, with total monthly rainfall far exceeding that expected. 
Heavy rainfall prevents foraging activity in bees, and consequently a reduction 
in the rate of colony reproduction, a factor vital for mite reproduction. These 
results suggest that the extreme rainfall was correlated with a significant impact 
on Varroa population dynamics, leading to decreased levels of infestation in 
both hives. 
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Figure 5.3. PO response of bees in low level infected hive to No Challenge and 
LPS treatment groups. Samples were taken over a period of 157 days (one set 
of samples every month) for 6 months, with Day 0 = 30th May 2007. There was 
a significant effect of time, treatment and thorax width on PO (Table 5.1). All 
treatment groups showed a reduction in PO concentration over time. Data are 
log10 transformed. 
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Figure 5.4. ProPO response of bees in the low level infected hive to No 
Challenge and LPS treatment groups. Samples were taken over a period of 157 
days (one set of samples every month) for 6 months, with Day 0 = 30th May 
2007. There was a significant interaction between treatment and time (data are 
log10 transformed). 
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Source d.f. Sum of F-value P 
squares 
Thorax width 1 0.555 11.1 <0.001 
Treatment 3 0.650 4.35 0.00475 
Time (linear) 1 5.75 115 <0.0001 
Time (quadratic) 1 0.373 7.49 0.006348 
Residuals 859 42.8 
Table 5.1. PO results for low level Varroa-infested hive throughout summer 
2007 (results are log10 transformed). There was a significant quadratic effect of 
time on PO activity. The LPS treatment group produced lower levels of PO than 
the controls. 
Source d.f. Sum of 
squares F-value P 
Thorax width 1 1.01 22.2 <0.0001 
Treatment 3 0.977 7.17 <0.0001 
Time (linear) 1 4.69 103 <0.0001 
Time (quadratic) 1 0.266 5.85 0.01581 
Treatment x time (linear) 3 0.404 2.96 0.03139 
Residuals 856 38.9 
Table 5.2. ProPO results for low level Varroa-infested hive throughout summer 
2007 (results are log1 0 transformed). There was a Significant interaction of time 
on ProPO activity 
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. Figure 5.5. PO response of bees in high level infested hive to the No Challenge 
and LPS treatment groups. Samples were taken over a period of 157 days (one 
set of samples every month) for 6 months, with Day 0 = 30th May 2007. 
There was a significant interaction of time with treatment (data are log10 
transformed). All treatment groups showed a drop in PO response down to July, 
rising sharply again in September and October. The LPS treatment group 
showed a lower drop and a reduced rise at the end of the season compared to 
the controls. 
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Figure 5.6. ProPO response of bees in high level infested hive to the No 
Challenge and LPS treatment groups. Samples were taken over a period of 157 
days (one set of samples every month) for 6 months, with Day 0 = 30th May 
2007. There was a significant effect of time, treatment and thorax width on 
ProPO concentrations (Table 5.4). The LPS challenge resulted in lower ProPO 
concentrations throughout the season. Data are log10 transformed. 
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Source d.f. Sum of F-value P 
squares 
Thorax width 1 0.083 1.96 0.1621 
Treatment 3 0.430 3.36 0.01830 
Time (linear) 1 1.17 27.4 <0.0001 
Time (quadratic) 1 4.62 108 <0.0001 
Treatment x time (linear) 3 1.71 13.4 <0.0001 
Residuals 858 36.6 
Table 5.3. PO results for high level Varroa-infested hive throughout summer 
2007 (results are log10 transformed). There was a significant interaction of time 
and treatment on PO activity. 
Source d.f. Sum of F-value P squares 
Thorax width 1 0.503 17.5 <0.0001 
Treatment 3 0.496 5.76 <0.001 
Time (linear) 1 1.00 34.9 <0.0001 
Time (quadratic) 1 7.90 275. <0.0001 
Residuals 861 24.7 
Table 5.4. ProPO results for high level Varroa-infested hive throughout summer 
2007 (results are log10 transformed). There was a significant effect of time and 
treatment on ProPO levels. Activity followed a quadratic curve, with the LPS 
treatment group having lower levels of ProPO activity than the controls. 
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Figure 5.7. Mite counts for low and high level infested hives for the period 
June-October 2007. There was a significant difference between the mite counts 
of the two hives, and counts varied significantly over time. 
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Figure 5.8, Rainfall and mite population dynamics. Mite population (grey lines) 
for high level infested hive in 2007 (solid line) compared to a model population 
growth (see Martin, 2001a, dashed line). Rainfall in Sheffield (black lines) was 
plotted as total rainfall for each month in 2007 (solid line) against the expected 
rainfall (dashed line), taken as the average monthly rainfall in Sheffield from 
data collected over 29 years (1971-2000), 
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5.3.2 Effect of acaricide on immune response 
Effect of Apistan on mites: 
Figure 5.9 shows the mite numbers (as a % of bees infested with one or more 
mites) for hives A and B over the period September - November 2006. 
Sampling dates for the two hives varied slightly, but overall the proportion of 
mite infestation was very similar for the two hives. Following treatment with the 
acaricide Apistan, the proportion bees infested with mites was effectively 
reduced to zero within a month. This strongly suggests that the hives did not 
contain Apistan-resistant Varroa. 
Effect of Apistan on bees: 
When added into the models, there was a significant effect of hive on both the 
PO (ANCOVA, F1,997 = 8.59, p=0.003450. data are log10 transformed) and 
ProPO (ANCOVA, F1,1017= 5.24, p=0.02232, data are log10 transformed) 
results. Hives were therefore analysed separately. 
Hive A: PO and ProPO showed different patterns of response. The results for 
both were log10 transformed to follow a normal distribution. 
PO: The results showed a significant interaction with time and treatment on PO 
concentration (Figure 5.10, Table 5.5, data are log10 transformed). The immune 
response follows a quadratic curve, with all treatment groups up-regulating PO 
concentration at the end of November. Challenge with LPS resulted in a much 
lower drop in the curve. 
ProPO: The results showed a significant interaction of time and treatment on 
ProPO concentration (AN COVA , F3,541 = 3.14, p=0.02510, Figure 5.11, Table 
5.6, data are log10 transformed). The immune response followed a quadratic 
distribution, with all treatment groups increasing ProPO concentration towards 
the end of the season. Challenge with LPS resulted in lower levels of ProPO 
acivity. 
Hive B: 
PO: There was a significant interaction of time and immune challenge on PO 
concentration (ANCOVA, F3,467 = 14.2, p<0.0001, Figure 5.12, Table 5.7, data 
are log10 transformed). The No Challenge and LPS groups showed a reduction 
in PO concentration over time, with LPS producing a much steeper decline. 
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ProPO: The results showed significant effects of time and immune challenge on 
ProPO concentration (Figure 5.13, Table 5.8, data are log10 transformed). All 
treatment groups showed an up-regulation in ProPO concentration at the 
beginning of November, which decreased again towards the end of the month. 
In all cases, across both hives, challenging the immune system with LPS led to 
a decrease in PO and ProPO activity. 80th hives were infested with similar mite 
numbers (Figure 5.9), yet exhibited huge variation in PO and ProPO responses. 
Hive A showed an up-regulation of PO activity in response to the 
increase in mite numbers, whilst Hive 8 showed the opposite result. As with the 
previous experiment (Figure 5.5), this up-regulation was seen in bees assayed 
in the following month's sample. ProPO activity in both hives showed an 
increase in activity towards the end of the season. 
5.3.3 Effect of deformed wings on the immune response 
PO: There was no significant difference between the PO values for bees 
with/without mites (Figure 5.14, F1,52 = 0.233, p=0.6314) and with/without visible 
wing deformities (F1,52 = 0.414, p=0.5231). 
ProPO: There was no significant difference between the ProPO values for bees 
with/without mites (Figure 5.15, F1,52= 0.031, p=0.5563) and with/without visibly 
deformed wings (F1,52 = 1.49, p=0.2278). 
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Figure 5.9. Percentage of recently eclosed bees in Hives A and B with at least 
one V81T08 mite, over a period of 76 days from the beginning of September to 
late November 2006 (Days = days from first sample). The acaricide Apistan was 
added to the hives immediately after October sampling (black and grey dashed 
lines, respectively), and was successful at removing 100% mites in both hives 
within a month. 
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Figure 5.10. PO response of bees in Hive A to No Challenge and LPS 
treatment groups. Dashed lines indicate the point at which Apistan was added. 
There was a significant interaction of time with treatment on PO concentration 
(Table 5.5). All treatment groups showed an increase in PO towards the end of 
the sampling period. Results are log10 transformed. 
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Figure 5.11. ProPO response of bees in Hive A to the No Challenge and LPS 
treatment groups. Dashed line indicates the point at which Apistan was added. 
There was a significant interaction of immune challenge and time on ProPO 
concentration (ANCOVA, F3,541 = 3.137, p=0.0251, see Table 5.6). Results are 
log10 transformed. 
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Sum of 
Source dJ. F-value P 
squares 
Thorax width 1 0.019 0.175 0.6756 
Treatment 3 15.4 46.6 <0.0001 
Time (linear) 1 3.49 31.8 <0.0001 
Time (quadratic) 1 18.9 172 <0.0001 
Treatment x time (linear) 3 4.78 14.5 <0.0001 
Treatment x time (quadratic) 3 3.11 9.44 <0.0001 
Residuals 538 59.1 
Table 5.5. PO results for Hive A (results are log10 transformed). There was a 
Significant interaction of treatment with time, with the LPS treatment group 
producing a significantly lower quadratic curve of PO activity over time than the 
control groups. 
Sum of 
Source d.f. F-value P squares 
Thorax width 1 0.001 0.0350 0.8517 
Treatment 3 1.71 15.7 <0.0001 
Time (linear) 1 0.426 11.7 <0.001 
Time (quadratic) 1 0.527 14.5 <0.001 
Treatment x time (linear) 3 0.342 3.14 0.02510 
Residuals 541 19.7 
Table 5.6. ProPO results for Hive A (results are log10 transformed). There was 
a significant interaction of treatment with time, with the LPS treatment group 
producing lower ProPO activity levels throughout the experiment. 
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Figure 6.12. PO response of bees in Hive B to the No Challenge and LPS 
treatment groups. The dashed line indicates the point at which Apistan was 
added. There was a significant interaction of time with immune challenge on PO 
concentration (see Table 5.7). Results are log10 transformed. 
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Figure 6.13. ProPO response of bees in Hive B to No Challenge and LPS 
treatment groups. The dashed line indicates the point at which Apistan was 
added. There were significant effects time, immune challenge and thorax width 
on ProPO concentration (see Table 5.8). Results are log10 transformed. 
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Sum of 
Source d.f. F-value P 
squares 
Thorax width 1 0.049 0.695 0.4048 
Treatment 3 6.04 28.4 <0.0001 
Time (linear) 1 1.63 22.9 <0.0001 
Time (quadratic) 1 0.347 4.89 0.02754 
Treatment x time (linear) 3 3.02 14.2 <0.0001 
Residuals 467 33.2 
Table 5.7. PO results for Hive B (results are log10 transformed). There was a 
significant interaction of treatment and time, with the LPS treatment group 
having both a lower and steeper decline in PO activity over time than the 
controls. 
Sum of 
Source d.f. F-value P 
squares 
Thorax width 1 0.273 8.371 0.003990 
Treatment 3 0.504 5.145 0.001652 
Time (linear) 1 0.291 8.925 0.002961 
Time (quadratic) 1 0.330 10.121 0.001563 
Residuals 470 15.332 
Table 5.7. ProPO results for Hive B (results are log10 transformed). There was 
a significant effect of treatment and time on ProPO activity. The LPS treatment 
group produced lower ProPO activity levels than the controls. 
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Figure 5.14. PO concentrations for bees with deformed wings and mites 
(Deformed wings), normal wings and mites (Normal + mites), and normal wings 
with no mites (Normal- mites). There was no significant difference between the 
PO values for bees withlwithout mites and with/without visible deformities. Data 
are log1 0 transformed. 
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Figure 5.15. ProPO concentrations for bees with deformed wings and mites 
(Deformed wings), normal wings and mites (Normal + mites), and normal wings 
with no mites (Normal- mites). There was no significant difference between the 
ProPO values for bees with/without mites and with/without visible deformities. 
Data are log10 transformed. 
165 
5.4 Discussion 
The results suggest that, when infested with Varroa mites, bees alter 
investment in their immune response at a colony level. This change in immune 
investment varied between colonies, but was generally seen as an up-
regulation in PO and ProPO concentrations. 
5.4.1 Seasonal immune response 
PO and ProPO investment was up-regulated in response to increased mite 
populations (Figures 5.5 & 5.6). The immediate threat to a bee of infection by 
Varroa is cuticle wounding and subsequent bacterial infection. Recent work has 
shown that following an infection in the mealworm beetle, Tenebrio molitor, 99% 
of bacteria are cleared from the haemolymph within 1 hour, and that this 
clearance is due to constitutive immune responses rather than induced 
antimicrobial peptides (Haine et al., 2008). With limited resources available, 
bees may preferentially invest in the immediate action of PO and ProPO rather 
than longer lasting immune responses. Bees in both hives initially exhibited a 
high immune response at the start of the season. This investment decreased 
over time as the threat of parasites remained absent, and maintaining a costly 
immune response proved unnecessary. 
Up-regulation of the immune response in the infested colony was 
initiated approximately one month after the peak in the mite population: new 
cohorts of bees produced elevated immune responses despite not physically 
encountering a mite themselves (to my knowledge). Cues for this response may 
come from pheromones or a change in the composition of food that is fed to 
larvae, or may be due to trans-generational immune priming (Moret & Schmid-
Hempel,2001). 
The up-regulation of the immune response in the high level infested hive 
undoubtedly increases stress on the bees. In this experiment, both hives 
survived to the next season. The low level infested hive was effectively mite-
free, and although the high level infested hive had a surge in the mite 
population in September, the numbers were not maintained into the winter, and 
levels did not breach the threshold for colony survival (Martin, 2001a). More 
severe levels of infestation may impact on up-regulation; if the majority of bees 
are infested, mounting an immune response to both the direct effect of V8rro8, 
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and any transmitted diseases may prove impossible if they are already 
compromised through a reduction in haemolymph from Varroa feeding. 
Although the results found from this seasonal work show quantitative and 
qualitative differences in the hive responses, this variation may be due to 
natural colony variation, or other factors associated with temporal change rather 
than a direct impact of Varroa infestation. Experiments from Chapters 2,3 and 4 
also showed quantitative differences in colony responses. Whilst the results 
obtained are suggestive, as only two hives were surveyed in this experiment, 
further replication at the colony level is needed to draw any firm conclusions. 
The weather has a major effect on Varroa populations. As predicted, the 
prolonged heavy rainfall experienced at the start of the summer led to reduced 
foraging and delayed brood build up in the hives (Riessberger & Crailsheim, 
1997). As mites are dependent on brood cells for their reproduction, this 
resulted in vastly reduced populations. 
5.4.2 Effect of acaricide treatment 
The ability of Apistan to eradicate Varroa proved successful. It is difficult to 
ascertain how this loss of Varroa may have affected the immune response of 
the bees. Results from this experiment showed variation between the colonies, 
but showed a general trend for the up-regulation in PO and ProPO in response 
to increasing mite numbers. The different responses of PO and ProPO within 
each hive may be a result of differing sensitivity towards the effects of Apistan. 
However, again, only two colonies were surveyed in this experiment, with no 
control (no Apistan added). Therefore, as with the previous experiment, the 
variation in immune responses seen may be due to natural colony variation over 
time. Additionally, Apistan may directly impact on the immune response itself. 
Although Apistan is reported to have no detrimental effects on colonies 
(Delaplane, 1995), there has been little investigation into its impact on the 
individual immune response, despite the fact that pyrethroids have been shown 
to cause sub-lethal effects on the physiology of the honey bee (Desneux at al., 
2007). Alterations in physiology and resource partitioning due to the effect of the 
pesticide may therefore explain the immune responses seen in this experiment. 
The methods for measuring mite populations differed between the two 
experiments, as they were run over different years, and techniques were 
improved. Mite numbers in the previous experiment (low and high levels of 
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infection) were measured as drop numbers, from which an estimate of total 
population can be obtained. Mite numbers in Hives A and B were taken as the 
proportion of emerging bees infested with one or more mites. As such, it is 
difficult to know how the numbers in the two experiments correspond to each 
other. However, I believe that mite infestations in all the hives for the two 
experiments were much lower than expected due to the bad weather and late 
summer, with mite numbers unable to sufficiently increase population numbers 
before brood production decreased (Martin, 2001 a). 
5.4.3 Effect of deformed wings 
Within the Varroa-infested colony there was no difference in PO and ProPO 
responses between normal infested and non-infested bees, and those 
exhibiting typical wing deformities similar to those caused by DWV. Mite-free 
bees from infested colonies have been shown to have a higher expression of 
genes encoding PO than deformed bees (Yang & Cox-Foster, 2005), but these 
results have not been compared to uninfested colonies. If, as shown by the 
experiments in this chapter, the response of colonies to ValTOa infestation is 
highly variable, both these results may hold true, and pinpointing a specific 
consistant immune response may prove difficult. 
5.4.4 Summary 
This chapter examined the effect of mite population dynamics on the 
phenoloxidase (PO) and prophenoloxidase (ProPO) responses in worker bees. 
Using the assays developed in Chapter 2, I have shown that: 
1 a. The PO immune response responded to the presence of Varroa mites 
with an increase in titre (Section 5.3.1) 
1 b. The ProPO immune response also showed an increase in titre with 
increasing Varroa numbers (Section 5.3.1) 
2. Eliminating Varroa using an acaricide produced variation in both the 
a) PO and b) ProPO immune response (Section 5.3.2) 
3. There was no difference in the a) PO and b) ProPO immune 
responses in an infested colony exhibiting different levels of ValTOa 
infection and wing deformities (Section 5.3.3). 
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Extreme weather conditions experienced over the experimental seasons lead to 
favourable conditions in terms of parasite prevalence for the bees, but in turn, 
the inability to forage and expand the colony may have exerted pressures on 
the resources of the bees. As bees from mite-infested colonies have been 
shown to have a reduced immune response compared to mite-free bees, there 
is potentially some immune cost to infestation (Yang & Cox-Foster 2005). 
Whether this cost is in response to Varroa wounding, bacterial challenge or viral 
transmission remains to be seen. 
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Chapter 6 
General Discussion 
6.1 Synopsis of the thesis 
This thesis has examined the ecological immunity of the honey bee in a life-
history context. It has used immunological techniques to explore aspects of the 
constitutive and induced innate immune response in a model organism, and 
shown how these responses are affected by life-history and parasite infection. 
This chapter summarises the main findings of this thesis, expands on issues 
arising from this work, and highlights areas for potential future work. 
6.2 Summary of the chapters 
Chapter 1 introduced the innate immune system in insects, detailed the 
immune responses investigated in this work, and discussed the associated 
underlying mechanisms. Investment in immunity focussing on changes 
throughout development and aging was discussed, with particular reference to 
the social insects and their ecological constraints. Finally, the honey bee, Apis 
mel/ifers, was introduced as a model organism. 
Chapter 2 described three immune assays encompassing both 
constitutive (PO, ProPO) and induced (AMPs) immune responses. The 
development and optimisation of these assays, including repeatabilities, was 
covered, and the importance of re-working assays for species-specificity was 
discussed. Protocols of the standardised assays developed for the three 
immune measures were recorded. All three assays were subsequently used in 
Chapters 3 and 4, and the PO and ProPO assays were used to assess 
response to parasite infestation in Chapter 5. 
The change in immunity during development in honey bees has 
provoked little academic interest to date, despite bees being prone to 
pathogens during these stages. Chapter 3 charted the course of the PO and 
ProPO immune responses throughout all developmental stages, and discovered 
a stage-specific increase in ProPO production between the red-eyed pupa and 
eclosed adult stages. The behavioural and physiological changes that 
accompany the switch from hive to forager in worker bees have been 
extensively studied (Neukirch, 1982; Robinson, 1987; Winston, 1987; Robinson, 
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1992; Hooper, 1997; Omholt & Amdam, 2004; Amdam et al., 2005}. This 
chapter found that, despite previous evidence to the contrary (Bendick et a/., 
2001; Amdam et al., 2005), PO, ProPO and AMP immune responses all 
increase with age, although AMP production shows signs of senescence 
following an immune challenge. 
Chapter 4 covered the same experiments, this time looking at drones. 
Due to their low numbers and lack of foraging activity within a colony, drones 
are largely overlooked, but they are potentially subject to the same range of 
pathogens as workers (Hooper, 1997; Boomsma et al., 2005; Cremer et al., 
2007), and in some cases, are favoured over workers for pathogen infection 
(Otten and Fuchs, 1988; Fuchs, 1992). ProPO was found to increase 
sequentially with developmental age, with PO activity following a similar pattern, 
but dropping during the red-eyed pupal stage, possibly due to its use in cuticle 
melanisation or sperm production. As with workers, PO activity was found to 
increase with age in adult drones, whilst ProPO levels remained constant 
throughout. AMP production was elicited only following an immune challenge, 
and, as with workers, the response showed signs of senescence in old drones. 
The Vam>a mite, Vam>a destructor, is one of the major pathogens of 
honey bees and may be an important component of colony collapse (Shimanuki 
et al., 1994; De Jong & De Jong, 1983; Akratanakul & Burgett, 1975; Hung et 
al., 1995; Martin et al., 1998; Sammataro et al., 2000; Kralj et al., 2007). 
Chapter 6 investigated the impact of Varroa infestation on the immune 
responses within and between colonies. Levels of immune response decreased 
when the threat of parasite infestation was low, and increased following a peak 
in the mite populations. Rainfall was found to playa vital role in levels of colony 
infestation, and the impact of pesticide use on immunity was investigated. 
Physical deformities (most likely caused by Deformed Wing Virus) were found 
to have a negligible effect on the immune response in a Varroa-infested colony. 
The implications of mite infestation on bee immunity were discussed, with 
particular focus on external environmental constraints. 
Appendix 1 expanded on Chapter 2, providing further information on the 
complexities of enzyme kinetics. The effects of freeze-thawing and lipid 
presence on PO and ProPO assays were investigated, with both found to have 
a negative effect. Finally, Appendix 2 catalogued all results figures from this 
thesis, presenting the data from all four immune challenge treatment groups. 
171 
6.3 Discussions arising from the thesis 
6.3.1 The importance of age 
Although components of the immune response in the honey bee have been 
shown to vary with age, to date no work has comprehensively covered all 
developmental stages in such detail across two of the three castes (Amdam et 
al., 2004; Amdam et al., 2005; Schmid et al., 2008; Wilson-Rich et al., 2008). 
This work has shown that differences within what may be considered a single 
developmental stage, e.g. Ipupae', when split into white- and red-eyed groups in 
fact have fundamental differences in investment of immune effecter systems 
such as phenoloxidase. Indeed, a similar result has recently been shown within 
a single larval stage of the tobacco hornworm Manduca sexta (Eleftherianos et 
al., 2008). However, this thesis provides evidence that during some 
developmental stages (larval and early pupal stages), PO and ProPO are most 
likely not employed directly as immune defence in either workers or drones. The 
stage-specific changes in activity levels are likely to be linked to either 
physiological process associated with development, such as cuticle 
melanisation, or in the case of drones, sperm development. The ProPO gene is 
expressed more strongly in older pupae and adults compared to larval and 
young pupae, suggesting that it is produced when required for cuticle 
melanisation (Lourenc;o et al., 2005). In a similar pattern, the honey bee 
antimicrobial peptide hymenoptaecin has been found to be expressed in lower 
amounts in larvae compared to adult bees (Chan et al., 2006). The reason for 
this apparent lack of an immune response in developing bees is unknown. 
Larval and pupal stages face parasite pressures, all be it different ones to those 
encountered as adults. Developing bees may not possess the resources to form 
an immune response, or their constant monitoring by nurse bees, and the 
hygienic behaviours associated with this may remove the necessity for 
immunity. 
The immune response is, however, very much required in adult life, with 
PO, ProPO and AMPs all employed. Both workers and drones showed variation 
in immunity with age. PO responses were similar in both castes, but ProPO 
levels in drones were lower than workers and remained unaltered with age or 
immune challenge. Adult workers have been shown to have higher levels of 
expression of the gene encoding ProPO than drones, and it may be that drones 
maintain a maximum level of available ProPO throughout their adult life 
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(Louren<;o et al., 2005). 
In adult workers, contrary to expectations, all three immune responses 
increased with age. In the case of PO and ProPO this has been shown to be a 
gradual increase, unrelated to task or pathogen encounters outside of the hive. 
In both workers and drones, AMP production increased following an immune 
challenge, and the maintenance of these elevated levels showed signs of 
senescence. This suggests that components of the induced immune response 
are more costly to maintain, and more susceptible to aging than constitutive 
immune responses. It is likely that the up-regulation in AMP production occurs 
only following a specific immune challenge; foragers may exhibit higher levels 
due to cumulative pathogen encounters, but not because of physiological 
processes directly associated with age polyethism. The increased levels of 
immunity seen in older bees highlights their importance to the colony: whether 
for their own survival and subsequent success as foragers or mates, or to 
prevent contamination of the hive on their return, it undoubtedly works for the 
greater good and survival of the colony as a whole. 
6.3.2 Why do drones need immunity? 
The presence of an immune response in adult drones was in some ways 
unexpected. PO only responded to an immune challenge in young drones, but 
its increase with age may represent an immune response that can be 
maintained throughout all challenges. However, the production of AMPs 
following a challenge with LPS shows that they have the resources available for 
specific immunity when needed. The question is why? The drones sampled at 
two weeks old were at the peak of sexual maturity, with maximum sperm 
viability and everything to play for (Page & Peng, 2001), yet showed a 
significant drop in AMP response compared to young drones. This disparity 
between the immune responses of the two age groups may well be due to 
resource allocation. The availability of high levels of AMP production in sexually 
immature drones will enable them to survive long enough to have a shot at 
reproduction, which is their sole purpose in life. Once sexually mature, the 
window of opportunity for mating is only approximately 9 days long (based on 
average life-expectancy (Hooper, 1997); there is no (negative) trade-off 
between energy expended for flight and lifespan (Rueppell et al., 2004». During 
this time they may choose to invest all their energy into mating flights and 
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chasing queens, and consequently this may lead to a reduction in investment in 
resource sinks, such as immunity. 
6.3.3 Temporal changes in immunity 
Chapter 5 highlights the temporal changes that can occur in colony immunity. 
Although the immune responses of honey bee colonies can be altered through 
artificial manipulation of the colony structure (Amdam et al., 2005), seasonal 
variation in immunity within a single developmental stage of bees unparasitised 
by Varroa, as recorded in Section 5.3.1, has, I believe, not been recorded 
before. The adaptive value of this phenotypic plasticity, with colony immunity 
responding as one organism is unknown. The costs of maintaining an immune 
response have been widely reported (Schmid-Hempel, 2005; Siva-Jothy et al., 
2005) and the ability to be flexible with regard to immune investment must 
therefore be a benefit. 
6.3.4 Parasites and immunity 
This thesis has identified an up-regulation of immune investment in Varroa-
infested hives, observed in uninfested individuals following a surge in the mite 
population. This response has prophylactic ramifications: previous experience 
with a pathogen can provide individuals, or in this case, the newly emerging 
brood, with an enhanced immunity (little & Kraaijeveld, 2004; Sadd & Schmid-
Hempel, 2007). Along with the additional cost of maintaining an elevated 
response, this represents important issues in the study of host-parasite 
evolution. Honey bee colonies represent a high density environment with ideal 
conditions for parasite spread. Consequently, bees have developed several 
behavioural mechanisms to deal with infection in the hive (Sammataro et al., 
2000; Spivak & Boecking, 2001). If these behavioural measures are not 
successful, how is the need for an increased immune response detected, and 
what pressures does the additional cost exert on the colony as a whole? 
Pheromones may well playa part: they allow nurse bees to detect and remove 
diseased larvae from the colony, and such messages are able to spread 
throughout the colony to elicit change in the colony response as a whole 
(Winston, 1987; Bailey & Ball, 1991). The fact that all bees sampled during this 
experiment were 24 hours old, and had no visible sign of parasitism or disease 
means that the level of immune investment must have been set either through 
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an alteration of egg physiology or brood food composition or altered nursing 
behaviour that resulted in an increased immune response. 
6.3.5 Single colonies as a measure of general bee response 
Colonies used in Chapters 2, 3 and 4 were Varroa-free in the build-up to, and 
during experimental periods. Results from all experiments in these chapters 
found that colonies showed qualitatively (though not quantitatively) identical 
responses within each experiment. However, the colonies used in Chapter 5 
showed both quantitative and qualitative variation in their immune responses. 
With Varroa infestations sweeping through UK hives, the presence of Varroa-
free colonies is a rarity, and only achievable in this thesis due to a combination 
of extreme weather conditions and strategic pesticide application. 
Although the variation seen in Chapter 5 may be due to natural variation 
at the colony level over time, further investigation may show it to be a colony 
response to Varroa infestation. If this is the case, experimental designs which 
have previously sampled only one colony as representative of the honey bee 
population as a whole should perhaps be carefully reconsidered. 
6.3.6 Is PO a good measure of the immune response? 
PO undoubtedly plays many crucial roles in the organisation and efficacy of the 
innate immune system of insects, and it has long been used to measure an 
individual's immune defence ability (Brookman at a/., 1989; SOderhall & 
Cerenius, 1998; Wilson at a/., 2001; Sugumaran, 2002). Nevertheless, 
contradictory evidence exists that increasing PO concentrations are indeed 
correlated with an increased resistance to pathogens, and the use of PO assays 
as a good measure of the immune response of an individual is not without 
controversy (Adamo, 2004; MUCklow at a/., 2004). 
Variation in cuticle colour in the mealworm beetle, Tanabrio molitor, due to 
increased melanin production correlates with PO levels, with darker beetles 
having an elevated PO level and an increased resistance to pathogens (Barnes 
& Siva-Jothy, 2000; Armitage & Siva-Jothy, 2005). However, cuticle 
melanisation is a prophylactic response: although the majority of studies have 
shown that it confers an increased resistance to pathogen invasion, it is not a 
measure of the immune capabilities of PO in response to a direct immune 
challenge (Wilson at a/., 2001). 
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Whilst some studies have shown no correlation between PO 
concentration and pathogen susceptibility (Adamo, 2004; Mucklow et al., 2004; 
Leclerc et al., 2006; Schwarzenbach & Ward, 2007), others provide compelling 
evidence to suggest otherwise. 
Active PO levels double in bumble bees (Bombus terrestris) infected with 
the trypanosome gut parasite Crithidia bombi, compared to non-infected 
individuals (Brown et al., 2003). Although the trypanosomes are non-invasive, 
this suggests that a messenger system exists between the gut and the ProPO-
AS, with PO being up-regulated in preparation for an immune response to 
invading pathogens (Wilson et al., 2001; Brown et al., 2003). In Drosophila, 
mutant strains devoid of blood phenoloxidase activity showed a decreased 
resistance to infection with fungal spores (Braun at al., 1998). Haemolymph 
concentrations of ProPO and PO of tsetse fly species (Glossina palpa/is 
palpa/is) bred for refractoriness to Trypanosoma brucei rhodesiens were higher 
than in species susceptible to infection (Nigam et al., 1997). Further evidence 
comes from Photorhabdus luminescens, a virulent bacterial pathogen of the 
tobacco hornworm, Manduca sexta, which secretes a compound to inhibit host 
PO production. Mutant bacteria that lack this compound are non-virulent, 
suggesting that PO is needed for host defence (Eleftherianos et al., 2008). 
6.3.7 Applied relevance of findings 
During the period of this research, honey bees have been thrust into the global 
limelight, as Colony Collapse Disorder (CCO) arrived and continues to cause 
widespread devastation to bee populations in America and potentially, the UK 
(Cox-Foster at al., 2007). Given their contribution to the British economy as crop 
pollinators (Carreck & Williams, 1998), it has never been more relevant to study 
the honey bee. Whilst ongoing research is attempting to identify the factors 
causing CCD, the work of this thesis to establish a grounding in honey bee 
immunity provides the opportunity of an additional perspective from which to 
address the issues associated with CCD and other bee diseases. 
6.4 Future Research 
6.4.1 Queen immunity 
This thesis has not covered the immune responses of honey bee queens, 
although the selective pressures exerted on them as the sole producer of 
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offspring for the colony, and the consequences that this has on immune 
investment, make them an obvious choice for study. However, several problems 
arise when attempting this. Large numbers of queens can be obtained through 
artificial grafting of eggs. Several attempts were made during this thesis to graft 
queens. Whilst some were successful, they did not yield a workable sample size 
due to additional complications of incubator malfunctions and cell destruction by 
other queens (Winston, 1987). Once emerged, adult queens may be introduced 
into queenless colonies, where they can live for 3-4 years (Hooper, 1997), or 
can be kept in queen cages with a couple of worker attendants and successfully 
maintained in an incubator for at least a month (S. Martin, pers. comm.). 
However, to gain a perspective of their ecological immunity, experimental 
queens should be returned to a colony so they can start reproduction. Queens 
do not show a trade-off with reproduction and longevity, and this is thought to 
be due to the yolk precursor vitellogenin (Corona et al., 2007). In workers, a 
decrease in vitellogenin concentration with age is associated with haemocyte 
pycnosis (Amdam et al., 2004). In queens however, vitellogenin titres increase 
with age, and is associated with increasing longevity and resistance to oxidative 
stress (Corona et al., 2007). This suggests that high haemocyte numbers 
should be maintained throughout their life, and may lead in an increased ability 
for immune investment. 
6.4.2 The honey bee-Varroa mite system 
The groundwork covered in this thesis has built up a comprehensive picture of 
honey bee immunity and investment in workers and drones throughout the 
whole life-cycle. It was initiated with the aim of looking to honey bees, Varroa 
mites and a virus (Deformed Wing Virus, DWV) they vector as an ideal model 
system with which to empirically study parasite competition and the evolution of 
virulence. Chapter 5 has started this work, exploring the effects of Varroa on the 
immune response. Other work on this system has so far focussed on the 
identification and quantification of viral strains within bees and mites (e.g. Chen 
et al., 2005a; Chen et al., 2006; Cox-Foster et al., 2007), presence of multiple 
infections in hosts (e.g. Tentcheva et al., 2004; Chen et al., 2004b; Chen et al., 
2005b; Chen et al., 2005c; Shen et al., 2005a, Shen et al., 2005b) and modes 
of transmission (Bowen-Walker et al., 1999; Nordstrom, 2003; Chen et al., 
2004b), but due to the relatively recent introduction of Varroa and DWV to 
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European bees, this work is still in its infancy. 
Of particular interest to me are the host responses to multiple virus 
infections, with a view to developing further assays and techniques to 
investigate the mechanism of viral infection. Within-host selection on the virus, 
incorporating transmission dynamics and virulence levels in the host and vector 
are also prime targets for investigation. OWV has been found in all 
developmental stages of all host castes, and its presence in queen ovaries and 
spermathecae suggest mechanisms for vertical as well as horizontal transfer 
(Chen et a/., 2004a; Chen et a/., 2005a; Chen et a/., 2005b; Chen et a/., 2006). 
OWV has been shown to replicate within the mite vector (Bowen-Walker 
et a/., 1999; Ongus et a/., 2004) which gives rise to the possibility that Varroa 
could vector the virus to a wider host range than previously imagined (Genersch 
et a/., 2006). Its recent detection in bumble bees (Bomb us terrestris and 
Bombus pascuorum) turns this possibility into a reality and provides a platform 
to study the evolution of host shift in a virus (Genersch et a/., 2006). 
Multiple viral infections within a single individual have been well 
documented (Anderson & Gibbs, 1988; Martin et a/., 1998; Brodsgaard et a/., 
2000; Benjeddou et a/., 2001; Evans, 2001; Tentcheva et a/., 2004; Chen et al., 
2004b; Chen et a/., 2005b; Chen et a/., 2005c; Shen et al., 2005a, Shen et a/., 
2005b), and development of multiplex RT-PCR allows these infections to be 
detected in a single test, but it is not known whether these co-infecting viruses 
are in direct competition (Chen et a/., 2004b). Increased replication in response 
to competition may effect transmission, and stimulate the replication of 
inapparent infections. 
6.4.3 Understanding the immune system 
One of the main findings of this thesis is that despite evidence showing that 
foraging workers have reduced numbers of functioning haemocytes (Flachuk, 
1998; Amdam et a/., 2004; Amdam et a/., 2005), the cellular PO and ProPO 
immune responses are increased in foragers compared to hive bees. This 
suggests that we cannot simply infer what appears to be logical, and that this 
'simple' immune system is in fact much more complex. The pycnotic effect on 
bee haemocytes is caused by apoptosis, and so irreversible (Amdam et a/., 
2005). However, honey bees are highly plastic in their division of labour, and 
reversal of foragers into nurse bees is possible (Robinson, 1992; Amdam et 81., 
178 
2005). This switch is associated with an increase in numbers of haemocytes, 
meaning old bees have the ability to rapidly recruit new haemocytes (Amdam et 
al., 2005). Investigation into correlations of the level of functional haemocytes in 
normal and reversed foragers and their cellular immune responses could 
provide an explanation for this disparity. 
6.5 Final conclusions 
When developing a novel system for immunity studies, it is vital to understand 
the basal immunity profile of the chosen animal for all the life-stages you wish to 
investigate. The findings of this thesis support this notion, with unexpected 
conclusions discovered within developmental, senescent, caste and colony 
level divisions. This knowledge, when placed in an ecological immunity context, 
opens new avenues with which to explore host-pathogen effects. In light of the 
current global crisis, this may be fundamentally important for the honey bee. 
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Appendix 1 
Methods 
A1.1 Enzyme kinetics 
The Michaelis-Menten equation is used to describe the kinetic behaviour of 
many enzymes. It assumes a hyperbolic relationship between the velocity of an 
enzyme reaction and the substrate concentration described by the equation: 
v= Vmax [s1 
Km + [s] 
v = velocity of the enzyme reaction 
Vmax = reaction velocity when all substrates are at saturating concentration 
[s] = substrate concentration 
Km = Michaelis constant; equal to the substrate concentration at which the 
reaction rate is half the maximum velocity (VmaX/2) of the enzyme 
(Henderson, 1992) 
If the reaction is not substrate limited then it should proceed at Vmax. However, 
this rarely happens due to limiting factors such as solubility restrictions (Tipton, 
1992). As the value of Km is specific to the enzyme and substrate used, it must 
be found in order to calculate the concentration of enzyme needed to prevent 
substrate limitation. As Km is equal to the substrate concentration at which the 
reaction proceeds at half its maximum velocity, doubling Km should give the 
substrate concentration needed to achieve maximum velocity (Henderson, 
1992). 
Figure A 1.1 shows a basic reaction curve of absorbance against time. 
The absorbency (measured photometrically) is proportional to the concentration 
of the product (dopachrome). By measuring the change in absorbency over time 
during the linear rate phase of the curve, the Vmax of the reaction can be found. 
The concentration of enzyme (PO) present in the sample is proportional to the 
Vmax (Tipton, 1992). 
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Time 
~--~I~I __ ~I~I ____ ~ 
1 2 3 
Figure A1.1. Typical enzyme-catalysed reaction curve showing an increase in 
product concentration over time. This curve is identical to that seen in the 
conversion of L-dopa to dopachrome by the action of the enzyme 
phenoloxidase. 
1 - Initial Lag Phase 
2 - Rate phase 
3 - End Lag Phase 
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A1.2 
A1.2.1 
The Effect of Repeated Defrosting on Haemolymph Samples 
Introduction 
All samples collected for this PhD were assayed for two different PO values: the 
'active' PO, and 'total immune potential' after the activation of ProPO. Previous 
studies have defrosted and refrozen the same sample on numerous occasions 
to take different measures. Doubt arose during preliminary experiments as to 
the value of defrosting the same sample when it was seen that PO levels 
increased with each defrosting event (pers. obs.). To determine whether this 
increase was due to extra activation of ProPO during periods out of the freezer, 
or additional cell breakdown caused by repeated freeze-thawing I the following 
experiment was carried out. 
A1.2.2 Materials and methods 
Worker bees were collected from a single colony in November 2005. Bees were 
split into two treatment groups: 
Group A: Haemolymph collected with a standard perfusion bleed (n=18), and 
frozen at -90°C for 24 hours. The sample was defrosted and assayed for PO 
and ProPO as standard (Sections 2.3.11 & 2.4.13). The sample was then spun 
and the supernatent removed and frozen separately. The supernatant was 
subsequently defrosted and assayed for PO and ProPO twice more. 
Group B: Haemolymph collected as standard and frozen at -90°C. Each 
sample was then defrosted and refrozen three times, with PO and ProPO 
assays taken after each defrosting (n=41). An initial PO and ProPO assay was 
run before the first freezing (n=21). 
A1.2.3 Results 
Group A: There was no significant effect of defrosting and re-freezing the 
samples once the supernatant had been separated from the pellet. This result 
was seen for both PO (Figure A1.2, F1.55 = 2.758, p=0.1024, data log10 
transformed) and ProPO (Figure A1.3, F1.55 = 1.373, p=0.2464, data log10 
transformed). 
Group B: There was a Significant increase in both PO (Figure A1.4, F1.139 = 
30.307, p<0.0001, data log10 transformed) and ProPO (Figure A1.5, F1•139 = 
12.381, p<0.001, data log10 transformed) concentrations with each defrosting 
event. 
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A 1.2.4 Discussion 
We conclude that the observed increase in PO and ProPO concentrations with 
assays taken from the same samples, repeatedly defrosted, is due to additional 
cellular breakdown during the freezing process. All subsequent samples taken 
in this thesis are frozen in aliquots to avoid this error. 
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A1.3 
A1.3.1 
The Effect of Lipid on PO and ProPO Assays 
Introduction 
As seen in Chapter 3, Section 3.3.2, a high percentage of the samples assayed 
from earlier developmental stages returned a concentration of PO (and in some 
cases, ProPO), which was so low as to be unrecordable by this assay. A 
standard enzyme curve, as seen in the majority of PO and ProPO assays is 
shown in Figure A 1.6. Many of the larval and pupal samples produced negative 
curves (Figure A1.7). This suggests that the sample is becoming a lighter colour 
over time. I highlighted three possible explanations for these results: 
1. PO is being produced at such a rate that it is being rapidly degraded to 
prevent its cytotoxiC effects, or it is aggregating into larger protein 
aggregates 
2. Although samples were centrifuged twice to remove fat, there was still 
some fat present in the sample, which gave it a slightly cloudy colour. 
Lipases may be working to break down the fat, so making the solLltion 
clearer over time 
3. Something is working to break down the L-dopa which is produced from 
the reaction with PO 
A1.3.2 Materials and Methods 
To test these hypotheses, 8 uncapped, unchallenged larval aliquots were 
defrosted from samples that had showed a negative enzyme curve in the 
developmental immunity experiment (Chapter 3, Section 3.3.2). Samples were 
defrosted on ice, and spun to remove the fat. Each sample was split into 4 
different treatment groups: 
1. Samples run as standard PO assay (Chapter 2, Section 2.3.11) 
2. Samples run with the dH20 replaced by dH20 into which a protease 
inhibitor was added (1 x COMPLETE Mini EDTA tablet dissolved in 7ml 
dH20) 
3. Samples run substituting L-dopa for 20J,J1 dH20 
4. Samples run substituting L-dopa for L-dopa which had been allowed to 
develop into dopachrome over 48 hours, so was already a dark colour 
Controls for all four treatments were run, along with a positive control (adult 
haemolymph). 
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A1.3.3 Results 
Treatment groups 2 to 4 showed no difference in the slope of the curves to that 
produced in the control (Treatment 1), i.e. in the case of Treatment 3, the same 
curve was produced without L-dopa being present. Treatment 4 produced the 
same curve, but shifted up the y-axis due to the darker colour of the sample. 
A 1.3.4 Discussion 
The production of a negative curve is due to the activity of lipase breaking down 
fats that are present in the samples collected from larvae and pupae. It can be 
seen from the y-axis of these curves that the change in optical density of the 
solutions is very small compared to that of the standard PO curve. It is therefore 
taken that all samples that returned a negative PO or ProPO curve contained no 
recordable levels of PO. 
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Appendix 2 
Figures 
This appendix chapter provides full figures for all 4 treatment groups used 
throughout this thesis. Figures are divided up into the relevant Chapters, and 
are ordered as they appear in each Chapter. 
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A2.1 Chapter 3: Ontogeny of worker immunity: Figures 
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Figure A2.1.1. Hive A: PO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for all 4 treatment groups (1 = No 
challenge, 2 = Needle (wounding control), 3 = 1 IJI Ringer (vehicle control), 4 = 
1 IJI LPS (immune challenge». 
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Figure A2.1.3. Hive A: PO concentrations for samples that returned a 
recordable value, for all 5 developmental stages (1 = uncapped larvae, 2 = 
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Figure A2.1.S. Hive A: ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
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Figure A2.1.6. Hive B: ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
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Figure A2.1.8. Hive A: ProPO concentrations for the two age groups, new and 
old, for all 4 treatment groups (1 = No challenge, 2 = Needle (wounding control), 
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196 
-....----------r-- -.-~--,--.-
... ~ ..... - .. 
... ... ... ... 
Figure A2.1.9. Hive B: PO concentrations for the two age groups, new and old, 
for all 4 treatment groups (1 = No challenge, 2 = Needle (wounding control), 3 = 
1~1 Ringer (vehicle control), 4 = 1~1 LPS (immune challenge)). 
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Figure A2.1.10. Hive B: ProPO concentrations for the two age groups, new and 
old, for all 4 treatment groups (1 = No challenge, 2 = Needle (wounding control), 
3 = 1 ~I Ringer (vehicle control), 4 = 1 ~I LPS (immune challenge)). 
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worker life, for all 4 treatment groups (1 = No challenge, 2 = Needle (wounding 
control), 3 = 11J1 Ringer (vehicle control), 4 = 11J1 LPS (immune challenge». 
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A2.2 Chapter 4: Ontogeny of drone immunity: Figures 
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Figure A2.2.1. Hive 0: Drone PO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for all 4 treatment groups (1 = No 
challenge, 2 = Needle (wounding control). 3 = 1 iJl Ringer (vehicle control). 4 = 
1 iJl LPS (immune challenge)). 
201 
1 2 
T 
o 
• 
o 
0 ~ - 0 ~ 0 
D. D. D. 
~ - Q ~ N 
• 0 
0 
T 
o I I 
I I ~- I 0 I .... 
I I 
I 0 jlG. 0 I • JJI · IlJ~ 
Q - 0 
I I 
1 234 5 1 2 3 4 5 
Developmental stage Developmental stage 
o 
.., 
~ 
0 
N 
0 
.... 
0 
T 
I 
I 
I j 
1 2 
3 
0 
T 
I 
T 
I 
I D. 
345 
Developmental stage 
4 
0 ~ 
D. 0 
T 
~ - I I 0 
o I 
I 0 
I 
I 
;~T ~ - I I 
..Dlrk 
o -
TT I I 
1 2 3 4 5 
Developmental stage 
Figure A2.2.2. Hive E: Drone PO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
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challenge, 2 = Needle (wounding control), 3 = 1 ~I Ringer (vehicle control), 4 = 
1 ~I LPS (immune challenge)). 
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Figure A2.2.3. Hive 0: Drone PO concentrations for samples that returned a 
recordable value, for all 5 developmental stages (1 = uncapped larvae, 2 = 
capped larvae, 3 = white..eyed pupae, 4 = red-eyed pupae, 5 = adults), for all 4 
treatment groups (1 = No challenge, 2 = Needle (wounding control), 3 = 11J1 
Ringer (vehicle control), 4 = 11J1 LPS (immune challenge». 
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Figure A2.2.4. Hive E: Drone PO concentrations for samples that returned a 
recordable value, for all 5 developmental stages (1 = uncapped larvae, 2 = 
capped larvae, 3 = white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for all 4 
treatment groups (1 = No challenge, 2 = Needle (wounding control), 3 = 1 ~I 
Ringer (vehicle control), 4 = 1 ~I LPS (immune challenge». 
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Figure A2.2.5. Hive 0: Drone ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
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challenge, 2 = Needle (wounding control), 3 = 11J1 Ringer (vehicle control), 4 = 
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Figure A2.2.6. Hive E: Drone ProPO concentrations for all samples for all 5 
developmental stages (1 = uncapped larvae, 2 = capped larvae, 3 = white-eyed 
pupae, 4 = red-eyed pupae, 5 = adults), for all 4 treatment groups (1 = No 
challenge, 2 = Needle (wounding control), 3 = 1 ~I Ringer (vehicle control), 4 = 
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Figure A2.2.7. Hive 0: Drone ProPO concentrations for samples that returned a 
recordable value, for all 5 developmental stages (1 = uncapped larvae, 2 = 
capped larvae, 3 = white-eyed pupae, 4 = red-eyed pupae, 5 = adults), for all 4 
treatment groups (1 = No challenge, 2 = Needle (wounding control), 3 = 11J1 
Ringer (vehicle control), 4 = 11J1 LPS (immune challenge». 
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Figure A2.2.8. Hive E: Drone ProPO concentrations for samples that returned a 
recordable value, for all 5 developmental stages (1 = uncapped larvae, 2 = 
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treatment groups (1 = No challenge, 2 = Needle (wounding control), 3 = 11-11 
Ringer (vehicle control), 4 = 11-11 LPS (immune challenge)). 
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Figure A2.2.9. PO response of the two age groups, new and old drones, for all 
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Figure A2.3.1. PO response of bees in low level infected hive for all 4 treatment 
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